SOUTH-SOUTH TRADE PROMOTION PROGRAMME
BANGLADESH
SUPPLY AND DEMAND SURVEY ON
PHARMACEUTICALS AND NATURAL PRODUCTS
December 2007
The Dhaka Chamber of Commerce and
Industry (DCCI)
65-66, Motijheel C/A , Dhaka-1000, Bangladesh
Tel: 88-02-9552562 (Hunting)
Fax: 88-02-9560830
E-mail: dcci@bangla.net
Website: www.dhakachamber.com
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
The designations employed and the presentation of the material in this document do not imply the
expression of any opinion whatsoever on the part of the International Trade Centre (ITC)
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries.
While every effort has been made to verify the information contained in this document, ITC
cannot accept any responsibility for any errors that it may contain.
This report has not been formally edited by the International Trade Centre (ITC).
- ii -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Table of content
I.
SUPPLY AND DEMAND SURVEY OF BANGLADESH PHARMACEUTICAL
INDUSTRY
1
A. BACKGROUND .....................................................................................................1
B. SUPPLY SITUATION OF BANGLADESH PHARMACEUTICAL INDUSTRY .........................1
C. INTRODUCTION ....................................................................................................1
II. SUMMARY OF RECOMMENDATIONS AND CONCLUSIONS
4
A. RECOMMENDATIONS ............................................................................................4
B. B. CONCLUSIONS ................................................................................................6
III. MAIN REPORT
A.
B.
C.
D.
E.
F.
G.
H.
I.
J.
K.
L.
M.
N.
O.
P.
Q.
R.
7
HIGHLIGHTS OF THE PHARMACEUTICAL INDUSTRY OF BANGLADESH .......................7
PROFILE OF THE PHARMACEUTICAL INDUSTRY .......................................................7
STRUCTURE OF THE INDUSTRY .............................................................................9
CAPACITY AND PRODUCTION ............................................................................. 14
RAW MATERIALS ............................................................................................... 15
OTHER PRODUCTION INPUTS ............................................................................. 16
QUALITY STANDARDS ........................................................................................ 17
RESEARCH AND DEVELOPMENT ......................................................................... 18
DOMESTIC DEMAND .......................................................................................... 18
EXPORTS 20
EXPORT POLICIES AND INCENTIVES .................................................................... 23
EXPORT CHANNELS ........................................................................................... 24
SHIPPING 25
PACKAGING ...................................................................................................... 25
EXPORT CREDIT AND FINANCE ........................................................................... 25
TRADE PROMOTION ........................................................................................... 25
STRENGTHS, WEAKNESSES, OPPORTUNITIES AND THREATS ................................ 26
CONCLUSIONS AND RECOMMENDATIONS ............................................................ 28
IV. DEMAND SITUATION OF BANGLADESH PHARMACEUTICALS INDUSTRY
A.
B.
C.
D.
E.
F.
37
OBJECTIVES OF THE DEMAND SURVEY ............................................................... 37
STRUCTURE OF THE DEMAND SURVEY REPORT................................................... 37
SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS ....................................... 40
MAIN REPORT ................................................................................................... 40
IMPORT POLICY AND PROCEDURES .................................................................... 49
IMPORT PRACTICES ........................................................................................... 55
- iii -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
G. MARKET COMPETITIONS AND PRICES ................................................................. 56
H. MARKET PROSPECTS AND MARKET ENTRY STRATEGY ......................................... 58
IV. USEFUL OFFICE ADDRESSES
62
List of tables
Table 1: Category of pharmaceuticals and natural industry ..............................................................11
Table 2: Category of pharmaceutical companies...............................................................................13
Table 3: Price fixation policy .................................................................................................................15
Table 4: Share of export and domestic demand of pharmaceuticals (Value in million US$)............19
Table 5: Export Statistics for Pharmaceutical Industries (in Calendar Year) – In million US$).......29
Table 6: Trade Opinion on Production Prioritisation.........................................................................35
Table 7: Yearly local production of finished drugs and raw materials (in million US$) ..................42
Table 8: Yearly imports of pharmaceutical products (in million US $) ............................................45
Table 9: Projected annual imports of pharmaceutical products (Value in US$) ...............................47
Table 10: Local consumption of pharmaceuticals (Calender Year) ..................................................47
Table 11: Medicinal plants utilized by compnay size and sector ......................................................60
List of graphics
Chart 1: Export Share of Pharmaceuticals in 2006-07.......................................................................10
Chart 2: Structure of pharmaceutical industry ...................................................................................12
Chart 3: Increasing share of export compared to domestic demand ..................................................19
Chart 4: Growth in export of pharmaceuticals...................................................................................20
Chart 5: Share of pharmaceuticals import (US$ million) ..................................................................40
Chart 6: Local production of finished drug and raw materials (In million US$)...............................43
Chart 7: Import of pharmaceutical products ......................................................................................46
Chart 8: Projected import of pharmaceuticals....................................................................................47
Chart 9: Local consumption of pharmaceuticals................................................................................48
Chart 10: Projection of future consumption.......................................................................................49
- iv -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
List of annexes
Annex I – List of officials interviewed for the survey.......................................................................64
Annex II - Excerpts of Export and Import Policy 2006-09................................................................65
Annex III - List of some important ISO certified Companies ...........................................................67
Annex IV - Country profile of Bangladesh-A brief...........................................................................68
Annex V - Abstract of National Drug Policy (Revised) 2005 ...........................................................69
Annex VI - Essential and supplementary drug list for essential and specialized drugs.....................75
Annex VII - List of imported pharmaceutical products (human and veterinary) ..............................80
Annex VIII - List of the top 40 pharmaceutical companies in Bangladesh.....................................123
Annex IX - Company-wise Export Information of 2006.................................................................128
Annex X - The drugs (control) ordinance, 1982..............................................................................144
Annex XI - Incentives and facilities for the foreign investors.........................................................150
Annex XII - Composition of Board of Directors of EDCL .............................................................153
Annex XIII - Bangladesh Healthcare And Pharmaceutical Sector:.................................................154
-v-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
NOTES
The following abbreviations are used:
API
Active Pharmaceutical Ingredients
AIT
Advance Income Tax
BAPI
Bangladesh Pharmaceutical Industry
BIAA
Bangladesh Importers’ Agents Association
BMRE
Balancing, Modernization, Replacement and Expansion
BMDC
Bangladesh Medical and Dental Council
CIF
Cost, Insurance, Freight
DDA
Directorate of Drug Administration
DGDA
Directorate General of Drug Administration
EDCL
Essential Drugs Company Limited
GLP
Good Laboratory Practice
GMP
Good Manufacturing practice
IMS
Indian Medical Service
MNCs
Multi National Companies
MRP
Maximum Retail Price
NGO
Non Governmental Organization
ITC
International Trade Centre
TRIPS
Trade Related Intellectual Property Support
USFDA
United States Food and Drug Administration
WHO
World Health Organization
WTO
World Trade Organization
INN
International Non-Preparatory Drugs
ETP
Effluent Treatment Plant
BP
British Pharmacopoeia
USP
United States Pharmacopoeia
IP
International Pharmacopoeia
- vi -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
I.
SUPPLY AND DEMAND SURVEY OF BANGLADESH
PHARMACEUTICAL INDUSTRY
A. Background
The International Trade centre (ITC) is organizing “AsiaHealthCare2008”, a regional event on
pharmaceuticals and natural products in Malaysia during March 2008. This event aims at improving
availability of and access to essential medicines in South and South-East Asia by increasing
regional trade, investment, cooperation and exchange of experience. Participants will include
enterprises, business associations and service providers from Bangladesh, Cambodia, China, India,
Indonesia, Lao PDR, Malaysia, Myanmar, Nepal, Pakistan, Singapore, Sri Lanka, Thailand, the
Philippines and Vietnam.
B. Supply situation of Bangladesh pharmaceutical industry
1.
Objective
Main objective of the supply survey is to provide detailed information on the Bangladeshi
pharmaceutical companies, their product profiles including technical specifications, prices and
packaging, country’s export capacity and information on business and regulatory environment in
order to facilitate the potential buyers and importers of pharmaceutical products to expand their
trade opportunities.
The supply survey aims to cover the following:
(b) Describing the characteristics and structure of the industry;
(c) Identifying impediments affecting the exports;
(d) Indicating possibilities for augmenting supplies and new investment opportunities;
(e) Determining technical assistance requirements, in the areas of product development, packaging,
market promotion, joint export marketing, export financing, costing and pricing, training in
export marketing, etc.
C. Introduction
1.
Executive summary
The International Trade Centre (ITC), since several years has been organizing "AsiaHealthCare" – a
buyers/sellers meeting and a regional event. AsiaHealthCare 2008 is going to be held in Malaysia.
The aims of the event is to improve the availability and access to essential medicines in South and
South East Asian Countries and by this way increase regional trade, investment, cooperation &
exchange of information and over and above to increase business in the pharmaceuticals and natural
products sector.
-1-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
AsiaHealthCare 2005 was held in Singapore from 23-25 November 2005, like in the previous year
the event of 2008 in Malaysia will be attended by a large number of business enterprises involved in
manufacturing, research, trading, services, distribute international organization and NGOs involved
in the pharmaceuticals and natural products sector.
The number of participating countries is 15; they are Bangladesh, Cambodia, China, India,
Indonesia, Lao PDR, Malaysia, Myanmar, Nepal, Pakistan, Singapore, Sri Lanka, Thailand, the
Philippines and Vietnam. Participating countries will prepare individual country report to be
discussed and distributed in the meeting in Malaysia.
The product sectors include active ingredients and starting materials, formulations, finished
products etc.
The report covers both supply and demand aspects of pharmaceuticals and natural products in
Bangladesh. The first part of the report describes the supply side and the second part demand side –
covering all relative aspects. The report also includes a set of recommendations based on the
findings and comments from the cross section of people including stakeholders, policy makers,
pharmaceutical and herbal medicine, manufacturers, representatives of the chambers and
associations, etc.
Based on the TOR, the study compiles the comprehensive scenario of the pharmaceutical sector of
Bangladesh. The report explains both demand and supply aspects of the sector highlighting the
major issues which are important for facilitating discussion on the bilateral trade-related matters in
the forthcoming Buyers/Sellers Meeting (BSM) to be attended by representative from 15 countries
in Malaysia.
All pharmaceutical products and natural products are covered under the study. A list of imported
goods with HS Code and Tariff structure has been included as Annex VII of the report.
The product contributes significantly to the national economy as about 85% of the domestic
consumption of medicine is mitigated from the locally manufactured medicine. The sector also
contributes significantly to the foreign trade sector. Import of the sector is about US$ 143.62
million while export is about US$ 28.16 million in the year 2006-07.
Sector specific objective of the survey is to analyse the present situation, problems with regard to
policy issues and suggest on how to move forward so that contribution of the sector to the economy
can be increased.
2.
Methodology applied for the study
Methodology applied to carry out the study include desk studies, desk research and review of
important and related statistics, interview with key entrepreneurs and senior officials1of different
companies, government officials involved in the industry, policy makers and trade representatives
and other stakeholders.
1
Enclosed as Annex I: List of the Officials interviewed
-2-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Secondary data has been collected from different sources like government gazette notification,
newspapers articles and journals, expert publications, annual reports of the sector association and
leading companies, documents of Directorate of Drug Administration (DDA), Export Promotion
Bureau (EPB), Bangladesh Bank, National Board of Revenue, Bureau of Statistics, relevant Import
and Export Policies2 of the government, Chambers and Associates etc. Discussions and meetings
held with relevant and concerned persons that include bankers, researchers, quality experts, sector
specialists, individual entrepreneurs, CEOs, Secretaries of concerned associations etc. Necessary
analysis has been made using both primary and secondary sources, literatures, books and brochures
collected during the study.
2
Enclosed as Annex II: Relevant excerptes of Export and Import Policy 2006-09
-3-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
II. SUMMARY OF RECOMMENDATIONS AND CONCLUSIONS
A. Recommendations
The following issues have been suggested by the major stakeholders and concerned parties during
the cross section discussions and subsequent analysis on the findings of the study:
1. Support from the International Support Organizations /Agencies
International agencies like ITC, UNIDO, WHO, World Bank etc should extend technical support
through educating the local industry representatives on TRIPS and its potential benefits.
International agencies may also extend technical assistance to Bangladesh pharmaceutical industry
sector for setting up world class “Drug Testing Laboratory” for testing of medicines. Multilateral
financing agencies should provide soft funds to set-up plants for producing active pharmaceutical
ingredients. External financial support may be explored for combined water treatment plant for
‘waste management’ of the proposed API manufacturing plants.
2. Support from the Local Authority /Organizations
Relevant agencies like Board of Investment, Export Processing Zones Authority, local and
multilateral Development Finance Institutions and others should be instructed and assisted by the
Ministry of Health and Family Affairs, Government of Bangladesh (GoB) to undertake immediate
measures in this regard.
Simultaneously, the Ministry of Commerce and Export Promotion Bureau should jointly undertake
an “in depth study” on the problems and prospects of TRIPS for the local pharmaceutical industry
without any further delay to come up with a set of solid and realistic strategic recommendations for
long term sustainability through local and external experts.
The government should also consider giving ‘export incentive’ to the local pharmaceuticals
exporters to be competitive, as the competing countries have already taken such provisions (India
offers cash incentives at 20% and 30% on raw materials and finished products and China also offers
huge incentives to its exporters). Cash incentive should be offered to the exporters of
pharmaceuticals products. Exporters should also be awarded nationally.
Incinerator & Effluent Treatment Plant (IETP) for facilitating waste management and environment
protection through Central Environmental Treatment Plant (CETP), Dumping and Incinerating for
at least 50 plants is required with API industrial Park.
3. Positive and enabling business environment
Information on importing countries like import procedures, freight components, banking facilities
and addresses of chambers and business associations shall be made available.
Combined efforts should be given by the Ministry of Health and Family Planning, the Ministry of
Commerce, local chambers and trade associations for effective coordination for export expansion in
the overseas.
-4-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
4. Pharmaceutical has been declared as the product of the year
The target of export for the year 2008-09 will be doubled to US$ 64 million; all necessary
preparation should be taken to fulfil the target.
5. Recommendations of BAPI for implementing government
pharmaceutical products as export product of the year
announcement
of
The ceiling for allocation of foreign exchange should be increased at least up to $ 0.1 million
dollars from the present level of $ 60 thousand for establishing office of the company at abroad
such as: Singapore, Russia, Europe, Latin America etc. The issue was discussed in a recent meeting
and finally agreed that it could be 25% of the total sales of the respective country.
Sample export amount should also be increased from existing about $ 1,500.
In case of sending samples of the medicine practitioners it could be at least 10% of each
consignment.
In case of sending publicity materials, printed materials there should not be any ceilings. In case of
sending samples, “Samples by post” to be written on the packet should be withdrawn.
Single country fair to be organized in Kenya, Senegal, South Africa, Ghana, Chilli, Dubai, Brazil,
Mexico.
6. Recommendations for Medicine market made of Natural Products
•
The total value of the herbal medicinal market, at trade prices, is expected to increase from
about $ 53.62 million in 2003 to $ 84.78 million in 2008. It is apparent that certain products
could exhibit long-term opportunities once Bangladesh recognizes Pharmacopoeia other than its
own. All necessary efforts should be taken to meet the target of the sector.
•
Some of our population love to use and depend on natural products. There is huge potential of
diversification in Bangladesh although scientific cultivation creating information based for
commercialization of medicinal plant production is required.
•
Primary and secondary processing are carried out by different groups of persons now. There is
a need for close linkage between beparies3 and processors to facilitate better supply of quality
raw materials required by the processors.
•
Aloe Vera drinks is a product recognized in a number of different markets, including United
States of America, Japan and Europe. In Bangladesh the ‘sharbet’ also includes ulat kambol and
shotomuli, both for the flavour and pharmacological properties. There is a good probability that
Aloe Vera ‘sharbet’ can be developed into a properly processed and packed drink.
•
A Medicinal Plant Forum can be established with an appropriate secretariat involving active
participants with an outer network of interested parties.
3
Local name of Retailer
-5-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
B. B. Conclusions
Bangladesh is one of the poorest countries in the world where about 80%4 of the population are
living below poverty level. So, ‘Malnutrition and Poor Health Conditions’ exits. On the contrary,
the country is also developing day by day, per capita income is growing and the purchasing power
of the common people is increasing slowly but steadily. In 2007, the per capita income is US$ 482,
which was US$ 470 in 2005, GDP growth was 6.5%. The target of GDP growth in 2007-08 is 7%.
Since the population growth is still there and gradual increase in health consciousness among mass
people. All these factors have positive impact on the demand of the pharmaceutical products. As a
result, the demand for imported raw materials will also be increased.
The pharmaceuticals sector is the second largest sector after agriculture that contributes to the
revenue generation of the Bangladesh Government. The sector has growth potentials both in local
and export market. There is an increasing trend in the export of pharmaceuticals that indicates very
good future prospects for the country.
In the local market, there is an increasing demand for medicines for anti-cancer, anti-hypertension,
anti-diabetics, AIDS, cardiovascular, different vaccines etc. So far, the local pharmaceutical
companies are not producing medicines for serious diseases like cancer, HIV/AIDS, diabetics etc.
Recently, there are few initiatives and projects to produce high value drugs of the above categories.
For example Beximco, Square, Incepta, Popular have started Bio-Technology units to work with
Vaccines and Insulines. But it will take some time to make these products available in the local
market. Local market demand is increasing gradually, it is apparent that both import and domestic
production is increasing.
Traditionally, there is a common belief that herbal medicines do not have any side effect. A large
majority of people living in rural Bangladesh are still traditional in their attitude. This segment of
people demand natural products for all kinds of diseases. So, there is large potential market for
herbal products in Bangladesh.
The demand of pharmaceutical raw materials has increased in the recent years and will increase
further in the coming years since the production volume of the local companies is increasing day by
day due to increased local consumption and export.
As of now, the local companies are exporting to 68 countries worth US$ 28.16 million (in the year
2006-07) million, which was only US$ 21.26 million in 2005-06, export increased at 32%. The
target for 2007-08 is $32 million.
4
In terms of calorie intake per day.
-6-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
III. MAIN REPORT
A. Highlights of the pharmaceutical industry of Bangladesh
•
Bangladesh Pharmaceutical Industries (BAPI) has received the major success in the area of
manufacturing world-class drugs and medicines.
•
Pharmaceutical sector is the one of the fastest growing sectors of Bangladesh, of which the
average growth rate is around 12%.
•
This is the largest white-collar labour-intensive employment sector of the country and the
second highest contributor to the National Ex-Chequer.
•
After meeting about 97% of the total country demand of drugs & medicines, the pharmaceutical
companies are now exporting wide range of medicines to about 68 countries of the world.
•
The new “Drug Policy – 2005” has spelled out the guidelines for manufacturing pharmaceutical
raw materials.
•
In the current “Export Policy 2006-2009 Bangladesh Government has included the
pharmaceutical sector in the highest priority sector.
•
The Government has already announced its desire for the establishment of API Park soon for
manufacturing pharmaceutical raw materials.
•
Bangladesh Association of Pharmaceutical Industries (BAPI) has been regularly organizing
Asia Pharma Expo, leading pharmaceutical industries of Bangladesh as well as pharmaceutical
companies abroad especially the South Asia region took part in these events. These exhibitions
display pharma processing equipment's plants and machinery, packaging, machinery and
material, R&D biotechnology, contact manufacturing, laboratory and analytical equipment, etc.
The Asia Pharma Expo – 2007 was jointly organized with GPE Expo Pvt. Ltd. UK, attracted
over 8500 Trade Professionals, 400 Exhibitory Companies from more than 25 countries from
India, China, Korea, Indonesia, Vietnam, Japan, Singapore, Taiwan, Germany, Switzerland,
Spain, Italy, France, USA, Pakistan etc.
B. Profile of the pharmaceutical industry
•
The finished drugs & medicines are being produced in accordance with WHO, cGMP criteria.
•
There are 239 registered pharmaceutical manufacturers in Bangladesh.
•
There are 8,000 Brand Formulations and 10,194 dosage forms and strengths registered with
DGDA.
•
This sector is mainly dominated by local companies.
•
The pharmaceuticals companies’ employees are the mostly educated & skilled manpower like
Pharmacists, Chemists, Doctors, Engineers, Bio-Chemists, Microbiologists, MBAs, etc.
•
In 2006 the total size of pharmaceutical market was about US$ 700 million.
-7-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
A significant number of pharmaceutical companies in Bangladesh received internationally
acclaimed "ISO – 9001, ISO – 9002, WHO & UNICEF, cGMP Certification in recognition of
their quality. The number of ISO 9001:2000 certified companies are close to hundred. A list of
some ISO 9001:2000 certified pharmaceutical companies is enclosed5.
•
Investment in last few years: More than US$ 300 million.
•
Full-fledged Drug Policy has been announced after 35 years of independence.
•
MoU signed with BSCIC for setting up API Park to reduce import of raw materials .The country
now desperately needs foreign investment to implement the project.
•
Single Country Fair in Nepal & Bhutan, Myanmar, Sri Lanka, Saudi Arab are being held
•
About 10 pharmaceutical companies are participating in International Tender of UNICEF.
•
Pharmaceutical sector is almost self-sufficient:
There are about 600 generics / substances registered in Bangladesh6. Out of these 600 generics,
117 are in the controlled category. The remaining 483 generics are in the decontrolled category.
The total number of brands / items that are registered in Bangladesh is currently estimated to be
8,000 while the total number of dosage forms and strengths are 10,914.
The finished formulation-manufacturing base of Bangladesh is very strong. Almost all of the
pharmaceutical companies have their own manufacturing facilities. Unlike most of the importbased countries of South Asia and Africa, 97% of the total demand of Bangladesh is being met
by local manufacturing. The remaining 3% basically constitutes import of very specialized
products like Vaccines, Anticancer products etc. Recently some of the companies in Bangladesh
have taken initiative to manufacture anticancer drugs, Hormones, Anti-retroviral (ARV),
Vaccines, etc. Bangladesh is expected to become self-sufficient in all therapeutic classes very
soon.
Bangladesh has become self-sufficient in some Active Pharmaceutical Ingredients (API's). It
also developed some new and exciting API's which have huge local and international demand.
hAmpicillin
hAmoxicillin
hCloxacillin
hFlucloxacillin
hCephalexin
hDiclofenac
hParacetamol
hCelecoxib
hCiprofloxacin
hGatifloxacin
hRanitidine
hAmlodipine
hFluconazol
hCetirizin etc.
•
The revised National Drug Policy 20057 allowed toll or contract manufacturing arrangements
under licensing system, it opened up huge opportunities for foreign companies and investors in
Bangladesh.
•
The local pharmaceutical industry sector of Bangladesh has become more competitive with a
number of new entrants with formulation plants.
5
List of ISO Certified Companies is enclosed as Annex III
A small country profile is enclosedd as Annex IV
7
The National Drug Policy 2005 is enclosed as Annex V
6
-8-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Several local pharmaceutical companies finalized their plans for producing API for their own
consumption as well as for others.
•
300 acres of land has already been sanctioned for API Park in Munshiganj District: The target of
implementing the Park is by 2009, it is estimated that this API Park will mitigate the demand of
20-70% of the raw material.
•
The government of Bangladesh has seriously planned for setting up of a “common waste
disposal and management facility” for at least 20 production units for Active Pharmaceutical
Ingredients (API) within shortest possible time.
•
Bangladeshi companies are preparing themselves to derive potential benefits of TRIPS.
•
One Indian company has already set-up joint venture in Bangladesh as the government
introduced attractive policy support for foreign investors. Kunming Pharmaceuticals
Corporation of China is going to set up five production plants for raw materials in Bangladesh.
•
Sector stakeholders strongly felt to set-up world-class drug testing and quality laboratory
including Bio-Equivalence facility due to lack of which export sector suffers for further growth.
•
Export subsidy issue needs to be considered by the government to make local exporters
competitive in the world market and to boost exports.
•
The government and major players realized that the sector needs to be developed in terms of
technology up grading, quality improvement and new investment for API for export capacity
expansion and reduction of dependency on imported raw materials.
•
Natural products are getting increasingly demanded and used by the consumers.
•
Health consciousness is increasing among the middle and lower middle class of population
every day that indicates increased demand in the local market.
C. Structure of the industry
The supply survey covered those products which are produced by the local companies including
those are exported. Formulations produced in the local companies include tablet, capsules, syrup,
inhaler, ointment, spray, cream, suppositories, Opthal preparations, ENT preparations, lotions,
injectables, mouthwash, parental (both large & small volume), basic chemicals etc. As of now, 150
drugs have been selected as “Essential” for therapeutic purpose and 100 drugs have been selected as
specialized drugs in the supplementary list8. Majority of the local pharmaceutical companies in
Bangladesh are manufacturing “Formulations”. As of now, 154 local companies are registered with
the trade body of pharmaceutical sector. 21 local companies are producing more than 40 different
types of Active Pharmaceutical Ingredients (API) and supplying these to other local companies for
producing various types of Formulations. The total estimated market for the pharmaceutical
products is US$ 700 million approximately, of which major portion captured by the local
companies including 5 multinational companies. Bangladeshi companies are supplying about 98%9
of the total market and the rest 2% is met by the multinationals. The market share of multinational
companies has drastically fallen down to 2% in 2006 from 35% in the year 1999.
8
9
For Essential and Supplementary Drugs (Specialised) List see Annex-6
Source : BAPI
-9-
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
1. Significance of the product to the economy and foreign trade sector
Pharmaceutical is the second largest sector contributing to the national revenue after agriculture.
Over last twelve years, the sector experienced healthy growth in the local market as well as in the
export market. During the year 2006-2007, the total export of pharmaceutical products was US$
28.1 million in 2006-2007. In 2004-2005, the total export of pharmaceutical products was more
than US$ 21.96 million against US$ 3.0 million in 1999. Although the present volume of export is
not significant compared to the national export, but there appears a great potential of export growth
after 2005. Share of country’s pharmaceuticals export is shown in the pie chart that indicates a
bigger space in the national export compared to last year and this will grow further provided
government and concerned authority continues right steps.
Chart 1: Export Share of Pharmaceuticals in 2006-07
Export Share of Pharmaceuticals
in 2006-07
28.16
12177.861
Pharmaceutical Export (28.16 Million US$)
Total National Export(12177.861MillionUS$)
The pharmaceutical sector continues to create increased number of employment in the country. As
of now, the number of employment created by pharmaceutical sector exceeds about 100,000,
against 78,000 during last year, majority of them are highly technical as mentioned by human
resources experts. As of 2007, the estimated annual turnover of this sector is more than Tk.60,000
million that equivalent to US$ 700 million approximately. Pharmaceuticals made significant
contribution to the foreign trade of the country, to both imports and exports. The country has been
generating reasonable amount of foreign currency from export of pharmaceutical, which is
increasing every year, last year’s growth was 32%(in 2006). Since 85% of the required raw
materials are imported from abroad, the country also spends huge amount of foreign currency for
import.
Considering the high import requirements, total value addition is minimal, target for export is more
for the coming years.
- 10 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2. Structure of Bangladesh pharmaceuticals industry
Bangladesh Pharmaceutical industry has:
•
World Class Manufacturing Technology;
•
State-of-the-art Quality Control Equipments;
•
WHO Approved Highest cGMP Standards;
•
Compliance to the British Pharmacopoeia (BP), United States Pharmacopoeia (USP),
international Pharmacopoeia (IP), European Pharmacopoeia (EP) and other Official Compendia;
•
Highly Stable & Attractive packaging;
•
Bangladesh Manufacturers finest Quality Formulations & active Pharmaceutical Ingredients
(APIs).
The pharmaceutical industry of Bangladesh was protected and controlled by the National Drug
Policy enforced in 1982. But, in early 2005 the Government of Bangladesh brought major changes
in the National Drug Policy through amendment to cope with world competitiveness. Price of 150
categories of essential drugs has been fixed by the Drug Administration Authority, but this number
has been recommended to reduce up to 50 in near future. Total market size was US$ 314 million in
1999, which has increased at US$ 700 million and the annual growth rate, is around 8.5%, as
against 14% growth in the Asian region, according to IMS report. The total number of licensed
companies is 239, out of which 161 are functional and regular in reporting. Present market size of
pharmaceuticals has increased a lot and it is increasing gradually.
The entire pharmaceutical and natural products industry may be grouped under five categories as
shown below:
Table 1: Category of pharmaceuticals and natural industry
Sl. No
Type of Entity
1.
Allopathic
2.
Herbal/ Unani
3.
Ayurvedia
4.
Homeopathic and Bio-clinical
Total
Number
23910
263
167
77
738
Although, 239 companies have valid license from the government, but 20-25 local companies
dominate 86% of the total market. MNCs account for roughly 5% of the total market. The
Directorate of Drug Administration (DDA) office regulates and controls all kinds of commercial
activities of the above organizations who are registered. Allopathic sub-sector has experienced
growth since majority of the population in Bangladesh takes allopathic medicines. Herbal sector
was growing but recently they have slowed down. Ayurvedia sector is facing relatively slow
growth. However, growth in veterinary sector is increasing due to the increased demand of growing
number of poultry, dairy and fish farming businesses in the country. The pie chart below
graphically presents the structure of the pharmaceutical industry:
10
As per Statistics given by Directorate of Drug Administration.
- 11 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Chart 2: Structure of pharmaceutical industry
Structure of Pharmaceutical Industry According to Market Share(Value in
million US$)
18
32 8.5
Ayurvedic
Unani
Homeopathy
Allopathic
714
In Bangladesh, more than 18 local pharmaceutical companies are listed in the stock exchange,
which is more than 7% of the total paid-up capital of all sectors companies listed. The companies in
the Stock Exchange are: Ambee Pharmaceuticals, Beximco Pharma, GlaxoSmithKline Bangladesh
Limited, ACI Limited, Renata Limited, Reckit Benkiser, Pharmaco Therapeutics, Pharma Aids, The
Ibn-Sina, Rahman Chemicals, Wata Chemicals, Libra Infusions, Orion Infusions, Square
Pharmaceuticals, etc. The companies also contributed around US$ 1,600 million to the total market
capitalization.
In 2005, per capita expenditure on medicine in Bangladesh is estimated at US$ 4.50; which is still
much lower than global average rate. Growth in per capita income has direct positive impact on this
sector. Also, the increased rate of literacy is another factor that contributes to the growth of the
sector.
Export of pharmaceutical products has experienced remarkable growth towards steep growth in near
future. The existing volume of export will be expanded to great extent since the government and
private sectors are very aggressive in taking joint initiatives. According to the Export Promotion
Bureau, Bangladesh exported pharmaceutical products to more than 68 countries worth US$ 28.16
million in the financial year 2006-2007 and US$ 21.25 million during the financial year 2005-2006
Per capita expenditure of medicine has also increased.
Export of pharmaceutical products grew more than 60% during the last year because of quality
product, standard packaging and competitive price. During the year 2003-2004, the highest amount
of export was made to Brazil, second highest was Belgium and third highest was Sri Lanka.
- 12 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Bangladesh exports pharmaceutical products to countries namely Pakistan, Nepal, Mynmar, Brazil,
India, Bhutan, Sir Lanka, Malaysia, Indonesia, Thailand, Vietnam, Singapore, Hong Kong,
Philippines, Japan, Jordan, Taiwan, Saudi Arabia, Iran, Yemen, Kuwait, Cyprus, Hungary,
Yugoslavia, Greece, Djibouti, Spain, Britain, France, Germany, Austria, Norway, Denmark,
Sweden, Netherlands, Colombia, PNG, Dominican Republic, Oman, Egypt, UAE, Ethiopia,
Finland, Cambodia, Zimbabwe, Guinea, Afghanistan, Mauritius, Libya, Liberia, Niger, Sierra
Leone, Slovenia, Namibia, Syria, Mozambique, Uzbekistan, Senegal, Portugal, Poland, Kiribati,
South Africa, Ukraine, Sudan, Ghana, Kenya, Russia, United States of America, Australia, and
Venezuela, Brazil, Kosovo, Ecuador, Georgia.
3.
Manufacturing characteristics
Manufacturing process and technology applied by the local pharmaceutical industries is almost
same, except a few shortcomings with some companies. No product is produced if it is not within
the “block list” of DDA. However, this list has been prepared following the WHO model list. As of
now, there are 450 items in the list having all kinds of dosage forms like tablet, dry syrup, liquid,
capsules, Injectables, inhalers, ENT Preparations, spray, Ointment, Basic chemicals, etc. Most
regular companies manufacturing pharmaceutical products strictly adhere to “Good Manufacturing
Practice (GMP)” standard. Both raw materials (API) and finished products are produced in
Bangladesh. Total number of Brands that are registered in Bangladesh is currently estimated to be
8,000 and there are 10914 strengths in the local market. Among the registered companies, there 161
companies including five MNCs are in regular operation and they produce products as
recommended by the National Drug Control Committee and DDA. The multinational companies are
namely, Aventis, Glaxo Smith Kline, Organon, Novartis and Roche. Out of 35-40 companies, 20
companies including MNCs are having tough competition in the local market. Sun Pharmaceutical
and Healthcare are the new joint venture companies having production plants in Bangladesh
recently.
Table 2: Category of pharmaceutical companies
Category Company Type
I
World Class large scale
No. of companies
(assumed)
9
II
Multinationals
5
III
Joint Venture companies
2
IV
Large Scale P/C
25
V
Medium Scale P/C
34
V
VI
Small Scale PC
Licensed oriented PC
Total
43
121
239
Quality Control Practice
Global standard in quality control
practice
Global standard in quality control
practice
Global standard in quality control
practice
High standard in quality control
practice
Satisfactory standard in quality
control practice
Sub-standard quality control practice
Incomplete Production Plant
(Above classification is done based on their production facilities, technology applied, quality
control equipment and practice, brand image, continuity of production, market presence, manpower
strength etc)
- 13 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
D. Capacity and production
1. Production capacity of pharmaceutical industries
The pharmaceutical sector is producing drugs worth more than US$ 600 million11 with 8.5% growth
rate. Domestic industries are producing about 96% including MNCs. In 2007, the total production
of the sector was US$ 646.55, which is less than 50% of the total production capacity, as assumed
by the DDA official. Production capacity of this sector is under utilized. There are companies who
obtained license but did not produce at desired level due to many reasons. On the other hand, 10-12
local pharmaceutical companies are undertaking BMRE program. 4-5 companies undertook projects
to set-up new manufacturing plants for bulk drug production. Total production capacity can be
profitably utilized provided the government and private sector jointly initiate appropriate actions
through exploring the export market more aggressively. In fact, a few leading companies are after
utilizing their full capacity undertook project expansion of their production capacity. There are
companies who have record of over utilization of their production capacity since they have good
market in terms of quality, price, prompt delivery and efficient sales forces and well-organized
distribution network. Companies like Square, Beximco, ACME, Opsonin, Aristopharma, Jayson,
Renata, ACI, Incepta etc have utilized their full capacity and as such, they have undertaken BMRE
plans.
Many companies suffer for under utilization of their capacity due to reasons like:
•
Weak manufacturing plan, lack of modern facilities,
•
Absence of proper quality control equipment and system,
•
Lack of technical know how,
•
Limited product ranges, unorganized sales, marketing and distribution,
•
Weak promotional plans,
•
Absence of research and development practice,
•
Financial constraints,
•
Disruption of power,
•
Delay in procurement of raw materials,
•
Trade union’s dispute,
•
Political stability etc.
•
High cost of raw materials
•
Policy changes, etc.
Potentials of fuller utilization of capacity are there, but effective steps need be taken to attain it.
These may be done through strengthening:
•
11
The present manufacturing set-up with modern machinery and equipment,
Source : BAPI
- 14 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Creation of adequate quality control system with sizable research and development laboratory,
•
Recruitment of required technical experts,
•
Introducing wide variety of products,
•
Efficient organization of dedicated sales and marketing forces with well-designed distribution
system.
•
Policy reform in favour of utilization of TRIPS waiver etc.
Since there is a growing market, full capacity utilization and setting up of new unit may be
profitable because Bangladesh has been enjoying definites of exemption of Patent Law up to 2016.
E. Raw materials
1. Major raw materials required for production
To produce different kinds of finished products, the local companies need more than 750 different
types of raw materials, 90% of which is imported. 40 different types of raw materials produced
locally at smaller quantity and the rest of Active Ingredients are imported. Main sources of raw
materials include Germany, Switzerland, Belgium, France, Italy, Denmark, Netherlands, UK, USA,
UAE, China, Taiwan, South Korea, Japan, Spain, and India.
Recently, 4-5 API projects are under implementation and once they are in commercial production, a
significant percentage of raw material requirements will be mitigated from local sources.
2. Impact of prices of raw materials
Change in the price of raw materials directly affects the price of finished products. Any price
change must be brought to the knowledge of the DGDA. Price may also change due to currency
devaluation. DGDA follows certain formulae to fix and adjust the prices of finished products as
mentioned below:
Table 3: Price fixation policy
Item
Tablet
Capsules & coated Tablets
Syrups
Vials
Price fixation formulae
Total raw materials cost + packaging cost X 2.25
Total raw materials cost + packaging cost X 2.30
Total raw materials cost + Packaging cost X 2.80
Total raw materials cost + Packaging cost X 3.40
Any product not within the Essential Drug list, the individual manufacturer shall apply to increase
price of such drug (s) as the price of raw materials increases. Price increase will be allowed subject
to the satisfaction of the DGDA.
- 15 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
3. Government incentive for supply of raw materials
Recently, the government introduced flat rate of import duty of 5% on import of raw materials12 .
The pharmaceutical products produced from the imported raw materials for ultimate export enjoy
“duty draw back facilities”. Locally procured raw materials enjoy the “Value-Added Tax”
exemption benefit if the products are exported. So far, there is no special cash incentive for export
production. But, government is being persuaded by the industry representatives to declare cash
incentive. For finished goods, suggested rate of cash incentive is 20% while for raw materials to be
used for export is 30%. In the year 2007-2008 no cash incentives have been announced for the
pharmaceutical sectors, though some of the export products of Bangladesh enjoy a certain
percentage of Cash Incentives to remain in competition in the international markets.
F. Other production inputs
1. Packing and packaging materials
Packing materials used in the local pharmaceutical industries include aluminum foil (blister &
strip), Alu alu foil, rubber stropper, flip-off seal, printing materials, plastic cap, injectible, tear-off
seal, tube, PVC, PVDC, level, bottle (white & color), plastic container, paper cartoon, printing
materials, packets, etc. Almost every packing material is locally available except aluminum foil,
alualu foil, PVC, PVDC, color bottles, etc which are imported from countries like Korea, Dubai,
India, China and so on. It is expected that a number of packaging industries will appear in near
future as backward and forward linkages to support pharmaceutical sector.
2. Manpower in the pharmaceutical sector
In Bangladesh, there exists a pool of qualified professionals and experts engaged in the
pharmaceutical industry sector. 15-16 leading companies including new entrants have their regular
‘product development research’. Every company hires a number of Pharmacists, Zoologists and
Chemists who obtained higher education from the local university followed by advanced degrees
from developed countries. There are about 34,000 pharmacists in the country, about 100,000 people
are involved in manufacturing, over all 350,000 people are involved directly or indirectly in
pharmaceuticals sector of Bangladesh. Technologies adopted in Bangladesh were introduced by the
multinationals which have been steadily replicated by the local professionals. Now, this sector hires
the highest number of professionally brilliant people in the country. Manpower and experts are
available in this sector. Both public and private institutions are in existence to train pharmacy
people. There is one Pharmacy Association. Pharmacist’s Council of Bangladesh13, Doctors’
Association of Bangladesh are working directly or indirectly to improve the sector. The Dhaka
Chamber of Commerce and Industry (DCCI) is the largest Chamber of the country acting as one of
the patronizer of the sector. There is also a strong pool of experts who are good in sales and
marketing in both local and international level. Moreover, the suppliers of pharmaceutical items
regularly provide demonstration on technology and technical know how to the local staff for their
self development.
12
13
See Annex X for list of import items
Pharmacist’s Council of Bangladesh, Kawran Bazar.
- 16 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
3. Availability of required utility services
All required utility facilities and services like water, gas, electricity etc. are available. Except
interruption in power supply, there is no problem in carrying out regular and smooth production of
the pharmaceutical industries. As substitute of power, the government waived import duty from
industrial Generator. Presently power generation capacity has also increased and private sector
power production has been encouraged and 15 years tax exemption from income of power project is
allowed.
G. Quality standards
1. Quality standards, certification and quality manpower
According to the Drug Rules 1946, every manufacturer of pharmaceutical products must have a
standard laboratory with all required quality control facilities. Like others, the local pharmaceutical
companies follow Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) besides Good
Manufacturing Practice (GMP). Presently, the local companies have attained a certain standard
level of quality that allows them to export their products to 68 countries including countries in
America and Europe. All good companies have the basic elements of quality management, as
required by the WHO standard. At least, 50 local pharmaceutical companies have obtained ISO
certificate. A list of leading companies having ISO 9000 and 9001 Certificates is enclosed14. They
have well designed QC department with adequate equipment and staff that includes Quality
Administration Manager, Quality Control Managers, Assistant Managers (Project Development &
Quality Control), etc. Local companies frequently hire experts and consulting services on quality
control management improvement that are representing the western organizations. There is a pool
of qualified personnel in the quality departments of all companies having scope for inter company
professional movement.
The government and other stakeholders are also seriously planning to set-up “world class
independent quality control laboratory” to ensure the production of quality drugs for both local and
export market. Also, proposal has been made to set-up “Bio-equivalence Testing Facility” as soon
as possible. Bangladesh needs huge investment for establishing these facilities.
In Bangladesh, every leading company has its own quality control laboratory. The government
regulatory authority i.e. DGDA has two quality control laboratories; one is located in Dhaka and
another located in Chittagong and these are basically Testing Laboratories. So far, there is no
independent testing laboratory for quality assurance. Most pharmaceutical companies are well
equipped with all modern QC machinery, equipment and apparatus imported from Japan, USA
Germany, Switzerland, UK and other developed countries. Commonly used quality equipment are
given below:
•
•
•
•
•
14
Gas Chromatography
High pressure liquid Chromatography
Infra Red Spectrophotometer
UV visible Spectrophotometer
Memo Titrator
•
•
•
List of leading companies anclosed as Annex VIII
- 17 -
HP Meter
Dissolution Tester
Micro Biology Laboratory that consists of
Incubator, Sterilizer, Autoclave, Colony
Counter, Partical Counter, Glass wears,
Conical Flask, Pipette, Measuring Cleve,
Burette etc.
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
H. Research and development
The leading pharmaceutical companies have been able to bring advanced technology from
developed countries. So far, there are no research findings on the “new molecule” in Bangladesh,
although there is continuous development of Formulations. Recently, some companies have set-up a
plant to produce anti-cancer hormone and specialized products.
Companies have their product development team who continuously undertake ‘Research and
Development’ activities. Common research and development activities are as follows:
•
Bibliographic search aided by resource libraries,
•
Design and selection of process maximizing efficiency,
•
Environmental impact assessment reduction,
•
Accelerated and longer stability testing,
•
Product quality optimization and
•
Translation of new scientific insights into the products.
•
Research on herbal medicine, availability of medicinal plants in the country and
commercialization of medicinal plants by increasing production.
Several companies have been conducting study on vaccine for critical disease like anti-cancer, antidiabetics, etc. in collaboration with foreign experts. Many studies are also being carried out to
produce herbal medicines. Formulations development is going on continuous basis in many
companies irrespective of their size. There is a good progress in raw materials development in
collaboration with the western countries. Test method is developed and validation is done according
to the British Pharmacopoeia and US Pharmacopoeia. Also, stability study and validation of process
is undertaken for new Formulations. Since the get-up of packing materials and packaging is very
important for export marketing, companies’ exports take extra care for modern and standard
packaging system with attractive printing materials and convenient storing and handling options.
I. Domestic demand
1. Shares of domestic and export demand
Estimated domestic pharmaceutical market of Bangladesh is US$ 740 million approximately,
whereas the last year’s export was only US$ 28.16 million. Export target for 2007-2008 of this
sector is US$ 32million. It is expected that local demand will increase by 10-12% yearly in the
coming future. Contract manufacturing will also increase at least up to 100% by 2007. A single
company Beximco Pharmaceuticals said by 2009 their sales will increase up to by Tk. 2,000 crore
(US$ 275.7). Presently, the share of export compared to the domestic market size is very nominal
i.e only 2.87%. Bangladesh exports its pharmaceutical products to 68 countries15 and the volume of
exports has grown at 32% last year. The main business turnover comes from the local market,
which is 97% of the total country’s production. But, the share of pharmaceutical exports in the total
business market is increasing every year. The relative shares of domestic and export demand can be
seen from the data tabled below:
15
Name of the countries have been mentioned in several places of the report
- 18 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Table 4: Share of export and domestic demand of pharmaceuticals (Value in million US$)
Particulars
Export
of
Pharmaceuticals
Estimated Local
demand
of
Pharmaceuticals
Total
2000-01
6.90
2001-02
6.60
2002-03
9.11
2003-04
12.69
2004-05
21.26
2005-06
23.38
2006-07
28.15
2007-08
32
446.43
473.68
517.24
697.00
740.92
760.38
800
830
453.33
480.28
526.35
709.69
762.18
783.38
828.15
862
Chart 3 below shows the export performance for the last couple of years.
Chart 3: Increasing share of export compared to domestic demand
Increasing Share of Export Compared to Domestic Demand (million US$)
2006-07
Estimated Local demand of
Pharmaceuticals
2004-05
Export of Pharmaceuticals
2002-03
2000-01
0
200
400
600
800
1000
It is evident from the figure that the industry is still local market dominated and the gap between
export and local consumption is very wide that indicates lesser impact of export supplies on the
local demand. Again, if effective measures are taken for export market development then the sector
will experience larger turnover that would contribute to the overall economy significantly as
understood from the rapid growth in last year’s export (growth rate was 60%). Export can be
increased a lot.
- 19 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
J. Exports
1. Export of pharmaceuticals
(a)
Trend of export
Export of local pharmaceutical products has experienced significant positive growth16 during the
last decade and an exciting growth during the year 2004-2005. In fact, this has been a great
achievement for the sector as a whole, which has been eventually possible because of the
government liberalization policy including a favourable and conducive National Drug Policy in
1982. First export of pharmaceutical products was made in 1972 and the amount was very
insignificant. Growth in the volume of export of pharmaceuticals was very slow till 1990. After
1990, the volume of export of pharmaceuticals had started growing and over the years, the volume
has increased gradually. Increasing trend in the export of pharmaceuticals has continued till this
year. During the year 2005-2006, Bangladesh exported US$ 28.16 million which was US$ 15.47
million plus than that of 12.69 in 2003-2004.
At present, Bangladeshi pharmaceutical companies export to about 68 countries that include
Bhutan, Myanmar, Cambodia, Hong Kong, India, Indonesia, Japan, Korea, Maldives, Nepal,
Pakistan, Philippines, Singapore, Sri Lanka, Thailand, Vietnam, Brazil, Colombia, Egypt, Ethiopia,
Finland, France, Ghana, Greece, Iran, Jordan, Kenya, Korea Republic, Mexico, Netherlands,
Norway, Papua New Guinea, Saudi Arabia, Sudan, Yemen, Djibouti, Senegal, Germany, USA,
Oman, Russia, Ukraine, Austria, Australia, Belgium, Malawi, Malaysia, Middle East etc. Several
companies have opened their overseas branch to promote export market. Local pharmaceutical
companies17 exporting products are namely, Beximco, Square, Jayson, ACME, Renata,
Gonoshastha, Novartis, Eskayef, Essential Drugs, Global Capsules, Navana, Maxfair, Millat,
Skylab, Aristopharma, UniMed and Unihealth, Modern, Beximco Infusion, Opsonin, Drug
International, Medimet, ACI, General, Nipa and Aventis, etc. Figure below indicates the upward
trend in the export of pharmaceuticals against national export over the last twelve years:
Chart 4: Growth in export of pharmaceuticals
Export
Export of Pharmaceuticals (Million US$)
30
25
20
15
10
5
0
2000-01
2001-02
2002-03
2003-04
Year
16
17
Export figure have been mentioned in several chapters of the report.
For company/wise export item see Annex IX
- 20 -
2004-05
2005-06
2006-07
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
From the above figures it is evident that export of pharmaceuticals has increased gradually during
the last ten years. During the last four years, the sector earned significant growth in export as a
result of extensive export promotion activities undertaken by the beneficiaries of the Export
Diversification Project (Matching Grant Facility Program) of the World Bank which is now phased
out, but some new projects are coming up. Growth in export of pharmaceuticals has also been
achieved in the participating countries those who are going to attend the “AsiaHealthCare2008”.
The export drive of BAPI is also important. Asia Health Pharma Expo has also contributed to create
awareness about Bangladesh’s competition in pharmaceutical sector.
AsiaHealthCare 2005 gathered 106 companies of 15 South & South-east Asian Countries as well as
Brazil. Companies established partnership arrangements including production, distribution, out
sourcing and technology transfer, transactions over US$ 1 million were reported from
AsiaHealthCare 2005. It is expected that the upcoming event will create a new opportunity to
increase the transaction figure.
(b)
Export impediments
Although the government has formulated favourable policies, the exporters of pharmaceuticals still
face the following constraints and impediments:
•
Absence of “Bio-equivalence test” facility in the country
•
Registration procedures in the importing countries is still difficult
•
Delay in issuing “Free Sale Certificate” by the National Regulatory Authority
•
Customs hassle for shipment of Samples and foreign currency allowed for sample export is not
sufficient
•
Inadequate/Limited fund allocated for overseas sales and market promotion
•
Lack of information on registration & other regulatory formalities in importing countries.
•
Stringent conditional ties of WHO for export
•
Inadequate fund for R& D.
•
Under Capacity utilization
•
No cash incentives
•
Increase of prices of raw materials. (The price of amoxicilin was tk 2200 before 3 months has
increased to tk 4000 now)
•
For Block List approval, some validity is required, but because of less frequency of the Board
Meeting, it takes too much time for getting approval.
•
Limit of foreign currency allowed for establishing offices abroad is much less than the required
level.
Apart from the above, the following are the factors adversely affecting the export marketing:
•
Absence of Export Incentive
•
Absence of Data Base on Importers and Exporters.
•
Difficulties in finding reliable Distributors/ Agents in importing countries
- 21 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Mitigation of costs for office set up at abroad.
2. Existing export development plans
Some 30 local pharmaceutical companies are regularly exporting from Bangladesh and all of them
have annual export development plans. New companies are planning to enter into export market and
developing their export plans. Individual companies initiate their export promotion activities.
Although, the government or the trade promotion office was reluctant to promote export, but
recently, the scenario has drastically changed. The Ministry of Commerce and Export Promotion
Bureau have taken aggressive export promotion activities in collaboration with the sector
association. A number of trade missions to Asia and Africa have been initiated. Trade mission to
Europe and other countries will also be initiated in near future. Upon viewing the excellent growth,
although volume is very small compared to apparel and other exports, the government has been
seriously eying this sector for further development and announced pharmaceuticals as the Product
of the year for 2008.
Individual companies promote their product through participating in the trade mission, attending
buyers/sellers meeting, visiting and displaying in the international Trade Fairs and Exhibitions of
pharmaceutical products, distribute product literature and visit to the prospective foreign buyers and
agents. The existing exporters apply the following techniques for export market development:
•
Joining market development missions in the overseas
•
Attending trade fairs,
•
Attending buyers/sellers meeting
•
Meeting the representatives of the business, trade associations and chambers
•
Holding clinical meetings
•
Meeting the officials of the commercial sections of the Embassy
•
Meeting the officials of the concerned regulatory authority.
The exporters also take the following promotional measures for export promotion:
•
Incentive to the local agents
•
Inviting local agents for sales meeting in the country
•
Setting up marketing office in the overseas
•
Contacts with the regulatory authorities and the ministries
•
Sponsoring participation of seminar of Doctors in Bangladesh
•
Distribution of product literature
•
Trade inquiries
•
Circulating brochures
•
E-mails
•
Direct Contact
•
Information from circulation
- 22 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Market Survey and Research etc.
K. Export policies and incentives
1.
Government policy on export
In general, Bangladesh government strongly encourages all kinds of export including
pharmaceutical products as the government is advocating for export-led growth strategy since early
nineties. In 2005, the government revised ‘National Drug Policy’ in order to make it more
conducive for the foreign investors as well as the local producers planning to promote exports.
Regarding rules and regulations of export of pharmaceuticals, the country’s existing “Export and
Import Policy” is followed. The government is planning to introduce more conducive policy to
boost export of pharmaceuticals in near future.
2.
Export incentives provided by the Government
So far, there is no provision for cash incentives for pharmaceuticals export. But, this issue has been
repeatedly discussed within the government and the stakeholders. The exporters are actively
pursuing for this cash incentive in order to remain competitive in the export market. The existing
Export Policy 2006-2009 of the government offers some incentives are applicable to all exporters
including pharmaceutical companies:
•
Value added tax at 15% is exempted on the products produced for export;
•
Any individual or organization can utilize foreign currency for the purpose of export of any
products;
•
Tax is exempted in case of corporate export income
•
In case of “Deemed Export”, VAT is totally exempted.
Apart from the above, other incentives for export are:
•
Export credit guarantee scheme for coverage to the exporter.
•
Export credit guarantee for pre-shipment
•
Export credit guarantee for post shipment
•
Export payment risk policy (Comprehensive guarantee)
•
Whole turnover pre-shipment finance guarantee. The government has its program but in reality
a few are being practiced.
•
Currency conversion facility (taka) under this system. Exporters are allowed to keep foreign
currency in their account.
•
Foreign currency utilization facility.
•
Exporters are allowed to utilize foreign currency carved from the further export purpose.
- 23 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Export Development fund: The fund will be utilized to provide assistance to the local
manufacturers and for export marketing, export diversification and development of export of
non-traditional items. These include attending seminar, trade fairs, setting up sales center in
foreign country.
•
Extension of export credit period from 180 days to 270 days. Period of export credit under
export development fund has been extended up to 270 days.
•
Export Financing: Credit card has been introduced to reduce risk of carrying cash dollars by the
exporters.
•
Limit of margin of export has been increased up to 90% i.e. any exporter can avail loan up to
90% of the contract price or L/C value.
•
Credit for new and fresh exporters is given, if they apply.
•
Total flow of export credit will be maintained.
•
Export loan portfolio has been introduced by the central bank to ensure regular export financing.
•
Incentive will be given in case of export of new industrial products.
•
50% of the total export earning will be tax exempted.
•
Duty draw back facility will be provided through commercial bank in order to keep the market
price competitive.
•
Bonded warehouse facility for exported goods has been encouraged.
•
Capital machinery may be imported without any tax.
•
Tax holiday provision shall be imposed by the government.
•
Sample for export: Limit for sending sample for trade fair is about US$ 2,000 and other purpose
the limit is US$ 1,500. Sending sample through parcel post is increased to US$ 59.00.
•
Re-export: Permission is not required from the Ministry of Commerce on case to case basis and
VAT is reduced at 5% from 10%
•
Export other than L/C: Products can be exported on the basis of buying contract, agreement, and
purchase order to advance payment. In this case, the exporter has to submit EXP Form and
shipping bill.
•
Import or advance payment L/C: L/C will not be required in case of import of capital machinery
and basic raw materials and perishable item for re-export.
•
Duty draw back: To keep export price at competitive level, arrangement shall be made for duty
draw back and cash incentive for export.
L. Export channels
Bangladesh Government has adopted extensive policy packages for improving exports of
pharmaceutical products. Private sector is also enthusiastic that export is possible to be improved in
the coming years by utilizing the positive policy packages announced by the government. A large
number of trade fairs, seminars, dialogues, negotiating meetings are being organized to explore new
export destinations. A significant number of new establishment and BMRE activities are going on
for direct exports.
- 24 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
As about 85% of the inputs are imported, the exporters at the same time importers. There are some
trading companies also who are bulk importing to facilitate small exporters.
Some small companies are also willing to be part of the large companies to penetration into the
export market.
M. Shipping
As the government is sincere to increase the export of pharmaceutical products, the efficiency of
port handling has been increased recently where exporters get priorities.
N. Packaging
Packaging sector for supporting for exports has also been flourishing. A large number of packaging
products are also produced locally and their quality is also improving. Some packaging associations
are moving forward for establishing a Packaging Institute for producing quality-packaging product.
Packing materials used in the local pharmaceutical industries include aluminum foil (blister &
strip), Alu alu foil, rubber stropper, flip-off seal, printing materials, plastic cap, injectible, tear-off
seal, tube, PVC, PVDC, level, bottle (white & color), plastic container, paper cartoon, printing
materials, packets, etc. Almost every packing material is locally available except aluminum foil,
alualu foil, PVC, PVDC, color bottles, etc which are imported from countries like Korea, Dubai,
India, China and so on. It is expected that a number of packaging industries will appear in near
future as backward and forward linkages to support pharmaceutical sector.
O. Export credit and finance
No special credit facility or system exists for financing export of pharmaceutical products. There
was an “Export Credit Guarantee Scheme” for all sorts of exports under the control and supervision
of the central bank, but the performance was not satisfactory. The scheme was targeted for overall
industrial sector, but not specifically for the export of pharmaceutical products. However, the local
and foreign banks working in Bangladesh have been supporting export activities of any kind
through extending their foreign trade services.
P. Trade promotion
1. Export development services
In Bangladesh, there is no special trade promotion office or cell providing export marketing and
promotion service for pharmaceutical sector. Export Promotion Bureau (EPB) is the only public
sector organization specialized in extending variety of export development and marketing services
to facilitate the local exporters of all sectors. EPB provides information on export market and
organizes activities related to export marketing and export market development. Besides, there is a
growing number of private consulting houses that provides business services including marketing
services. Individuals are working as marketing agent or distributors who explore export market for
local companies.
- 25 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Local consulting firms are also preparing the companies for export through quality certification and
other management development. Ministry of commerce re-activated WTO Cell and reconstituted
Working Committees to prepare Bangladesh’s negotiating positions in respect of multilateral issues.
A separate Working Commitee on TRIPS is working to consolidate its position to utilize benefits of
exemption given to Bangladesh.
2. Trade promotion activities
Recently, as mentioned earlier, the Ministry of Commerce and Export Promotion Bureau in
collaboration with the sector association of pharmaceutical companies i.e. BAPI have taken special
initiative or program for export promotion of pharmaceutical sector. Activities like organizing trade
missions and group visits to international trade fairs, displaying pharmaceutical products in
Bangladesh pavilion abroad and organizing buyers/sellers meet are the now regularly organized by
the Ministry of Commerce and Export Promotion Bureau and the trade bodies including Federation
of Bangladesh Chambers and Commerce and Industry (FBCCI). Asia Pharma expo, and some other
events, studies, seminars, training are helping promoting trade. The Dhaka Chamber of Commerce
& Industry as one of the leading Chamber is organizing seminars, trainings and collaborating with
other pharmaceuticals associations.
Q. Strengths, weaknesses, opportunities and threats
The strategic analysis on the pharmaceuticals industry of Bangladesh gives the following results.
1. Strengths of the industry
•
Some leading companies are producing world-class products.
•
Products acceptable in the global market as ‘Quality Products’
•
Wide range of products.
•
Price is competitive both in local and foreign market.
•
Strong brand image created by the market leaders parallel to MNCs.
•
Large pool of efficient and qualified technical manpower at minimum cost.
•
Supportive government policy attracting foreign investors.
•
Do not have to comply IPR until 2016.
•
Backward linkage support is being created.
•
Large domestic market with reasonable growth rate.
•
Oldest and one of the largest sector in terms of capital investment.
- 26 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2. Weaknesses of the industry
•
Patent law is not updated to accommodate benefits of LDCs. In Bangladesh patents are more
prohibited under Patents and Drugs Act 1911 as amended for time to time and patents and
Drugs Rules 1933. In order to make best use of compulsory licensing and parallel imports,
recent patent law needs to be updated.
•
A Task Force was created comprising members from EPB, Drug Authority, Ministry of Health,
Ministry of Commerce, NBR, Bangladesh Bank, Income Tax, Customs and so many but
unfortunately this committee could not work up to level of the requirement.
•
Dependency on imported raw materials or absence of API plants.
•
Absence of international standard quality control and testing laboratory.
•
Absence of bio-equivalence testing and clinical facilities.
•
Inadequate knowledge on TRIPS and trade related matters.
•
Little research and development on new molecule development etc.
3. Opportunities for the industry
•
We can now produce API for patented products
•
Large potential for export market expansion from 2006 till 2016 and on wards.
•
Huge potential to set-up manufacturing plant for API or bulk drugs.
•
Liberal government policy for the foreign investors for joint venture pharmaceuticals unit.
•
Large pool of qualified technical personnel may set up manufacturing units in other LDCs
•
Positive points of Drug policy, if foreign companies can show 7.5% saving of foreign exchange
mark up is flexible.
•
Local companies can offer technical know-how to LDCs for setting plants.
•
Domestic market is gradually increasing with the increase in GDP.
•
Scope for product diversification into herbal and animal healthcare.
•
Research and development activities may be initiated with external support.
•
Scope to take advantage of compulsory licensing, parallel import and bolar provisions.
•
Bangladesh can gain the markets, where India & Brazil used to sell until 2005, because the
countries are now excluded from supplying medicines subject to patents, there by strengthening
the competitive positions of Bangladeshi Producers of medicines.
•
Even India and China, being Champions of reverse engineering in producing the generic
versions of the patented API can now use Bangladesh as a platform to produce those APIs
which they cannot produce in their own country after 2005.
4. Threats for the industry
•
Cheaper medicine from China and India.
•
TRIPS may bring tough competition in the local and export market.
- 27 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
India has amended 1970 Patents Act as favorable as possible.
•
The sector is dependent on imported raw materials, any fluctuation in raw material prices or rate
of exchange will have negative affect on competitive prices.
•
Entry of multinationals with large-scale investment and strong backward linkage support.
•
Neighbouring countries supplying products to Bangladesh through unauthorized channel.
•
Imported drugs will be in the local market after enactment of revised drug policy.
•
Increase of price of raw materials.
•
WTO members with strong generic industries that supply Bangladesh must give full patent
protection.
•
Availability and increase of the active ingredients to Bangladeshi Industry.
•
WHO GMP has changed to cGMP (Current Good Manufacture Practice) which is very much
stringent to be complied by the new entrant specifically.
R. Conclusions and recommendations
1. Conclusions
The pharmaceutical sector is the second largest sector after agriculture that contributes to the
revenue generation of the Bangladesh Government. The sector has growth potentials both in local
and export market. There is an increasing trend in the export of pharmaceuticals that indicates very
good future prospects for the country.
In the local market, there is an increasing demand for medicines for anti-cancer, anti-hypertension,
anti-diabetics, AIDS, cardiovascular, different vaccines etc. So far, the local pharmaceutical
companies are not producing medicines for serious diseases like cancer, HIV/AIDS, diabetics etc.
Recently, there are few initiatives and projects to produce high value drugs of the above categories.
For example Beximco, Square, Incepta, Popular has started Bio-Technology units to work with
Vaccines and Insulines. But it will take some time to make these products available in the local
market. Local market demand is increasing gradually, it is apparent that both import and domestic
production is increasing.
Traditionally, there is a common belief that herbal medicines do not have any side effect. A large
majority of people living in rural Bangladesh are still traditional in their attitude. This segment of
people demand natural products for all kinds of diseases. So, there is large potential market for
herbal products in Bangladesh.
The demand of pharmaceutical raw materials has increased in the recent years and will increase
further in the coming years since the production volume of the local companies is increasing day by
day due to increased local consumption and export.
As of now, the local companies are exporting to 68 countries worth US$ 28.16 million (in the year
2006-07) million, which was only US$ 21.26 million in 2005-06, export increased at 32%. The
target for 2007-08 is $32 million.
- 28 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Table 5: Export Statistics for Pharmaceutical Industries (in Calendar Year) – In million US$)
CALENDAR
FINISHED PRODUCTS
YEAR
2001
5.78
2002
7.08
2003
9.42
2004
23.75
2005
23.14
2006
37.57
(Source: Drug Administration)
RAW MATERIALS
0.20
0.75
1.51
2.35
2.40
2.14
NO.
COUNTRIES
17
32
51
62
67
61
OF
So, with the increase in export of pharmaceuticals, the requirement for raw materials will be higher.
But, there have not been enough initiatives to produce raw materials locally except 4-5 companies
that undertaken projects recently. For example: Beximco Pharmaceuticals18, Gonoshastho. Some
other pharmaceutical companies have been taking preparation for expansion. To ensure smooth
supply of raw materials, the government is determined to set-up industrial park for production of the
active pharmaceutical ingredients in Dhaka instead of earlier plan in Chittagong. 300 acres of land
has already been sanctioned for API Park. Although the government regulates the business of this
sector including consumers’ price, the recent policy change by the government has tremendously
increased the scope for new investors and multinational companies to invest in both formulation and
API sector.
There are some 200,000 pharmacies in the country who sell pharmaceutical products at retail level,
of which 75,000 are registered with DGDA through Druggists and Chemists Association. It is
estimated that in total 125,000 pharmacies are operating in the retail market and are yet to be
registered. There are about 34,000 pharmacists in the country19. According to Bangladesh Medical
and Dental Council (BMDC) there are 38,674 registered doctors in the country. Since media
campaigning and advertisement is prohibited, sales promotion is made through offering incentives
to the field level sales force as well as to the medical practitioners.
After eyeing huge market prospects, a good number of new companies including foreign owned
have entered into the market with their manufacturing plants for formulations. The existing leading
companies20 (Beximco, Square, etc.) have also invested large volume of fund in the sector. Reasons
are the future scope of opportunities resulting from Trade Related Intellectual Property Support
(TRIPS) after 2005 and to comply with the improved WHO standards to be enforced in near future.
According to TRIPS /WTO agreement, all developing countries along with China & India will have
to implement “patent laws” in their respective countries from January1, 2005. LDCs are exempted
from there compulsory implementation. Bangladesh is the only country which has a very strong
manufacturing base in pharmaceutical sector. Bangladesh will be able to manufacture & export
patented drugs to at least 49 LDCs.
A task force was created comprising members from the EPB, Drugs authority and concerned
Ministry for taking immediate measure to make best use of Compulsory Licensing & Parallel
imports. Bangladesh needs to upgrade Patents & Design Act (1911) and Patent and Design Rules
(1933).
18
Beximco Pharmaceuticals Ltd., for address see Annex -8
Source: The daily Naya Digonto.
20
List of some leading companies is enclosed as Annex-8.
19
- 29 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Prospective investors with huge capital investment may be encouraged to set up plant for API since
the country has huge requirement for raw materials. For producing Formulation, mergers and buy
out may be effective option for foreign companies and investors, as there exists a good number of
factories still dormant. Recently, there are also instances of joint venture project negotiations with
India, China, Laos and so many.
Formulations are regularly developed in the leading local companies. So, the exporters of
Formulations of the participating countries should target the market segment of high tech medicines
and vaccines that are not being produced by the local industries. So far, the country could not
undertake any successful study and research on “new molecule” or development of basic raw
materials. Recently, one or two companies are working for development of molecule or basic
chemicals.
There are untapped opportunities for the manufacturers of packing materials required by many
industries. Except a few leading companies, many have no manufacturing facilities to produce
packing materials and they depend on imported packing materials. Since more and more companies
are coming into export, the requirement of good quality packing materials has been increased along
with literature with different languages. Dependency on import for packing materials is decreasing
as the local production providing 80-82% of the total demand for packing materials; this includes
bottles, covers, and printing materials. But for foils Bangladesh still depends on import.
2. Production, quality and standards
The local pharmaceutical companies those who are regular in production follow World Health
Organization standard in manufacturing their products i.e. ‘Good Manufacturing Practices’ (GMP).
The local companies are also pursuing other certification and standards like USFDA, British MCA
etc. Bangladesh pharmaceuticals industry is mainly dominated by domestic manufacturers. Of the
total pharmaceutical market of Bangladesh, the local companies are enjoying a market share
reaching around 80%, while the multinational companies (MNCs) are having a market share of
20%. Out of top ten pharmaceutical companies, while only one is MNC. The leading Bangladeshi
pharmaceuticals companies have earned good name for quality medicines. 5-6 local companies are
now of global standard in terms of product quality. Square, Beximco, Incepta, Ibn Sina,
Aristopharma, Eskaef, Aventis, ACI, LKL, Globe, General, Opsonin is well reputed in the world
market for quality products.
The annual turnover of Square Pharmaceuticals is about US$ 86.95 million. With the manpower of
more than 4000, this company exports minimum 7.5 million dollars of medicines each year. Square
is famous for Antibiotic, Vitamins and Anti-Diabetes. Vitamin C, Renitid and Inhaler of Square are
also of good quality.
Beximco Pharma remains at the second position in terms of market share. The number of
employees is around 3,000. Annual turnover is about US$ 45 million. Beximco exports about US$ 7
million of medicines each year.
Square and Beximco account for the market share of about 25%, while the top ten domestic
manufacturers contribute about 60% of the total pharmaceuticals market.
Incepta pharmaceuticals accounts for 5-6% of the total market share. With the export of US$ 2.89
million, the annual turnover of Incepta is about US$ 44 million.
- 30 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
The local pharmaceuticals sector has acquired technical knowledge and know-how from
multinationals from USA and Europe during 70’s and they are maintaining the progress
3. Highest quality standards
Very recently, quality consciousness has assumed a higher priority.
The pharmaceutical industry of Bangladesh is now capable of producing drug products meeting the
highest quality standard. It maintains high standards of Quality Assurance in the manufacture and
control of drugs and drug products. A competent regulatory authority known as the Directorate of
Drug Administration is in presence. Bangladesh ensures compliance of the manufacturing facility
and practices with the requirements of GMP and regulations.
Bangladesh has manufacturing facilities meeting the highest cGMP requirements. Quality control
laboratories are equipped with sophisticated equipment and meet the requirements of Good
Laboratory Practice (GLP). Specifications and test methods for raw materials and drug products are
based on British Pharmacopoeia (BP), United States Pharmacopoeia (USP) and European
Pharmacopoeia (EP).
Quality Assurance system is in place ensures that the facility, equipment, process and test methods
are validated and instruments are routinely calibrated, qualified and trained.
As of now, at least 29 local companies are ISO 9001: 2000 certified and many of them are in
progress to obtain ISO certificates.21. Two leading companies (ACI Pharmaceuticals and Square
Pharmaceuticals) have obtained pass mark to comply with the rigorous USFDA. Square
Pharmaceuticals have also obtained pass mark to comply with UK MCA certification tests.
Beximco Pharmaceuticals is preparing itself for USFDA certification.
Other leading companies are also actively pursuing for such certification to export their products to
all parts of the world and also ready to comply with new WHO standards to be enforced in near
future. A number of companies are in process of obtaining UKMHRA, EU, TGA Australia and US
FDA certification. A large number of local manufacturers are making huge investments in their
facilities to meet the post WTO challenges.
Regulatory environment and recent changes in the National Drug Policy
In order to ensure adequate supply and availability of good quality essential drugs at affordable
prices, a radical and far-reaching National Drug Policy (NDP) was formulated in 198222. Following
the guidelines of the NDP, a Drug (Control) Ordinance was also promulgated in the same year.
These two documents produced tremendous positive effects on rapid development of the local
pharmaceutical sector and gradual improvement in the drug sector for the country.
After having 22 years of steady growth in the local pharmaceuticals industry sector, the government
and other stakeholders updated and modified the policy through inclusion of new elements in order
to properly deal with the changes and development that have taken place so far. Accordingly, the
National Drug Policy 2005 has been formulated meeting the current needs of the country as well as
the global business environment.
21
22
See Annex III
Drug Control Ordinaces 1982 is enclosed as Annex X
- 31 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Revised National Drug Policy 2005 has focussed on the following:
•
Applicability, effectiveness and adaptability to the recent remarkable technological
advancement in the medicine world.
•
A competitive drug sector to perform better in the world market
•
A brand name in the world as a producer and exporter of quality drugs.
The revised policy empowered more authority to the Directorate of Drug Administration (DDA)
through converting it into Directorate General of Drug Administration (DGDA), which will reduce
bureaucracy in one sense and speed up workflow under the same roof. All modern facilities planned
to be created for testing and other purposes and the officials will be trained on latest tools and
techniques in order to improve regulatory environment as well as to deliver quality services to the
industry. The new policy also helps better and strict monitoring of illegal activities and malpractices
in the industry. It is more open to the multinational companies who are interested to undertake
‘research and development’ for producing improved quality and innovative drugs. This policy also
helps in setting up of plant for producing raw materials i.e. active ingredients by the local and
foreign investors. There is also provision for Toll or Contract Manufacturing, licensed
manufacturing, franchising and other facilities to attract the foreign investors. Some very important
national committees have been formed like Drug Control Committee, Packaging improvement
committees etc.
4. Recommendations
The following issues have been suggested by the major stakeholders and concerned parties during
the cross section discussions and subsequent analysis on the findings of the study:
(a)
Support from the International Support Organizations /Agencies
International agencies like ITC, UNIDO, WHO, World Bank etc should extend technical support
through educating the local industry representatives on TRIPS and its potential benefits.
International agencies may also extend technical assistance to Bangladesh pharmaceutical industry
sector for setting up world class “Drug Testing Laboratory” for testing of medicines. Similar
laboratory shall also include facility for bio-equivalence test, as it is essential for export expansion.
JICA, WB, UNICEF is willing to provide fund for setting up a testing laboratory. Government has
promised to allocate lands also.23
Multilateral financing agencies should provide soft funds to set-up plants for producing active
pharmaceutical ingredients. External financial support may be explored for combined water
treatment plant for ‘waste management’ of the proposed API manufacturing plants.
ITC, WHO, etc., should take immediate and effective steps to ensure ‘simplified procedure for
product registration and licensing’ in different countries. A unified procedure should be proposed
for all countries participating in the buyers/sellers meeting.
Regional and international agencies should also extend support for “Research and Development” on
molecule and innovative health care items for the serious diseases.
23
Source: The Daily Naya Digonto.
- 32 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
International financial institutions should come forward to finance modernization and expansion
plans of the existing companies to cope with newly set standards of WHO as well as to more
competitive.
ITC and other agencies should extend “international marketing support” in order to promote export
market for the local pharmaceutical industries. Increased number of business mission, trade fairs
and exchange of business delegates should be taken place with external support.
International Trade Centre should initiate a program to record and compile large database of
importers, exporters, wholesalers, manufacturers, research institutes and trade support organizations
of participating countries which can be used by the interested parties through electronic media for
mutual benefits. ITC should develop and launch a separate ‘web portal’ providing all kinds of
information on the traders, exporters, importers, researchers of pharmaceuticals and natural
products of the participating countries. Strengthening the activities of the associations / Chambers
for managing a database.
ITC, WTO, WHO and other relevant agencies may also extend policy support and assistance
through advocacy on important areas and help adopting new policies in the health and
pharmaceutical sectors.
Finally, different policy support on bilateral trade and commerce in this sector should continue
further with more emphasis than earlier.
(b)
Support from the Local Authority /Organizations
Immediate measures and steps should be taken to facilitate setting-up plants for manufacturing API
for both local and export market consumption. Relevant agencies like Board of Investment, Export
Processing Zones Authority, local and multilateral Development Finance Institutions and others
should be instructed and assisted by the Ministry of Health and Family Affairs, Government of
Bangladesh (GoB) to undertake immediate measures in this regard.
Simultaneously, the Ministry of Commerce and Export Promotion Bureau should jointly undertake
an “in depth study” on the problems and prospects of TRIPS for the local pharmaceuticals industry
without any further delay to come up with a set of “solid and realistic” strategic recommendations
for long term sustainability through local and external experts.
The entire data base relating to the ‘certification of products’ should be automated immediately to
expedite certification process of finished products as well as to speed up approval of block list of
raw materials to be imported.
The government of Bangladesh should immediately take initiative for setting up world class “Drug
Testing Laboratory” for testing of medicines. For the lack of Standard Drug Testing Laboratories,
the quality of medicine is not ensured.
The government of Bangladesh should create facility for Bio-equivalence test as it is essential for
rapid export expansion. The extra cost of bio-equivalence tests from other country increases the
export expenses.
There should be a separate cell for “Pharmaceuticals Export Promotion”. The proposed export
promotion cell should be managed by dynamic and efficient team of professionals. Under this cell,
a number of branches or wings may be opened in the commercial section of the Bangladeshi
- 33 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Embassies abroad. Presently there is no such cell is available to support pharmaceuticals expertise.
Initially this type of cell can be established in those countries where we export more.
The government should also consider giving ‘export incentive’ to the local pharmaceuticals
exporters to be competitive, as the competing countries have already taken such provisions (India
offers cash incentives at 20% and 30% on raw materials and finished products and China also offers
huge incentives to its exporters). Cash incentive should be offered to the exporters of
pharmaceuticals products. Exporters should also be awarded nationally.
The sector should get all policy priority and supports to expand its export rapidly and establish a
strong base for export supportive activities.
Advanced training courses should be offered to the pharmacists and quality control personnel for
continuous improvement of the quality. Bangla subtitle to be included in the label of all medicines
to help check adulterated drugs and other drugs smuggled from other countries, since smuggled
drugs do not want to incur the extra cost and delay of doing the labelling.
Incinerator & Effluent Treatment Plant (IETP) for facilitating waste management and environment
protection through Central Environmental Treatment Plant (CETP), Dumping and Incinerating for
at least 50 plants is required with API industrial Park.
(c)
Positive and enabling business environment
Information on importing countries like import procedures, freight components, banking facilities
and addresses of chambers and business associations shall be made available.
Combined efforts should be given by the Ministry of Health and Family Planning, the Ministry of
Commerce, local chambers and trade associations for effective coordination for export expansion in
the overseas.
Benefits being provided to the other industrial sectors by the government should also be ensured
and extended to the pharmaceuticals sector through back-to-back letter of credit and bonded
warehouse, etc.
The government should time to time monitor the effectiveness and impact of the licensing system,
contract manufacturing and other positive measures taken under the National Drug Policy 2005.
The government should undertake special program for export market development. Unhealthy
competition should be avoided among the local companies.
Development of new and innovative products should be encouraged and nurtured.
(d)
Pharmaceuticals has been declared as the product of the year
The government of Bangladesh in its Export Policy 2006-09 (Chapter-5, Para 5.8), has declared
pharmaceuticals products as export product of the year. Export Promotion Bureau has taken several
steps for announcing pharmaceutical products as export product of the year in 2008. An SRO /
Public Notice will be issued soon from the concerned Ministry. Jointly formed Committee
comprising members from Export Promotion Bureau (EPB) and BAPI will collect export related
rules, regulations of different countries through Ministry of Foreign Affairs and different Missions
of Bangladesh in different parts of the world.
- 34 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
The target of export for the year 2008-09 will be made double to US$ 64 million.
(e)
Recommendations of BAPI for implementing government announcement of
pharmaceutical products as export product of the year
The ceiling for allocation of foreign exchange should be increased at least up to $0.1 million dollars
from the present level of $60 thousand for establishing office of the company at abroad such as:
Singapore, Russia, Europe, Latin America etc. The issue was discussed in a recent meeting and
finally agreed that it could be 25% of the total sales of the respective country.
Sample export amount should also be increased from existing US$ 1,500.
In case of sending samples of the medicine practitioners it could be at least 10% of each
consignment.
In case of sending publicity materials, printed materials there should not be any ceilings. In case of
sending samples, “Samples by post” should be withdrawn.
Single country fair to be organized in Kenya, Senegal, South Africa, Ghana, Chilli, Dubai, Brazil,
Mexico.
(f)
Recommendations for Medicine market made of Natural Products
•
The total Value of the herbal medicinal market, at trade prices, is expected to increase from
about US$ 53.62 million in 2003 to US$ 84.78 million in 2008. As a result of the government’s
active promotion, market liberalization and the dynamism of the corporate. These growth rates
should be exceeded. A recent research demonstrates that the demand for medicinal raw
materials per year is expected to increase from about US$ 11.59 million to US$ 15.94 million,
an increase of US$ 4.34 million. The bulk-increased demand for raw material is likely to take
place in the formal Ayurvedic and Unani sectors. Currently Bangladesh holds around 40% by
value of the medicinal herb market, worth US$ 4.92 million.
•
Trade opinion on Production Prioritisation is shown in the table given below:
Table 6: Trade Opinion on Production Prioritization
Expanding Demand
Short Supply
Import Substitution
Amloki
Arshwagandha
Haritaki
Haritaki
Amloki
Amloki
Bahera
Bahera
Bahera
Arshwagandha
Dhaiful
Ada
Shotomuli
Haritaki
Peepul
Kalomegh
Peepul
Arshwagandha
Source: Medicinal Plant Marketing in Bangladesh, by IFC, WB & SEDF.
•
Overall Assessment
Amloki
Haritaki
Bahera
Arshwagandha
Shotomuli
Peepul
It is apparent that certain products could exhibit long-term opportunities once Bangladesh
recognizes Pharmacopoeia other than its own.
- 35 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Some of our population love to use and depend on natural products, there is huge potential of
diversification and natural herbs in Bangladesh through scientific cultivation creating
information based for commercialization of medicinal plant production is required.
•
Primary & secondary processing are carried out by different group of persons now, there is a
need for close linkage between beparies24 and processors to facilitate better supply of raw
materials that once required by the processors in the quality and the quality they demand.
•
Aloe Vera drink is a product recognized in a number of different markets, including United
States of America, Japan and Europe. In Bangladesh the ‘sharbet’ also includes ulat kambol and
shotomuli, both for the flavour and pharmacological properties. There is a good probability that
Aloe Vera ‘sharbet’ can be developed into a properly processed and packed drink.
•
A medicinal Plant Forum can be established with an appropriate secretariat involving active
participants with an outer network of interested parties.
24
Local name of Retailer
- 36 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
IV. DEMAND SITUATION OF BANGLADESH
PHARMACEUTICALS INDUSTRY
A. Objectives of the demand survey
The demand survey aims to provide comprehensive information on the Bangladesh pharmaceutical
market for selected products in order to assist the prospective foreign exporters/suppliers to take
advantage of prevailing business opportunities. The demand survey, will, in particular, aim at:
•
Describing the characteristics and structure of the market, including details concerning
individual importers /end users.
•
Assessing the potential for increasing demand and /or changing to new sources of supply
•
Identifying impediments affecting imports
•
Determining areas in which specific measures are required, with reference to customs
procedures, payment arrangements, licensing and other rules and regulations.
In addition to describing market characteristics for the benefit of potential suppliers in other
aforementioned countries, the survey also aims at analyzing the existing constraints in the import
sector concerned and at formulating recommendations for action by governments and others having
development responsibilities.
The guiding factor in the interpretation of the above objectives and in the formulation of research
design for collection of information and analysis will be trade expansion possibilities among the
bilateral partners of Bangladesh.
The subsequent sections of the report explain various aspects of the demand survey:
B. Structure of the demand survey report
The demand survey report has provided detailed information on national demand situation of the
production concerned and the findings are presented under different headings of the report.
1.
Executive summary
The pharmaceutical sector is the second largest sector after agriculture that contributes to the
revenue generation of the Bangladesh Government. The sector has growth potentials both in local
and export market. There is an increasing trend in the export of pharmaceutical products that
indicates very good future prospects for the country.
In the local market, there is an increasing demand for medicines for anti-cancer, anti-hypertension,
anti-diabetics, AIDS, cardiovascular, different vaccines etc. So far, the local pharmaceutical
companies are not producing medicines for serious diseases like cancer, HIV/AIDS, diabetics etc.
Recently, there are few initiatives and projects to produce high value drugs of the above categories.
- 37 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
For example Beximco, Square, Incepta, Popular has started Bio-Technology units to work with
Vaccines and Insulines. But it will take some time to make these products available in the local
market. Local market demand is increasing gradually, it is apparent that both import and domestic
production is increasing.
Pharmaceutical sector made significant contribution to the foreign trade of the country by both
import and export. The country has been generating an impressive amount of foreign currency from
export of pharmaceutical. During the year 2005-2006, the growth rate of export was 32%. For the
year 2008-09, the export target is to make double than the announced export target of US$ 32m. On
the other hand, due to increased demand in both domestic and export market, more than 85% of the
required raw materials are imported from abroad, and that indicates huge spending of foreign
currency. In 2006, the amount of import of both finished products and raw materials for
pharmaceutical sector was US$ 143.623 million, which is about 1% of the total commodities import
of the economy during the same year.
2.
Products covered under the survey
The demand survey covers those products that are under the list of ‘Essential Drugs’25 approved by
the Drug Administration Authority, Bangladesh within the purview of the National Drug (Control)
Ordinance, 1982.
Majority of the local pharmaceutical companies in Bangladesh are manufacturing “Formulations”.
As of now, 239 local companies are registered with the Directorate General of Drug Administration
(DGDA), 161 of which are in operation. 144 of them are regular members of the trade body of
pharmaceutical sector i.e. Bangladesh Association of Pharmaceuticals Industries (BAPI)26. There
are 600 generic products, of which 117 are essentials and controlled drugs and 483 decontrolled
products. The total number of brands / items that are registered in Bangladesh is currently estimated
to be 8,000 while the total number of dosage forms and strengths are 10,914. 21 local companies are
producing active pharmaceutical ingredients (API) although at a ‘limited range and mostly
intermediate in nature’ and supplying these to other local companies for producing various types of
Formulations. More than 40 different types of active ingredients are produced by the local
companies and these are ORS, Paracetamol BP, Amoxicillin trihydrate/powder, Ampicillin comp
ached/powder, cloxacillin sodium BP, Cefalexin trihydrate compacted, EG shell, Diclofenac
Sodium, Empty hard gilatine, sodium chloride, potassium chloride, Parasulphate, Zinc sulphate, etc.
Another 4-5 companies have taken up new projects to produce active ingredients under groups like
chephalosporin, macrolide antibiotic, anti-ulcerative, anti-inflamatory, etc.
Demand for high tech and high value medicine like anti-cancer, anti-hypertensive, anti-diabetics
etc. is increasing. Local companies among those produce raw materials are Square, Beximco,
Opsonin, Jayson, Eskyef, Remo Chemicals, Drug International, Gonoshastha, Globe, Pharmatek,
Seftchem, Syripsn and Global Capsules are prominent. One company named MCC has set-up plant
to produce anti-cancer and hormonal products.
25
26
For List of Essential Drugs See AnnexVI
Bangladesh Association of Pharmaceitical Industry (BAPI): For address see page 59.
- 38 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
3.
Significance of the product to the economy and foreign trade sector
Bangladesh is one of the densely populated countries in the world having more than 140 million
people in a landed area measuring 147,570 square kilometres. With a positive population growth
rate of 1.42%, combined with increasing rate of health consciousness resulted from increased
number of educated people and increased per capita income, the demand of pharmaceutical
products has been increasing day by day at a higher rate. Another factor that contributes positively
to the demand of medicines is the average malnutrition among a major portion of country’s
population. Per capita expenditure on health and family planning is among the lowest in the region.
But, with the advancement of country’s overall economic situation it creates additional demand for
medicines and health care products and services. The growth rate of pharmaceuticals consumption
is around 12%. People prefer the products of the local companies and they have faith and
confidence on the locally produced products.
As mentioned earlier, the pharmaceutical sector is the second largest sector from where the
government earns huge revenue. One obvious reason behind significant growth of this sector is that
Bangladesh is highly prone to tropical diseases with poor health and hygiene condition. Per capita
expenditure on medicine in Bangladesh was around US$ 3 or Tk. 150 per annum in 1999, which
increased at US$ 4.00 per person in 2004, it is more than US$ 4 in 2005. This is projected figure by
the researchers as there is a significant increase in per capita income. This indicates a very
optimistic scenario for the new marketers. On an average 5% of household income is spent on
medicine. Per capita income has a positive impact on the increase of expenditure on medicine. In
2006-200727, the per capita income has grown US$ 482 which was US$ 44428in 2004. Per capita
expenditure on medicine has been increasing as people as gradually becoming health conscious.
With the inclusion of new entrants in the pharmaceutical sector, additional number of employment
has been created. As of now, the number of employment created by pharmaceutical sector exceeds
100,000 in manufacturing, of which around 54% are highly educated and technical. As of June
2005, the estimated annual turnover of this sector was Tk. 46,000 million that equivalent to
US$ 700 million approximately, as mentioned by the industry representative which is less than the
estimated market size projected by IMS report.
Pharmaceutical sector made significant contribution to the foreign trade of the country by both
import and export. The country has been generating an impressive amount of foreign currency from
export of pharmaceutical. During the year 2005-2006, the growth rate of export was 32%. For the
year 2008-09, the export target is to make double than the announced export target of US$ 32m. On
the other hand, due to increased demand in both domestic and export market, more than 85% of the
required raw materials are imported from abroad, and that indicates huge spending of foreign
currency. In 2006, the amount of import of both finished products and raw materials for
pharmaceutical sector was US$ 143.623 million, which is about 1% of the total commodities import
of the economy during the same year. The pie chart presented below indicates the share of import of
pharmaceuticals in the total imports in the economy:
27
28
Bangladesh Economic Survey 2007.
Bangladesh Economic Survey 2004.
- 39 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Chart 5: Share of pharmaceuticals import (US$ million)
Share of Pharmaceuticals Sector in National Import
143.629
16532.9792
Pharmaceutical Import
Total National Import
Methodology of the survey is mentioned in the first part of the introduction.
C. Summary of conclusions and recommendations
Recommendations and conclusions have been included in the first part of the report.
D. Main report
1. Market size
Domestic pharmaceuticals industry
Domestic pharmaceuticals industry comprises of Allopathic, Ayurvedic, Herbal/Unani,
Homeopathic, Diagnostic centre, Hospitals, Pharmacies, Bio-clinical etc. In 2006, the total market
size of pharmaceutical products was estimated US$ 600 million approximately, which was only
US$ 350 million in the year 1998-99. In Bangladesh, the total demand for pharmaceutical products
will further increase in future for several reasons as mentioned earlier.
Herbal medicines are now produced in large scale for commercial purpose by a number of
manufacturers like Sadhana Aushadhalaya, Sakti Oushadhalaya, Hamdard, Ayurvedya Pharmacy,
etc. Indigenous populations depend on traditional system of medicines and medicinal plants as
primary sources of healthcare. Commercial manufacture of herbal medicines in Bangladesh is done
according to recognized traditional systems: Unani and Ayurvedic systems. WHO has officially
recognized and recommended herbal medicines and as such, the local manufacturers are now more
active. Recently, several pharmaceutical companies also expanded their production units for herbal
medicines production. Namely, Jayson Pharmaceuticals, Renata Limited and ACME Laboratories
have started its herbal unit with few items. Another 10-12 items are in their research for marketing
of herbal products.
- 40 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Total volume of herbal medicines sold in Bangladesh has increased at US$ 60 million, where
Hamdard Laboratories- a leading herbal medicine producer occupied lion share. Huge quantity of
herbs is imported from different countries for production of Unani and Ayurvedic medicines worth
around US$ 11.00 million. Recently, more than 500 cultivating medicinal herbs have been enlisted
in Bangladesh. Medicinal plants are also being cultivated by qualified researchers. Tea Board has
also taken up a plan to bring 1,000 hectares of land of tea gardens under medicinal tree plantation
program. Bangladesh has already possessed a small segment in the Middle East market for herbal
products and export prospects are very bright. Bio-pharma and bio-technology issues are
increasingly discussed in the country and 3 companies have already launched products in this sector
including Incepta Pharmaceuticals and Popular. Mainly they are producing Vaccines and Insulines).
Square Pharmaceuticals Ltd and Beximco Pharmaceuticals are in the process.
In total, the formally processed herbal medicine sector is worth approximately 13% of the allopathic
market. The Bangladesh herbal medicine market is valued at Tk 3,300 million ($60 million) at trade
prices and has been growing at rates considerably higher than 10% growth rate recorded for the
allopathic market. The fast growth in the Unani sector is believed to be fuelled by the large number
of trained Hakims29, its simpler and faster production process & easier treatment courses than
Ayurvedic medicine have increased its acceptability to the lower middle class people. Homeopathy
is the smallest sector, but is reported to be growing rapidly because of the low treatment costs.
However, because of the specialist’s nature of the herbs used and the existing low volumes of raw
materials required, the homeopathy sector has a different nature to be developed.
The sector has a significant percentage of users because of the long-century believe and poor
affordability, the sector is lagging behind for development facilities and education. Only one
government run Homeopathy Medical College and Hospital is in existence to educate people in this
sector.
Currently there is no existing policy of biotechnology in Bangladesh30. Recently the government
has shown strong commitments on biotechnology as can be seen from the inclusion of
biotechnology in the Action Plan of Agriculture Policy 1999. The government has started preparing
the country for biotechnology impacts by adopting the major conventions and treaties concerning
biotechnology & related issues including Convention of Biodiversity 1992, Cartegena Protocol on
Bio safety 2000, and the Trade Related Aspects of Intellectual Property Rights 1995. There is an
urgent need to generate national policy on biotechnology.
Square Group –a leading business house in Bangladesh is planning to build a tissue culture
laboratory to commercially process potato, banana, chrysanthemum, carnation, marigold, gladiolus,
garlic, ginger etc. The tissue culture at BRAC was established in 1997, with a working space of
6000 square meters. AP (Dhaka) ltd. has established in 1912 with the main business producing
herbal medicines. The company is facing unstable supply of herbs and lack of quality controlled
raw materials. The Bio safety Act is in process to finalization. It is hoped that diversification of
herbal production will increase in future in Bangladesh.
29
30
The local meaning is near to doctor.
The Potential of Commercialization of Biotechnology in Bangladesh by BIOTEC for SEDF, Bangkok, Thailand,
July, 2003.
- 41 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Present production capacity
There are 239 pharmaceutical industries registered for production of various types of Formulations
for more than 140.6 million people in Bangladesh. Out of 239 companies, some 161 companies are
regular in operation according to DDA office. Of these, 20-30 companies are large units including 5
Multi-National Companies (MNCs) having their manufacturing plants in Bangladesh. Top 20
companies enjoy 82% of the total market. Two joint venture companies are there; Roche Healthcare
and Sun Pharma. Sun Pharma, an Indian company has started their operation in partnership with
one local company. The local companies including MNCs are meeting 97% of the total domestic
market and the rest 3% is being imported from abroad. There are also a number of importers of
Formulations in the local market. Only 35-40 companies are regular in production of quality
medicines. The rest are ongoing but not regular in production and their quantity of production is
insignificant and quality of their products needs to be updated. There are a few new entrants in the
local pharmaceutical industry. 6-7 existing companies have undertaken expansion programs to
increase their production capacity as well as for modernization.
21 local industrial units are producing more than 40 different types of raw materials including
packing materials. The local industries produced raw materials and medicines worth US$ 711.98
million in 2006, US$ 804.61 million in 2005, the local industries produced raw materials and
medicines worth US$ 590.08 million in 2003, US$ 555.1 million in 2002. In 2001, the local
industries produced medicines worth US$ 377.09 million and in 2000 it was US$ 327.10 million.
So, there is a gradual increase (annual average estimated growth rate is 29% till 2002) in the local
production of pharmaceuticals to meet domestic demand and also for exports. But, the growth of
production decreased in percentage during 2005. Table below shows local production of
pharmaceuticals during the last six years including raw materials:
Table 7: Yearly local production of finished drugs and raw materials (in million US$)
Year
Finished Drug
Raw Materials
Total
2000
2001
2002
2003
2004
2005
2006
356.12
378.37
531.09
563.88
657.49
779.62
685.94
20.87
23.41
24.01
26.20
27.66
24.99
26.04
377.09
401.78
555.10
590.08
685.15
804.61
711.98
(Source: Drug Administration)
- 42 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Chart 6: Local production of finished drug and raw materials (In million US$)
900
800
700
600
500
400
300
200
100
0
Finished Drug
Raw Materials
Total
2000
2001
2002
2003
2004
2005
2006
The demand for total import of raw materials will increase to cater 30 local companies involved in
exporting their products to 68 different countries. It is also assumed that full installed capacity of
local pharmaceutical companies has not been utilized. When the full capacity is utilized the demand
for imported raw materials will increase further. Main reasons behind under utilization of capacities
are lack of marketability of products due to poor quality, lack of adequate financial support, absence
of proper technical expertise and skills and long-term business goals. However, leading companies
do not face much problem. Apart from the above micro level problems, there are some macro
environment problems that hamper production and these are hartal, frequent power failure, delay in
sourcing raw materials, late shipment, bureaucratic difficulties, etc. Recently exporters are facing
serious problem for exorbitant increase of the prices of raw materials etc. If companies were
operated in full capacity, demand for imported raw materials would have increased a lot.
2. Product specification, quality and output
Most regular companies strictly follow current Good Manufacturing Practice (GMP). The National
Drug Policy, drawn in line with the recommendations of World Health Organization (WHO),
guides the local industries. According to the policy, products like cough syrup, alkali syrup, gripe
water, combination products had been banned for production and import. The Drug Policy has
introduced a “list of essential drugs” in line with the essential product list of WHO. The Drug
Control Committee approves new molecules, if any, after assessing therapeutic value, safety and
necessity of the product for the country. High-tech medicines like anti-cancer, anti-hypertension,
anti-diabetic, etc., are permitted to import.
After having satisfactory report on ‘quality control facilities’ of a company, the government issues
or renews “drug manufacturing license” to a company which is renewable every 2 years upon
satisfactory results of Quality Control laboratory inspection. In order to get registration each
product has to pass through a test for import or local production. Each and every product must have
manufacturing and expiry date, batch number and price (Maximum Retailed Price) and other
necessary labelling requirements. All leading companies are well equipped with all modern
machinery and equipment.
- 43 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
3. Price, distribution and promotion
Prices of products under controlled category are determined by the government. Manufacturing
companies are allowed to propose the prices of the products that are under decontrolled category
and the approvals of these proposed prices are given by the government. The local Drug
Administration Authority strictly controls prices of products. Prices needed to be fixed by a
company within the band announced by the government. The MRP should not exceed the double of
the price of the basic ingredients i.e. if the price of Amoxicillin is US$ 0.10, then MRP shall not be
more than US$ 0.20. In Bangladesh, promotion of pharmaceutical products in the mass media is
strictly prohibited. Manufacturing companies can only promote their brands to the health
professionals by personal selling, clinical meetings, seminars, symposia etc. For promotion with
printed promotional materials like literatures, pads, posters, stickers etc, the manufacturing
companies have to submit the same to the drugs administration for approval and upon their
clearance the companies can promote their products using those promotional tools.
According to the government regulation, the pharmacies / chemists are entitled to get 16% retail
margins on top of the trade prices of the products. Most of the leading pharmaceutical
manufacturers have their own distribution network and ensure supply of products up to retail level.
But the companies, who do not have their own distribution network, have to distribute their
products through distributors / wholesalers. In that case, they usually fix the distributors margin as
mutually agreed between them and distributors / wholesalers.
With regards to raw material sourcing, the pharmaceutical manufacturers in Bangladesh procure
raw materials from various countries namely USA, UK, France, Germany, Japan, Holland, Italy,
Denmark, China, Switzerland, Austria, Hungary, India, Ireland etc.
4. Possibility of capacity expansions in future
Bangladesh being the signatory of World Trade Organization (WTO) will be part of Trade Related
Intellectual Property Support (TRIPS). Under TRIPS, the local pharmaceutical industries will enjoy
vast opportunity to expand their market including export from the year 2006 to 2016. But, there is
enough doubt whether Bangladeshi companies can derive benefits out of TRIPS since India has
been permitted to produce patented drugs. However, China will not produce patented drugs.
Bangladeshi companies will have the opportunity to export to 49 LDCs. Upon eyeing this vast
potential, the leading local companies have made aggressive plans to expand their production
capacities. Besides expanding production capacity, the local companies are also expanding their
product range i.e. new Formulations namely Inhaler, Slow Release Form, Suppositories etc. Mystic,
Apex, Rangs Medicine, Rangs Pharma, Shamsul Alamin, Popular, Silva, Marksman, INNOVA,
Bristol, Syntho, Crystal, Jams, Healthcare, Sun Pharma, etc. are the new entrants in the sector who
have made investment worth US$ 100 million. According to the DDA, another 25 new companies
waiting for license and negotiations are underway to take over at least 10 sick pharmaceutical
companies by new entrepreneurs.
5-6 existing companies have already undertaken projects for producing API and these are namely:
ACME, Orion, Navana, Opsonin, Incepta and Ibn Sina. Estimated amount of future investment is
about US$ 20 million. Another 4-5 companies have also finalized their plans for setting–up API
plants. Square Pharmaceuticals Ltd. has already made an expansion plan at a cost of US$ 40.00
million. Beximco has made a large investment for modernization and expansion of their production
facility.
- 44 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
The proposed industrial park will be established in Dhaka instead of Chittagong as planned earlier.
Finally, the government has decided to allocate 300 acres of land to set-up common facility for
water treatment plant which can be used by at least 20 companies producing API, which will
provide about 20% to 80% of total raw materials.
5. Imports of pharmaceuticals
Yearly import of pharmaceuticals
In Bangladesh, both finished products and raw materials are imported every year from abroad in
large quantity. More than 700 different types of finished products are being imported every year. A
list of the permitted items that has been imported can be seen in the attachment31. More than 750
numbers of basic raw materials including packing materials are being imported in Bangladesh for
the use of the local pharmaceutical companies. Two categories of raw materials used and imported
i) Active Ingredients/basic materials and ii) Excipients. Almost 85% of the required raw materials
are being imported. But, the percentage of imported finished products is negligible i.e. around 3%
of the total consumption in the local market. Table below shows the statistics on import:
Table 8: Yearly imports of pharmaceutical products (in million US $)
Year
2000
2001
2002
2003
2004
2005
2006
Imported
Raw Materials
118.09
122.58
125.49
136.92
91.94
105.93
99.03
Packing Materials
22.91
25.45
14.31
15.61
8.06
9.67
9.39
Finished Product
4.41
34.86
45.42
35.41
31.66
39.92
39.31
(Source:DGDA)
Data in the above table is graphically presented below in Chart-2 that again shows an increasing
trend in the total value of imports of pharmaceuticals during the last six years from 2000 to 2006.
31
For list of import items see Annex-7.
- 45 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Chart 7: Import of pharmaceutical products
160
140
120
100
Raw Materials
80
Packing Materials
60
Finished Products
40
20
0
2000
2001
2002
2003
2004
22005
2006
6. Countries of import
Pharmaceuticals products including raw materials are being imported from Germany, Switzerland,
France, USA, Denmark, Cyprus, Ireland, United Kingdom, Hungary, Austria, Greece, Italy,
Belgium, Netherlands, Pakistan, Spain and other west European countries, Japan, Korea, Singapore,
China, India, and United Arab Emirates etc. 50% of the total raw materials are imported from
China, 20% from India, and the rest 20% are imported from other countries. A number of packing
materials are used by the local companies; a portion of which are produced locally. Locally
produced packing materials include cartoon, product literature, white bottles, empty
syringe/injectible, strips, cork, plastic containers, droppers, etc. Imported packing materials are:
aluminium foil, colour bottle, foil (blister & strip), alu alu, rubber stopper, flip off seal, tear off seal,
tube, PVC, PVDC etc. 80% of the toatl packing materials are producing locally including bottles,
printing materials etc. But the country still depends on import for foils.
Obstacles to import of pharmaceuticals
There is no obstacle to import of raw materials, but import of formulation is to some extent
restricted. As per present system, if a product is produced by at least three local companies, is not
allowed to import. High-tech drugs that are not produced in the country can be imported easily.
Except government bureaucratic formalities, there is no problem in import of basic raw materials.
Volume of import may be affected due to several reasons like sudden fall in demand of certain
medicines, delay in shipment and sudden increase in demand, etc., are some of the reasons and can
be termed as import problems.
7. Projection of import of pharmaceuticals
In view of the improved socio-economic scenario and with the increase in the per capita income,
literacy rate in the country and also due to increased concern about health of a certain group of
people in the urban areas, it is assumed that total demand for all kinds of medicines and health care
products will grow in Bangladesh in the near future. Simultaneously, with the increasing trend in
the export of pharmaceuticals, the demand for raw materials will also increase substantially.
However, taking into consideration of the past performance as well as introduction of new entrants
in the sector, it is expected that the import will experience at an annual average growth rate of at
least 10% in the next 4-5 years. This rate may decrease once the existing API projects are in
commercial operation. Projected import of pharmaceuticals can be shown in table below:
- 46 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Table 9: Projected annual imports of pharmaceutical products (Value in US$)
Products
Raw Materials
Formulations
Estimated Import
2007
162
43.22
205.24
2008
178.22
47.56
225.76
2009
196.02
52.32
248.33
2010
215.62
57.55
273.17
2011
237.18
63.3
300.48
2012
260.9
69.63
330.53
The above projection is graphically presented as below:
Chart 8: Projected import of pharmaceuticals
Projected Annual Imports of Pharmaceutical Products (million US $)
350
300
250
200
150
100
50
0
Raw Materials
Formulations
Estimated Import
2007
2008
2009
2010
2011
2012
8. Apparent consumption of pharmaceuticals
The total consumption of raw materials of pharmaceuticals can be calculated from both the quantity
produced for local market and the total annual import. Local consumption of pharmaceuticals can
be estimated from the total production and total export. Total consumption is increasing every year;
average growth rate is 10-12 %32. Consumption of medicine is also increasing at the same time
import is also increasing. Since the volume of local consumption as well as import and production
is increasing, the country has made significant progress in its exports. So, total consumption of raw
materials can also be assessed from the performance of local production and export.
Table 10: Local consumption of pharmaceuticals (Calendar Year)
Amount in million (US$)
Particulars
2001
2002
2003
2004
2005
2006
Total production 401.78 555.01 590.08 685.15 804.61 711.98
(estimated)
Total export
5.98 7.83
10.93 26.1
25.54 39.71
Total local
consumption
395.8 547.18 579.15 659.05 779.07 672.27
32
Source: Nazmul Hasan, CEO, Beximco Pharma
- 47 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
The above data is graphically presented below:
Chart 9: Local consumption of pharmaceuticals
Total Consumption
Total Local Consumption (million US $)
1000
800
600
Total Local
Consumption
400
200
0
2001
2002
2003
2004
2005
2006
Year
9. Potential consumption of pharmaceuticals
Since there is an increasing trend33 in both local and export market, it is assumed that the potential
demand for raw materials (category wise raw materials potentiality) will be increased at a
significant volume in near future. On the top of that, new companies have already started
production and another batch of new units is in the pipeline that will start production. So, there is a
good market potential for manufacturers and exporters of raw materials. Similarly, the potential
demand for finished products in Bangladesh will also increase due to several valid reasons. Reasons
are increased rate of literate persons tend to be more health conscious, elder people seeking higher
life expectancy, increase in per capita income, improved life style, large groups of educated and,
increased awareness among mass people about newly invented drugs and medicines and so on.
Finally, the volume of import of both basic materials and high tech Formulations used for serious
diseases will be increased substantially. Annual average growth rate of local production is around
13%. In view of the above assumptions and considering the previous average annual growth rate of
local production, the projection of future consumption has been made at growth rate at 20% as
shown in chart below.
33
Future projection may be seen at Chart-5.
- 48 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Chart 10: Projection of future consumption
Value in million( US$)
Projected Annual Consumption
2000
1500
Comsumption
1000
500
0
1
2
3
4
5
Year
E. Import policy and procedures
1. Directorate General of Drug Administration (DGDA)
After Independence and till 1981, the pharmaceutical sector of Bangladesh was regulated by the
rules and regulations drawn by the then Pakistan Government. During that period of time, the
MNCs dominated the local market and the domestic pharmaceutical companies had very little
market share. Then in 1982, the Government of Bangladesh introduced a radical and far-reaching
National Drug Policy (NDP) and a new ordinance called “Drug (Control) Ordinance, 198234 was
also introduced keeping in mind the World Health Organization (WHO) recommendations on
essential drugs. This had been done to ensure adequate supply and availability of good quality
essential drugs at affordable prices. These two documents produced tremendous positive effects on
rapid development of the local pharmaceutical sector and gradual improvement and gain in the drug
sector for the country. As a result of introducing these policies, the drug manufacturers could make
procurement at a competitive price thus enabled the local manufacturers to offer a competitive price
to the consumers. The Ordinance brought to an end to transfer pricing and over invoicing for import
of capital machinery and raw and packing materials which were common practices before 1982.
2. Positive Analysis of Drug Policy -200535:
After having 22 years of steady growth in the local pharmaceuticals industry sector, the government
and other stakeholders strongly felt that the policy should be updated and modified and new
elements should be included in order to properly deal with the changes and development that have
taken place in the drug sector over this long period of time. Accordingly, the National Drug Policy
2005 has been revised in order to accommodate current needs of the country as well as to make it
consistent to the global business environment.
34
35
For Drug Controll Ordinance -1982 See Annex – 10.
See Annex-5 for Drug Policy 2005
- 49 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Basic focus of the new drug policy is as follows:
•
To make it more applicable, effective and adaptive to the remarkable technological
advancement that has been made in the medicine world.
•
To guide the Drug sector of the country to perform better in the competitive world market
•
To make the country a producer and exporter of good quality drug in the world.
The revised policy is expected to empower more authority to the DDA through converting it into
Directorate General of Drug Administration (DGDA) which will reduce bureaucracy in one sense
and speed up workflow under the same roof. All modern facilities planned to be created for testing
laboratory and other purposes and the officials will be trained on latest tools and techniques in order
to improve regulatory environment as well as to deliver quality services to the industry. The new
policy will also help better and strict monitoring of illegal activities and malpractices in the
industry; it is more open to the multinational companies who are interested to undertake ‘research
and development’ for producing improved quality and innovative drugs. This policy will also help
setting up of plant for producing raw materials i.e. active ingredients by the local and foreign
investors. There is also provision for licensed manufacturing, franchising and other facilities to
attract the foreign investors. Further details can be seen in the annex36.
In Budget37 2007-2008, it was informed that the Government is taking steps to put in place
improved hospital management system for enhancement of quality of health services. Government
is very much eager to ensure increased involvement of the private sector at different levels of health
services. A decision has been taken to ensure increased involvement of NGOs in activities like
population control and prevention of malnutrition and contagious diseases The Government is
continuing duty free facility to different lifesaving drugs including insulin required for health
services of the general public.
Foreign Investment for API and formulations are encouraged. A large number of incentive scheme
are announced for 100% export oriented industry. (Details can be seen in www.boi.gov.bd)
Rules and regulations on import of pharmaceutical products
In Bangladesh, all kinds of import whether it is machinery or raw materials or finished goods are
made following the prescribed rules and regulations as stipulated in the “Imports and Exports
(Control) Act, 1950” and subsequently announced export and import policies. Presently Export
Policy 2006-09 and Import Policy 2006-09 is in existence. According to the Imports and Exports
(Control) Act, the raw and packing materials for the pharmaceutical industries may be imported
upon fulfilment of the conditions as below:
•
36
37
Only the government approved and recognized pharmaceutical industries, on the basis of their
annual production plans, may get approval of the Block list that comprised of
description/specification, price and quantity of import, etc. from the Director, Drug
Administration for importing raw and packing materials;
Foreign Investment Incentives is enclosed in Annex-11.
Source: Budget Speech 2007-2008
- 50 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Raw and packing materials mentioned in the Block list shall be imported at price and quantity as
specified in such list. Any goods not included in the Block list shall not be imported by the
pharmaceutical industries;
•
Any additional approval for import of raw and packing materials, other than allowed by the
Director, Drug Administration, shall have to be obtained prior to import. Copy of the approved
Block list shall be supplied to the Director, Drug Administration Authority, Customs Authority
and Chief Controller of Import and Export;
•
For clearing goods from the Customs Authority, the invoice and detailed report of the imported
raw and packing materials shall be certified by the Director, Drug Administration or certificate
will be collected from the internationally reputed Pre-Shipment Inspection Agent who certifies
quantity, price and quality of the imported products. On the basis of the aforesaid documents,
the Customs Authority exempts duty for the importer/manufacturers.
Overseas market regulatory requirement:
In order to enter into very highly regulated (USA, Western Europe) markets for upgrading standards
like USFDA, MCA, TGA, MCC, it needs huge investment; moderately regulated (Russia,
Singapore etc) markets requires Bioavailability, Bioequivalence, Clinical Trial, validation, Less
regulated (Myanmar, Kenya, Sri Lanka, Yemen) markets also required standard but it is relatively
less stringent. New requirement for moderately regulated markets are also coming up.
Different categories of importers of pharmaceuticals
Import license of raw materials is issued to all manufacturers that allow them to import from any
part of the world except Israel. Prospective Importers are issued license only for importing
Formulations, but not for raw materials. Importers of various pharmaceutical items can be grouped
under the following categories:
•
Distributors/Agents of foreign suppliers
•
Importers of Finished products (Formulations)
•
Indenters/Indenting houses for the local pharmaceuticals companies
•
Aid or grant projects of different donor agencies and NGO
•
Government owned organizations like Essential Drugs Company Ltd. (EDCL) is also operating.
It is a service oriented public company producing essential drugs for the government organization.
Contractual sale is possible subject to approval of the Board38. For normal sale they need to go for
Tender. The product of the EDCL is certified by UNICEF. Compliance authority, regulatory
authority of EDCL is UNDP. It was registered on October 1983. EDCL is run by Factory Act 1965.
Workers Staff services are governed by and regulated as per standing order of ACT 1965 as up to
date by amendment of the Act 2006. EDCL has 123 products. EDCL has a company in Bogura (a
district of Bangladesh).
38
Composition of the Board of EDCL is enclosed as Annex-12.
- 51 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Cepholoprin project with capacity of 18000 Vials (injections) will come into operation soon. A
contract was done with Beximco to buy products of the projects for 5 years. In addition to that a
Condom Manufacturing Industry in Khulna will come into operation by November 07. A joint
venture with an Indian company for producing Contraceptive is also in the process of negotiation.
Raw Material Procurement Process: EDCL procure raw material through International Tender. If it
is possible to collect from the local companies subject to the approval of the Drug Administration.
Sources of raw materials have to be validated earlier.
Drug Administration Authority shall approve all sorts of import as proposed in the related block list.
In general, there is no quantitative/value restriction on the imports of pharmaceuticals products but
the Drug Policy is the guiding factor. There is no specific restriction for imports from any country
except Israel. The prospective applicant or importers need to obtain and produce “Free Sales
Certificate” from the country of origin and another 2 developed countries. Import license is a
requirement for private and semi-private pharmaceutical sectors, but not for public sector.
Importer shall produce the following documents for license:
•
Trade license
•
Bank Solvency Certificate
•
Up to date rent receipts
•
Certificate of the Pharmacist
•
Contract with the landlord
•
Ownership title of land & building (in case of own property)
•
Undertaking of the Pharmacist in the letterhead pad
•
Form-9 duly filled-in and signed.
•
Payment evidence of fees
Transfer of import license is possible as per the rules of the DDA. Import License fee is US$ 507 is
needed. Extra cost may be incurred in some cases.
Steps required for product registration
Any prospective manufacturer/exporter has to apply in prescribed form for product registration and
certifications along with the followings documents:
•
Name and addresses of the manufacturer
•
Manufacturing license number
•
List of drugs
•
Proposed maximum retail price
•
Estimated treatment cost (daily & full course)
•
Product data sheet
•
Technical data sheet
- 52 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Pharmaceutical data sheet
•
Toxicological data sheet
•
Clinical data sheet
•
Report on environmental impact assessment / analysis
•
Names of the existing manufacturers and market size
•
Bio-data of the production, factory and quality control manager
3. Import duties
Import duty structure and basis of valuation
Import duty and other taxes are charged on both Formulations and raw and packing materials.
Import duty on any active ingredient exclusively used for pharmaceutical products is 5%. In case of
commercial import, the import duty is 15%. As per import Policy 2006-09, following rates are
applicable for sample import:
Types of Importers
Items
Quality/ C& F Value of the
item up to which import will
be allowed without import
permit/prior permission
medicines $1080
1.Importers/indentors/agents
of allopathic medicine
2. All importers, industry &
agents
Drugs
&
(Allopathic)
Other samples & advertising About $1500
materials
3. Agents of foreign
New brand of item or sale with $1080
manufacturers, appointed a view to introducing them to
in Bangladesh
the consumers
Other charges on imports
Value added tax is collected at 15% from all imports, but it is adjusted afterwards on the basis of
actual production output. Raw materials used for products to be exported ultimately require no duty.
Advance Income Tax (AIT) at 3% is also charged but to be refunded later. Development surcharge
(4%) was withdrawn for the year 2007-08.
Cost, Insurance and Freight (CIF) price of the materials to be imported on the basis of assessment of
import duty and other taxes. This may vary in an exceptional situation. In addition to duty
assessment, tariff value is also imposed. Such tariff value is assessed on the basis of the highest CIF
value of raw materials being imported by other importers. Assessment of tariff value depends on the
discretion of the customs authority, and it varies from case to case and it is a determinant factor of
actual landed cost of any imported materials. PSI is in existence for any import in Bangladesh,
which is 1% of the assessment value. Pharmaceutical raw materials are exempted from PSI.
Packaging materials required PSI.
- 53 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
An audit company has been appointed in this year to bring transparency of the activities of the PSI
companies. Apart from this, every import incurs basic costs that include license fee (0.25% of the
CIF value), L/C commission for opening letter of credit (0.3% to 0.5% of the L/C value or
minimum US$ 6.5), bank charges and insurance premium at 1% of the C & F value of the materials
to be imported.
Custom valuation
The Government Customs department through its designated officials assesses the value of import
in “local currency (Taka)”, based on the “invoice value”.
4. Documentary requirements for imports
Following documents should be submitted to obtain permission for import of pharmaceutical
products in Bangladesh:
•
Copy of approved “Block list” of Directorate of Drug Administration (DDA)
•
Copy of Import License from Chief Controller of Export and Import.
•
Import Relevant other papers for Block list
•
Approval for new products (in case of Formulations)
•
Certificate of country of origin
•
Copy of indent quoting source and price of goods (six copies)
•
Filled-in & stamped letter of credit application (full-set of documents Bank prescribed)
•
IMP form of Bangladesh Bank
•
Insurance coverage acceptable to the bank
•
Free Sales Certificate or No Objection Certificate from the two countries including the country
of origin (in case of Formulation)
Before import, a sample needs to be sent to the laboratory for testing quality. Once the sample is
found acceptable, then it will be sent to the DDA office for inclusion in the Block list. After getting
delivery of the products at the factory of the manufacturer another testing will be done. Following
documents, attested and certified by the Directorate of Drug Administration, should be produced to
the Customs Authority for clearing the imported goods from the port:
•
Certificate of analysis
•
Copy of Invoice
•
Copy of certificate of origin
•
Copy of bill of lading/ airway bill
•
Form-9 (an undertaking according to the World Wide Drug Rules 1945)
- 54 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
F.
Import practices
Any pharmaceutical product produced locally by at least 3 local pharmaceutical companies is not
allowed for import. Private Importers, Agents and Distributors directly import required goods and
market and distribute them through their own distribution channels. The end-users are unable to
import directly any product for their own use, as the product registration is mandatory before
import, except certain conditions. Government departments are not importing any Formulations but
basic materials. International Humanitarian Agencies (WHO & UNICEF) and organizations are
importing Formulations occasionally for direct supply to the end-users. No NGO imports
Formulations. But they import raw materials (Ganashastha Pharmaceuticals).
1. Profiles of importers, buying methods and modes of transport
Almost all pharmaceutical companies procure raw materials through indenting houses, except a few
big companies. Formulations are imported through the local agents of the foreign companies. But,
there are also direct importers, druggists and chemists who import products for trading purpose. In
case of import of raw materials and finished products, the local indenting houses and Clearing and
Forwarding Agents play an important role. In Bangladesh, the local importers of drugs and
medicines are well organized. Terms and conditions of import of raw materials vary from product to
product as well as manufacturers. There is no restriction on quantity and quantity depends on the
requirements of individual companies. There is no restriction on import of packing and packaging
materials. Lead-time of import depends on country of origin and mode of transports. In case of
Active Ingredients the provision for safety margin is 3-4 months (by sea) and 2 months (by air). For
Excipients safety margin provision is 6-8 months if the shipment is made by sea and 4 months (by
air). For Finished products, it is 2-4 weeks. Four different modes of transport are being used for
import and these are by air, by sea, by rail and by road. However, major parts of the imported
materials are coming by sea. Usual point of entry is Chittagong (90%) and Mongla (10%). For
import of high power but light and costly pharmaceuticals, the local importers use air route
frequently. Some portion of the import is also coming by road through land border mainly from
India.
A large number of indenting houses, leading representatives of manufacturers, agent of foreign
principals, local partners, are working in Bangladesh to facilitate pharmaceutical inputs.
2. Distribution channel, cost and mark-up
Since Formulations are basically retail market oriented items, distribution function is very crucial.
All companies directly distribute their products through their own distribution personnel and
channels except 2-3 leading companies who give special attention on distribution function. Separate
Distribution Functions are specifically done by some of the companies, a large number of big
retailers are also in operation. One of them is Lazz Pharma Limited39; they have several big
branches with 24 hours of services. Several other companies are also planning to separate the
distribution functions from market promotion in order to bring efficiency in delivery and
distribution. Multinational companies like GlaxoSmithkline, Novartis, Aventis, Eskayef and
Organon have been hiring local private distribution companies for distribution and delivery of
goods.
39
For address , see page 59
- 55 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
For example, Transcom Distribution Company Limited distributes products for others. Leading
local companies like Square, Beximco, ACI, Renata, ACME, Opsonin, Ambee, Navana,
Aristopharma, Ibn Sina, Orion, Essential, Incepta, Jayson etc. have their own distribution channels
and network with efficient staff and required infrastructure facilities. Many of them have depots in
different parts of the country beside the central warehouse to smoothen distribution function.
Indenting houses directly deliver the imported raw materials to the factory of the manufacturers.
The local agents and Importers store imported Formulations at their ‘Godown’ and distribute from
there. In pharmaceutical products, the ‘mark up’ differs from product to product. On an average,
mark up ranges from 15% to 30% of the MRP. Distribution costs ranges from 5% to 7.5% of sales
turnover. Local companies using bottle as packing materials incur more distribution cost, not
exceeding 10% of the sales turnover.
G. Market competitions and prices
In Bangladesh, there is an increasing competitive scenario in the pharmaceutical market. There are
new entrants like Jalpha lab limited, Lawai, Sylhet in the market with strong capital base and
corporate image. New entrants of the last two year though not many but some are going for
expansion and introduction of new products. Leading existing companies are also more organized
and serious about market promotion to capture a certain market niche. Local companies are
competing with the multinationals. At present, there are about 20-22 key competitors including the
multinational companies. The local companies have captured lion market share and dominating the
domestic market. Local companies namely Square, Beximco, ACME, Renata, Opsonin, ACI, Drug
International, Ambee Pharma, General Pharmaceuticals, Incepta, Jayson Pharmaceuticals,
Pharmadsh, Ibn Sina and so on have captured around 70-75% of the entire market. Multinationals
occupy very little market share not exceeding 10% of the total market. According to new Drug
policy, the competition will increase in future since foreign companies and investors are strongly
encouraged to market their products in Bangladesh.40
1. Strength and weaknesses of Bangladeshi companies
In general, Bangladeshi pharmaceuticals companies are now stronger in terms of quality product,
attractive design, safe packing, timely delivery, and competitive price. Almost every good company
has ISO certificate41 and sound quality control system run by qualified staff. The leading companies
are maintaining international standards in all spheres of their business activities. Several companies
are of world standard and deserve strong competitiveness in the world market. Main weakness with
the local companies is the dependency on the imported raw materials. Research and development
needs to be progressed further for long term sustainability.
2. Product design
Although product design varies from company to company, but the leading local and foreign
companies have certain standard on product designing that is acceptable to world market. They use
quality design of packs, strips, bottle cover etc.
40
41
A list of the top 40 pharmaceutical companies in Bangladesh see Annex-8.
See Annex-3 for the List of ISO Certified Pharmaceuticals
- 56 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
3. Quality
Top 25 companies are producing products of international standard and all manufacturers follow
Gross Manufacturing Practice (GMP).
4. Price
The prices of products under controlled category are determined by the government. The
manufacturing companies are allowed to propose the prices of the products that are under
decontrolled category and the approvals of these proposed prices are given by the government.
Since the local government strictly controls price of pharmaceutical products, there is a very
negligible price difference. The maximum retail-selling price of a product shall be just double the
price of API plus value added tax at 15% VAT. But, the price of raw materials is competitive which
is fixed based on international market situation. As Pharmaceutical manufacturers have to depend
on imported raw materials, increase in prices of raw materials internationally impact directly to the
cost of production.
5. Distribution
Most of the leading pharmaceutical manufacturers have their own distribution network and ensure
supply of products up to retail level. But the companies who does not have their own distribution
network, has to distribute their products through distributors / wholesalers. In that case, they usually
fix the distributors margin as mutually agreed between them and distributors / wholesalers.
With regards to raw material sourcing, the pharmaceutical manufacturers in Bangladesh procure
raw materials from various countries namely USA, UK, France, Germany, Japan, Holland, Italy,
Denmark, China, Switzerland, Austria, Hungary, India, Ireland etc.
6. Terms
Terms and conditions of sales are almost same for every company, since the profit margin is almost
same for every product. Usual discount for the traders/retailers’ level is 12-15% for local
Formulations and 10-12% discount for imported Formulations. Some companies offer special
discount time to time (seasonally) to the traders that ranges from 2.5% to 7.5%. Provision for credit
sales is not usual practice. But some companies are doing on the basis of their own policy based on
the demand of the product.
7. Back-up services
Back-up services are there at retailers’ level. Expired unsold products are refunded at a certain
percentage. Loss and damages are also compensated depending on the quantity of medicine.
8. Promotion
In Bangladesh, promotion of pharmaceutical products in the mass media is strictly prohibited.
Market and sales promotional activities are carried out by field level sales force. Every company
has its own sales at local and international level. Required transport facilities are given to the sales
force in the field to visit doctors, health care centers, hospitals and private practitioners.
- 57 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Manufacturing companies can only promote their brands to the health professionals by personal
selling, clinical meetings, seminars, symposia etc. For promotion with printed promotional
materials like literatures, pads, posters, stickers etc, the manufacturing companies have to submit
the same to the drugs administration for approval and upon their clearance the companies can
promote their products using those promotional tools. According to the government regulation, the
pharmacies / chemists are entitled to get 16% retail margins on top of the trade prices of the
products. Adequate promotional materials are distributed to the practicing Doctors for their regular
use. According to the local laws, advertisement on products or brands is not allowed through any
media. Product advertisement can be published in the medical journals provided there is prior
permission from the concerned authority.
H. Market prospects and market entry strategy
1. Macro economic environment
The overall macro economic environment is quite positive and favourable for international
business. Both import and export are increasing. Import is increasing since the country has moved
to manufacturing sector more aggressively due to availability of skilled and cheaper labour force. In
order to carry out international business smoothly, the national information infrastructure (NII) has
also improved. The government has introduced liberal policy to attract for the foreign investors,
business and commercial organizations. The country is experiencing slow but steady growth in the
Gross Domestic Product (GDP) at 6.5%. Key indicators of gradual improvement in the economy are
positive, per capita income has increased at US$ 482 (June 2007), adult literacy rate has increased
at 65%, average life expectancy rate has increased at 68.2 years, import grew only at 13%. Inflation
rate has increased to 9.2%.
Per capita expenditure on medicine has increased at more than US$ 4.00, (DAB & IMS Report)
which is among the lowest in Asian countries, compared to developed countries. But, this indicates
good potential for the growth of domestic market. The pharmaceuticals sector is a growing sector as
mentioned in the earlier chapters.
The export target of the year 2006-2007 was US$ 33 million against which export was US $ 28.16
million. The export target of this sector in 2007-2008 is 32 Million US Dollars.
But the manufacturer of pharmaceuticals predicts that the amount of export will increase
tremendously in the next 2-3 years. Export is targeted to increase at least double in the year 200809. Recent export performance has drawn the attention of the government. But, the pharmaceutical
industry sector is heavily depended on imported raw materials. Rapid growth in the export market
has created opportunity to expand production capacity. The sector can be viewed at a glance from
the attached sectoral profile42.
42
Sectoral Profile is enclosde as Annex - 13.
- 58 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2. Availability of marketing services
In Bangladesh, all kinds of marketing and market promotion services are available. There are
marketing companies who can take up assignment of marketing and distribution of products overall
the country. A large pool of sales force has been developed over the last 22 years who can take the
products to the doorstep of the end users through 200,000 retailed Pharmacies.43 To organize a sales
and marketing force, expert services can be taken from local source. Moreover, there are marketing
and promotional agencies, distributors, indentors and stockiest. Organizations are there to import
skill development training on sales, marketing and distribution. There are trade journals, newsletters
and trade bulletins specifically for the pharmaceuticals sector. There are a good number of event
organizers who can organize trade fairs, exhibitions and other events. In the year 2006-2007 Saigon
Medi Pharma Expo-2007 was held from 23-26 August, in 2007, Hochi Min City, Vietnam. Besides
there are some common goods and industrial products Expo is planned to be held in November and
December of the year.44
3. Recommended strategy for new entrants
Following the success stories of the leading companies, several factors have been considered as
critical to success and these are as follows:
•
Quality product through quality production system
•
Skilled and trained manpower for product promotion
•
New and wide range of products
•
Innovative promotional techniques.
•
Strong backward linkage support with or outside the country
•
Prompt and cost effective delivery and distribution network with depots
•
Attractive packing and packaging with detailed specifications
•
Continuous research and development for improvement of products
•
Sound operational plan including marketing and financial planning
In the days to come, the local market will be very competitive. A new company should be well
prepared with all sorts of planning like marketing and promotion, procurement and production,
distribution and delivery, sound financial management, innovative product development for the new
entrants’ requirement. A good combination of several major elements may bring success for any
new entrant in this sector and these are as follows:
(a)
Product characteristics
161 companies are selling common products, such as tablets, capsules, syrup (liquid) etc. To attain
competitive edge, new entrant should emphasis on new dosage forms like, Anti-biotic, drugs,
inhaler, suppositories, needle free injection, patch injection etc. Herbal products have a large
potential market in Bangladesh.
43
44
Source: Daily Naya Diganta.
List of International Trade Fairs & Single Country Trade Exhibition in 2007-2008 is enclosed as Annex XIV
- 59 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Table 11: Medicinal plants utilized by company size and sector
Local
$Million
Tonnes
Large Companies
3.25
3, 450
Small Companies
4.20
4,250
Formal
7.45
7,700
Practitioners
1.7
1,550
Self Treatment
4.8
3,250
Informal
6.5
5,400
(Source: SEDF/IFC: Medicinal Plant Marketing in Bangladesh)
Imported
Tonnes
1,520
1,800
3,320
650
1,000
1,950
It is estimated that some 12,500 tonnes of dried medicinal plant material produced in Bangladesh
for selling. These products are worth some Tk. 255 million (US$ 4.5 million) to the rural economy
and around Tk. 330 million (US$5.8 M) at the factory rate /wholesale. The 5,000 tonnes of
imported medicinal plants cost around Tk 480 million (US$8 Million). It is believed that there are
around 350 inter-district beparies who are serviced by 6,000 to 10,000 local collectors, pickers and
growers. In total there are said to be around 200 Unani and 200 ayurvedic registered factories, plus
some 70 homeopathic factories. Collectively they will employ 2,000 to 4,000 people. In addition,
there are said to be 5,000 qualified and 80, 000 unqualified herbal practitioners in the country.
(b)
Price
Since the government strictly controls price of pharmaceutical products, a new company should
adopt ‘shadow or indirect’ pricing method.
(c)
Trade channel
New companies should adopt trade channels that minimize their distribution and other costs.
Possibility should be explored to get institutional orders. Contract manufacturing can be one of the
options since the revised policy allows it. Bangladesh has all the infrastructure & facilities to be an
ideal place for contract manufacturing. It has state-of-the-art manufacturing facilities, highly
educated & skilled human resources, sophisticated & cutting edge quality control laboratories. It
can manufacture highest quality products conforming to all international standards like British
Pharmacopoeia (BP), United States Pharmacopoeia (USP), European Pharmacopoeia (EP) and any
other recognized standards.
Equipped with the most advanced technologies & following cGMP standards, Bangladesh
Pharmaceutical Industry can cater to any healthcare need of all concerned. Some of the
pharmaceutical manufacturers of Bangladesh have made multi-million dollar investments on new
plants and facilities conforming to USFDA standards. They have sufficient production capacity for
contract manufacturing. Since Bangladesh has abundant and cheap labor force, the cost of contract
manufacturing would be highly favourable compared to any other countries of the world.
- 60 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
(d)
Promotion
Since direct product promotion activities are prohibited other means should be applied. Push selling
system can be an effective technique for product promotion. Besides, incentives in different forms
may be given to the field level sales force, doctors and medical practitioners. Sponsoring various
events like workshops, seminars on medicines and healthcare related issues and financing charitable
healthcare activities can be adopted.
(e)
Joint venture arrangements
Joint venture arrangement with foreign reputed pharmaceutical companies having plant for API
possibly form USA, Europe-Scandinavian countries, Japan will be best option for any new entrant.
(f)
Buy out and mergers
Recently, many MNCs merged. In Bangladesh, there are some dormant factories which can be
bought and restarted through infusing fresh funds. At this moment there are some dormant
industries in Bangladesh as from the statistics it is seen that out of 239 registered industries 161 are
in operation.
(g)
Drug Testing Laboratories
Bangladesh badly needs a Drug Testing Laboratory. New entrants can also invest to set up a
Standard Drug Testing Laboratories.
- 61 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
IV. USEFUL OFFICE ADDRESSES
SL.
No.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Office
Addresses
Directorate of Drug Administration
104-105, Motijheel Commercial Area,
(3rd Floor), Dhaka
Tel: 9556126,9553456
Fax: 9568166
E-mail: drugs@citech.net
Bangladesh Association of Pharmaceutical House F 31, Road 4,Block F,
Industries
Banani, Dhaka-1213
Fax: 8816767
Tel:9889731
E-mail; bdass@bol-online.com
Federation of Bangladesh Chamber
Commerce and Industry (FBCCI)
of Federation Bhaban,
60, Motijheel Commercial Area
Dhaka
Dhaka Chamber of Commerce and Industry
65-66, Motijheel C/A
Motijheel Commercial Area
Dhaka -1000
Tel: 9552562, Fax:
Metropolitan Chamber of Commerce and 111-113 Motijheel Commercial Area,
Industries
Dhaka. Tel: 9565208-11 & 7161028-29
E-mail: sg@citechco.net
Website: www.mccibd.org
Export Promotion Bureau
TCB Bhaban,
1, Kawran Bazar, Dhaka-1215
Tel: 9144821-24, 8151496
Fax: 8802-9119531
Website: www.epb.gov.bd
Chief Controller of Export and Import
Motijheel Commercial Area
Dhaka
Association of Pharmaceuticals Importers of 5th Floor City Heart Center
Bangladesh
Kakrail, Opposite to jonaki Cinema
Hall, Dhaka
Bangladesh Chemist and Druggist Samity
1, Mitford Road,
Dhaka
Bangladesh Pharmaceuticals Executive Club New DOHS, Mohakhali, Dhaka
Limited
Lane 32 Corner Building (left)
Ministry of Commerce
Bangladesh Secretariat,
Government of People’s Republic of Topkhana Road
Bangladesh
Dhaka
Department of Pharmacy, University of Dhaka Science Building,
Dhaka University, Ramna
Statistics Department, Bangladesh Bank
Shapla Square
Motijheel Commercial Area
Dhaka
- 62 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
14
15
16
17
18
19
20
21
22
23
Pharmacist Council of Bangladesh
Karwan Bazar, Dhaka
Tel: 0188844241
SAKA International Ltd.
Suit 4B, (4th Floor )
Complete
solutions
providers
for Anam Rangs Plaza
Pharmaceutical Industries
Plot#61, Satmosjid Road , Dhaka-1209
Tel: 9120294
e-mail: saka@bol-online.com
saka@saka.com
Web: www.saka.com
Nest international (pvt) Ltd.
1, Monibag, 3rd Floor, Rajar Bag,
Dhaka
Tel: 9350180
E-mail:
munir-1@aitlbd.net,
nest@bdcom.com
Essential Drugs Co. Ltd.
395-397, Tejagaon industrial area
Dhaka-1208,
Fax: 8113463, 9130036
E-mail: syedmanik@yahoo.com
Former President
28, Dilkhusha C/A (9th Floor),
Bangladesh Indenting Agents’ Association
Dhaka-1000
Tel: 7169265, 9552436
Secretary
28, Dilkusha C/A, Dhaka-1000
Bangladesh Indenting Agents’ Association
Tel: 7169265, 9552436
CEO
9/29, Eastern Plaza, Hatirpul,
Khan and Deen Traders
Dhaka-1205
Tel:
8618781,
01199853997,
01711535380
Managing Director
15, New Baily Road
Bangla Chemicals
Dhaka-1217
Tel: 8362853, 9346780,01711520138
Managing Director
TNC Tower, Bangla Motor
Benham Pharmaceuticals
Dhaka
Tel: 8321340, 8313298
Managing Director
64/3, Lake Circus, Kalabagan, Mirpur
Lazz Pharma Limited
Road, Dhaka-1205
Tel:
0187595066,
0189289320,
01712926399
Website: www.lazzpharma.com
- 63 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex I – List of officials interviewed for the survey
1. Mr. Selim Barami, Superintendent of Drug, DA on 9th October 2007
2. Mr. Nazmul Hasan, CEO, Beximco Pharma, 17th October 2007
3. Mr. Ziaul Haque, Secretary, BAPI, 17th October 2007
4. Mr. Abdur Rouf, Deputy Director, EPB, 17th October 2007
5. Mr. Taher Ahmed, Manager, EDCL, 17th October 2007
6. Past President, BIAA, 18th October
7. Secretary, BIAA, 17th October 2007
8. Ms. Azra Salim, Director, Jayson Pharmaceuticals Ltd., 24th October, 2007
9. Mr. Md. Lutfor Rahman, Managing Director, Lazz Pharma Limited. , 26 October 2007
10. Professor M. Shahabuddin K. Choudhuri, dept. of Pharmacy, Jahangirnagar University
11. Md. Hasan Imam Khan
12. Dr. Md. Al-Emran Ali, Lecturer in Medicine & Pharmacy Incharge, Govt. Homeopathic
medicla College & Hospital
13. Dr. M.A. Hakim , Chairman , Bangladesh Neem Foundation
14. Ms. Stamina Halder, Associate Adviser, Market Development & private Sector,
Intercooperation
15. Md. Humayun Kabir, Manager, International Marketing Department, the ACME Laboratories
16. Dr. Ferdousi begum , Plant Biologist , Executive Director, Development of Biotechnology &
environmental Conservation centre
17. Mohd. Mynul Isalm, Sales Coordinator, Square Herbal & Nutraceuticals Ltd.
18. M. Ahsan Ullah, Mahaging Director, Alpha Ayurvedic limited
19. Dr. Md. Niyamot Ali Fakir, Principal, Govt. Homeopathic College & Hospital
20. Dr. Gurudas Sarker, Assistant Professor, Govt. Homeopathic College & Hospital
21. Mr. Zahid Hossain, Managing Director & CEO, ZAP Natural Product Limited
22. Md. Ata-a Moula, Plant Director, Gonoshasthaya Antibiotic Ltd.
23. Mr. Rafiqul Islam, Director marketing, Hamdard Laboratories (WAQF) Bangladesh
24. M. H. Khan, General Manager-Operations
25. Md. Nurul Isalm, Director, Bangladesh Institute of Apiculture
26. Dr. Md. Amin Uddin Mridha, Professsor, dept. of Botany, University of Chittagong
27. Farid Uddin Ahmed, Executive Director, Arannayk foundation
28. Dr. Md. Hossain sohrab, Project Director, Institute of Herbal Medicine and Research, BCSIR
29. Abu Zafur Md. Sadeque, Manager, Purchase, Hamdard Laboratories (WAQF) Bangladesh.
30. Mohammad Rafiqul Isalm, Director, Marketing and Sales, The ACME Laboratories Ltd.
31. Md. Humayun Kabir, Manager, International Marketing Department, The ACME Laboratories
Ltd.
32. Mr. M.S.I. Dastagir, Executive Vice-President & CEO, Excelsior Trading Corporation.
- 64 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex II - Excerpts of Export and Import Policy 2006-09
EXPORT POLICY 2006-2009
Highest priority sector:
The highest priority sector will refer to the products that have high export potentials but, for
different reasons, the potentials could not be used and necessary support could promote their
exports.
The following products will be listed as highest priority sector:
•
•
•
•
•
•
Agro-products and agro-processing products;
Light engineering products (including auto-parts & bicycles);
Leather products;
Pharmaceuticals
Software & ICT products;
Home Textile
Following incentives and facilities will be provided for highest priority sectors :
•
•
•
•
•
•
•
•
•
•
•
•
•
Project loan with lower interest rate on priority basis;
Income tax exemption;
Provide subsidy commensurate with WTO Agreement on Agriculture and Agreement on
Subsidies and Counter Veiling Measures
Provide financial incentive or subsidy on the utility charges for electricity, water, gas etc.
commensurate with WTO Agreement on Agriculture and Agreement on Subsidies and Counter
Veiling Measures
Financial incentives including cash assistance;
Export loan on easy term and lower interest rate;
Air transport facility with exempted transport fare;
Tax return/bond facility;
Assistance for setting up infrastructures and related units to reduce production cost;
Expansion of institutional and technical facilities for developing product quality and quality
control;
Assistance in marketing products;
Assistance in exploring markets abroad;
Assistance in foreign investment.
IMPORT POLICY ORDER 2006-2009
Medicine :
26.8.1 Medicine (Sulphonamides classifiable under H. S. Code No. 2935.00 under H. S. Heading
No. 29.35, H. S. Heading No. 29.37 to 29.39 and all items classified under them, anti-biotics
classified under H.S. No. 29.41, all items classified under H. S. Heading No. 30.01, all items
including live vaccine classified under H. S. Heading No. 30.02 all items classified under H.
S. Heading No. 30.03 and 30.04) Medicine included in importable list through government
- 65 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
gazette notification by Drug Administration Authority will be imported on prior approval by
the Director, Drug Administration and the amount of medicine, trade name and generic
name, value, registration number given by Drug Administration, date of manufacture and
date of expiry will be mentioned in the approval letter.
26.8.2 Engymes classified under H. S. Code No. 35.07 and all items classified under H. S. Code
Heading No. 29.36 are importable by importers and manufacturers of medicine on approval
of Director, Drug Administration and subject to conditions mentioned in para 24.4 and
26.8.1 of this Order.
26.8.3 Bandage (sterile surgical) classified under H. S. Code No. 3005.90 and H. S. Heading No.
30.05, composite diagnostics (invivo) classified under H. S. Code No. 3822.00 and H. S.
Heading No. 38.22, syringe (with or without disposable needle) in blister pack or in ribbon
pack classified under H. S. Code No. 90.18 and blood bags (sterile) for transfusion classified
under H. S. Code No. 1918.90 and H. S. Heading No. 90.18 are importable on permission of
Drug Administration and subject to the conditions mentioned in para 24.4 and 26.8.1 of this
order.
26.8.4 Parts and Fittings for Infusion Set are importable with clearance from the Director, Drugs
Administration and subject to prescribed conditions at para 24.4 and 26.8.1 of this Order.
- 66 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex III - List of some important ISO certified Companies
Following Pharmaceutical Industries are known to have ISO 9001:2000 certification:
1. Aristo Pharama
2. Chemico Laboratories
3. Drug International
4. Globe Drug Limited
5. Hamdard Laboratories
6. Opso Saline Limited
7. Rephco Laboratories
8. Square Pharmaceuticals Limited
9. Techno Drugs
10. Chemist Laboratoy
11. The ACME laboratories Ltd.
12. The Ibn Sina Pharmaceutical
13. ACI Ltd.
14. Ambee Pharmaceuticals Ltd.
15. Amico Laboratories
16. AP (Dhaka) Ltd
17. Apex Pharmaceuticals
18. Edruc Ltd.
19. Navana Pharmaceuticals
20. Nipa Pharma
21. Novus Pharma
22. Opsonin Chemical Industries Ltd
23. Orion Infusions Ltd.
24. Orion Laboratories Ltd.
25. Renata Ltd.
26. Silco Pharmaceutical
27. Modern Herbal
28. Beximco Infusions ltd.
2 Pharmaceuticals are USFDA certified.
1. ACI and
2. Square Pharmaceuticals.
- 67 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex IV - Country profile of Bangladesh-A brief
Located in the Northeastern part of South Asia Bangladesh is bounded by India on the east, west
and north but for a small strip of boundary with Myanmar on the southeast. Located on the Northern
shore of the Bay of Bengal, Bangladesh provides a natural bridge between South and Southeast
Asia Bangladesh has an area of 148,393 square KMs crisscrossed by numerous rivers. Over 80
percent of its land, being in the flat alluvial plains, is considered among the world's most fertile. The
Sunderbans, the world's largest mangrove forest and home to the world famous Royal Bengal
Tigers stretches along the Southwest coast. The world's longest natural sea beach lies along the
southeastern coast of Cox's Bazar. The hospitable people of Bangladesh are known for their
warmth. People of various faiths live in Bangladesh with peace and exemplary communal harmony.
Of about 140 million population, 85 percent live in the countryside. The nature has been at its best
in Bangladesh to provide the country with stunning scenic beauty, varied flora and fauna, mighty
rivers, long sunny beaches, large mangrove forests, ancient and historical relics, archaeological sites
and colourful tribal life.
Capital city
State language
Monetary Unit
Standard time
Temperature
:
:
:
:
:
Life expectancy at birth
Adult Literacy
Major industrial products
:
:
:
Dhaka
Bangla, English is also widely spoken and understood
Taka / Tk.(1 US dollar = Tk. 70)
GMT plus 6 hours
Varies from 90C to 140C in December to January, other
seasons from 250C to 400C
63.3 years
64 percent
Readymade garments, pharmaceuticals, jute goods,
fertilisers, textiles, cement, tea processing, leather goods.
- 68 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex V - Abstract of National Drug Policy (Revised) 2005
1.
Laws and Regulations
Relevant Laws and Regulations commensurate with the prevailing circumstances usually control
and regulate production, distribution, sale and use of drugs in a country and ensure that they are of
good quality, efficacious and safe. Currently, the Drugs Act, 1940 (XXIII of 1940) and the Drugs
(Control) Ordinance, 1982 (Ordinance No. VIII of 1982) regulate the process of registration,
manufacture, distribution, sale, import and export of drugs in Bangladesh. These drug regulatory
legal instruments of the country are now quite old. Recently, the drug policy 1982 has been revised
through necessary amendments to keep pace with newer developments in the drug sector. Similarly,
the Rules made under the above Act and Ordinance should also be updated and integrated into one
set of Rules.
If the functioning of these laws and regulations and their compatibility with other laws, either under
the responsibility of the Ministry of Health & Welfare or other Ministries and Departments, affect
implementation of the different aspects of the NDP, they should be amended accordingly.
2.
Drug Regulatory Authority (DRA)
A strong administrative set-up is essential for effective management of the various aspects of the
drug sector of a country. The Directorate of Drug Administration of Bangladesh has been proposed
to strengthen to effectively perform the various functions of the regulatory authority. The following
measures have been taken:
i.
The status of the Directorate of Drug Administration (DRA) rose to that of the Directorate
General of Drug Administration ((DGDA) with corresponding increase in its manpower and
infra-structure facilities.
ii.
The organgram of the DGDA accommodates all lawful systems of drugs and regulate them
under unified control.
iii.
The regulatory responsibilities have been decided to be delegated to different directors under
DGDA to expedite and facilitate the functional processes.
iv.
The decision-making processes will be guided by the objective, non-discriminatory and
transparent guidelines and procedures.
v.
The staff of the DGDA will be adequately trained, have clearly defined functions and
powers, and be entrusted with responsibility in relation to all aspects of registration,
manufacture, storage, distribution, sale, import, export and quality of drugs in order to
ensure compliance with the laws, rules and regulations.
3.
Drug registration
All drugs and medicine and other medicinal substances in finished dosage forms, which are
manufactured, imported, distributed, marketed or consumed in the country must be registered with
the Drug Regulatory Authority (DRA) of the country in the specific dosage form and strength as
recommended by the Drug Control Committee (DCC).
- 69 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
a)
Selection of drugs for registration
i.
Selection of a drug either for manufacture or import is one of the important functions of the
National Regulatory Authority (NRA). For this purpose the current system of having a drug
registration advisory committee (DCC), which comprises of experts and professionals from
various disciplines, will continue.
ii.
Quality, safety, efficacy and usefulness will always be the predetermining criteria for
approval for sale of pharmaceutical product.
iii.
The Directorate General of Drug Administration, with approval of the DCC, shall select and
make lists of Essential and Non-Prescription (OTC) drugs following the WHO Guidelines
and Model lists of such drugs time to time.
b)
Registration criteria
i.
As a general principle, registration for manufacture, import and sale of combination drugs
other than those of Unani, Ayurvedic & herbal preparations, vitamins and nutritional
preparations should not be allowed in the country. However, combinations like vitamins,
nutritional preparations and other drugs which are therapeutically useful and are registered
in the developed countries could be considered for registration.
In case of the Homeopathic system also, registration for manufacture, import and sale of
combination medicines shall not be generally allowed.
ii.
In case of imported allopathic drugs, the manufacturing site will be inspected for GMP
validation by the inspectors of the drug regulatory authority of Bangladesh. The inspections
will be scheduled by the DRA and the concerned manufacturers will bear the cost of any
such inspection. However, the inspections will not be a bar to the consideration of a new
drug application manufactured in a developed country included in the list of the Licensing
Authority.
iii.
Bioavailability and bioequivalence data will be considered as important criteria for the
registration of any imported medicine.
iv.
Any Unani, Ayurvedic or Herbal drug included in the formulary of other countries, if
considered essential and useful by the National Unani, AYURVEDIC & Herbal formulary
Committee, may be granted registration for manufacture and sale in the country. National
Unani, Ayurvedic & Herbal Formulary Committee will be constituted by the government
with the experts on Unani, Ayurvedic and Herbal drugs.
v.
Single registration for Mother Tinctures, Mother Triturations and 12 bio-chemic and their
1X potencies of the homeopathic system may be allowed.
vi.
Biochemical products will be registered by the Licensing Authority (Drugs) based on their
safety, quality and usefulness.
vii.
Liquid dosage forms of unani, ayurvedic and herbal ayurvedic and herbal drugs that contain
up to 5% (v/v) of 96% ethanol may be allowed to be registered, if use of such high
proportion of ethanol is absolutely needed for their better efficacy and keeping quality.
- 70 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
However, in exceptional cases, use of ethanol up to a maximum volume of 10% (v/v) may
be allowed, if recommended by the DCC.
viii.
Certain drugs, in spite of their known serious side-effects and possibility of being misused,
may be registered for import, production and sale in limited quantities for restricted use.
c)
Registration procedure
The current procedures adopted for registration of drugs of all the recognized systems, as specified
in the existing laws, should continue after modifying or upgrading them as appropriate. But, efforts
should be made to develop methods for expediting the processes of registration.
4.
Drug production
i.
One of the main objectives of the NDP is to produce good quality drugs in the country. The
current Good Manufacturing Practice (CGMP) guidelines of WHO should thus be strictly
followed in the manufacture of drugs in the country. In order to ensure strict compliance
with the requirements of CGMP, all drug production units should be subject to regular
inspection by the Inspectors of the Directorate of Drug Administration. The manufacturers
will also be expected to conduct periodic internal cGMP audit following the standard
“Check-list” of the Directorate of Drug Administration.
ii.
Another main objective of the NDP is to ensure self-sufficiency in all types of drugs.
Therefore, all necessary measures should be undertaken to ensure that the current trend of
increased rate of local production of drugs is sustained and further improved.
iii.
Priority should be given to production of adequate quantity of essential drugs. Efforts would
be made to ensure that all the essential drugs and non-prescription (OTC) drugs (lists f
which are appended to this policy) are manufactured in the country in sufficient quantities
and they are available at affordable prices.
iv.
Foreign and multinational companies will be allowed to invest and manufacture drugs in
Bangladesh as long as they have at least three of their original research product. Drugs
registered in at least two of the following countries: USA, UK, Switzerland, Germany,
France, Japan and Australia.
v.
Manufacture of drugs that are not included in the last five editions of the British or United
States Pharmacopoeia (USP) or International Pharmacopoeia (IP) or the British
Pharmaceutical codex (BPC); or in the WHO lists of the International Non-proprietary
Names (INN), will be prohibited.
vi.
In order to encourage transfer of technology and availability of the newly developed drugs,
foreign companies, with or without having manufacturing plants in Bangladesh, will be
allowed to manufacture drugs in the country under licensing agreements with any partners
of their choice.
vii.
The task of producing Unani, Ayurvedic and Herbal drugs will lie solely with national
manufacturers with a view to attaining self –sufficiency in respect of local resource based
drugs.
- 71 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
viii.
Both local and foreign companies having manufacturing plants in Bangladesh will be
allowed to manufacturers drugs under toll / contract manufacturing arrangements at any
other manufacturing plants o their choice.
ix.
For the purpose of export only, any drug may be allowed to be produced in the country in
accordance with the specific requirements of the importing country.
5.
Drug procurement
i.
Drugs and pharmaceuticals may be procured by local purchase or import, and by receiving
as donation or gift.
ii.
Drugs for personal use of individual patients or to meet any national emergency situation or
for the purpose of research and clinical trials or for any other specific use, which are not
registered, may be imported with prior approval of the Licensing Authority (Drugs) for
specific quantity and for non-commercial purpose.
iii.
Importation of a drug that is produced in the country in adequate quantity will not be
allowed as a measure of protection for the local industries. However, if local production of
any drug falls short of need for any reason, or in case of emergency arises, this condition
may be relaxed by the Government for a specified period.
iv.
Any basic pharmaceutical raw material, which is locally manufactured in sufficient quantity,
will be given protection by disallowing import of this raw material or its substitute in the
country. However, if needed for export purpose, importation of such pharmaceutical raw
materials will be allowed in competitive prices through international tender.
6.
Drugs distribution, sale and storage
Prompt and safe distribution and ethical sale of drugs from public/ private storage facilities to the
end –users should be ensured so that the quality of the products is maintained throughout the whole
process and good quality essential drugs are always available to those who need them.
i.
Only the drugs, which are registered in Bangladesh, should be allowed to be distributed and
sold in the country.
ii.
No Person without having professional qualification or holding valid professional license
should be allowed to stock, distribute or sell drugs and medicines.
iii.
No drugs or medicines, other than non-prescription (OTC) drugs, should be sold or
dispensed without prescriptions.
iv.
Maintenance of quality and safety of drugs in retail outlets and in storage should be ensured
by carrying out regular checks by Inspector of drugs on the quality of stored drugs at all
levels.
7.
Drug pricing
i.
Rational pricing of drugs should be ensured to make essential drugs available to the endusers at affordable prices.
- 72 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
ii.
The current system of controlling prices of commonly used essential drugs should be
continued and the existing list of the prices-controlled drugs should be updated in the light
of current pattern of changes of drugs used in the primary healthcare.
iii.
The existing system of linking prices of locally produced drugs with costs of raw and
packing materials and that of imported finished drugs with landed cost should be revised for
rational fixing of Maximum Retail Prices (MRP) of drugs.
8.
Quality assurance of drugs and pharmaceuticals
One of the most important objectives of the NDP is to make good quality drugs available at
affordable prices. In order to achieve this objective, quality building in a drug at the manufacturing
stage by in process quality control and quality keeping in the drug in transit and storage should be
ensured by testing it at different stages before it reaches the end –users.
i.
Each pharmaceutical company should have a quality control and quality assurance system,
which would monitor the entire process form the acquisition of raw material to its
conversion into a finished product.
ii.
Each Manufacturer should have a dedicated team of professionals for adequate product and
process design and statistical control of the process through in- process and end- product
testing.
iii.
There should be documented Standard Operating Procedure (SOP) based on WHO
recommended cGMP guidelines for manufacture of each product as well as for each
manufacturing unit process.
iv.
All the unit process should be periodically validated to ensure correct end –results. The
validation results should be properly documented.
v.
Qualified professionals related to pharmaceutical sciences should be employed in all the
relevant departments, related to quality control and quality assurance, of a manufacturing
plant following the guidelines of WHO in order to ensure production of good quality drugs.
vi.
Quality of marketed drugs should be ensured by frequent post-market surveillance by the
Drug Inspectors and testing random samples of the marketed drugs in the Quality Control
laboratories.
vii.
In addition to the QC laboratories of the companies there should be one Central Drug
Testing/ Quality Control Laboratory and a number of Regional Drug Testing/ Quality
Control Laboratories under the Directorate of Drug Administration with separate units for
unani, ayurvedic, herbal and homeopathic-biochemical drugs, manned by technical experts
of the respective disciplines.
9.
Manpower of the manufacturing units
i.
All manufacturing units should be staffed with adequate number of Professionals related to
Pharmaceutical sciences in accordance with WHO guidelines in order to produce good
quality, safe and effective drugs and pharmaceutical.
- 73 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
ii.
However, the unani, ayurvedic, herbal and homeopathic-biochemical drug manufacturing
units should be staffed with adequate number of Qualified persons of the respective
disciplines and, where necessary, pharmacists, chemists/ biochemists, and botanists.
iii.
Persons with relevant qualifications should be employed in the various departments of the
manufacturing units following the guidelines of WHO and strictly following the relevant
laws of the country.
iv.
Adequate number of other supporting trained and skilled technical personnel should be
employed for smooth functioning of the manufacturing plant.
10.
Drug information and monitoring
i.
The Directorate of Drug Administration should have a well-equipped Drug monitoring and
information Unit.
ii.
Data on production, import, export, procurement storage, distribution and sale should be
compiled, monitored and evaluated to ensure availability of drug at all levels of the
country’s health care facilities both in public and private sectors.
iii.
Safety, efficacy and quality of all registered drugs should be monitored regularly and
information on any substandard, spurious and counterfeit drugs should be made freely
available to all concerns by wide publicity in both print and electronic media.
iv.
Rational Use of Drugs (RUD) should be ensured by conducting surveys on the systems of
prescribing, dispensing and patient compliance.
v.
Monitoring and reporting of adverse reactions of drug (ADR) should be seriously done to
ensure safe and rational use of drugs in the country.
vi.
Objective and educational advertisements of Non-prescription (OTC) drug based on
scientifically established evidence and in good taste may be allowed with prior approval of
the Drug Regulatory Authority (Current lists of OTC drugs of allopathic, ayurvedic and
unani systems are appended to this Policy).
11.
Essential drugs
There will be a List of Essential Drugs for Bangladesh. The Directorate General of Drug
Administration shall update and maintain the list of essential drugs in line with the current list of
Essential Drugs of the World Health Organization.
- 74 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex VI - Essential and supplementary drug list for essential and
specialized drugs
LIST OF 150 ESSENTIAL DRUGS :
A.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
B.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
List of 12 Essential Drugs for Use by the Village Level Health Workers :
Aspirin Tablet.
Chloroquine Phosphate Tablet/ Syrup.
Aluminium Hydroxide Gel Tablet/ Suspension.
Piperazine Tablet/ Elixir.
Glucose Electrolyte Powder (ORS).
Phenoxymethyl Penicillin (Penicillin V) Tablet/ Syrup.
Ampicillin Capsule/ Syrup/ Injection.
Ergometrine/ Methylergometrine Maleate Tablet/ Injection.
Ferrous Sulphate Tablet/ Syrup.
Ephedrine.
Vitamin A 2,00,000 Units Capsule/ 1,00,000 Units Injection.
Chloramphenicol Eye/ Ear/ Ointment/ Drops.
List of Additional 33 Essential Drugs for Primary Health Care up to the Thana Health
Complex Level :
Paracetamol Table/ Elixir.
Pethidine Hydrochloride Injection.
Sulphadoxin with Pyrimethamine.
Levamisole Tablet/ Elixir/ Injection.
Chlorpheniramine Tablet/ Elixir/ Injection.
Lidocaine 1%.
Isoniazid with Thiacetazone Tablet.
Streptomycin Sulphate Injection.
Metronidazole Tablet/ Elixir/Injection.
Atropine Sulphate Injection.
Hyoscine-n-Butyl Bromide Tablet/ Injection.
Chlorohexidine/ Chloroxylenol Solution/ Cream.
Procaine Penicillin Injection.
Tetracycline/ Oxytetracycline Capsule/ Injection/ Ointment.
Phenobarbitone Tablet/ Injection.
Diazepam Tablet/ Injection.
Chlorpromazine Tablet/ Injection/ Syrup.
I. V. Saline of various strengths (0.9%, 0.25%, 0.18%) with 4% Dextrose/ 0.9%
Saline without Dextrose.
Dextrose in Water (5%, 25%, 50%).
Redistilled Water (Pyrogen free) Ampoules.
Cholera Fluid.
Oxytocin.
Furosemide Tablet/ Injection.
Prednisolone Tablet.
Propranolol Tablet/ Injection/ Tablet.
- 75 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
38.
39.
40.
41.
42.
43.
44.
45.
C.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
Aminophylline Injection/ Tablet.
Co-trimixazole Tablet/ Suspension.
Homatropine.
DT/ SPT/ POLIO/ Toxin.
Diptheria Anti-Toxin.
Vitamin B-Complex Tablet/ Multi-Vitamin Drops 15 ml.
Salicylic Acid and Benzole Acid Ointment.
Benzyl Benzoate Saponated.
List of Additional 105 Essential Drugs for Use up to Tertiary Level :
Indomethacin Capsule/ Suppository.
Morphine Sulphate Injection.
Allopurinol.
Quinine Tablet/ Powder/ Injection.
Corticosteroid Eye Drops/ Ointment.
Diethyl Carbamazine Tablet/ Suspension.
Chloramphenicol Skin Ointment.
Mebendazole Tablet.
Promethazine Tablet/ Injection/ Syrup.
Ether Anaesthetic.
Procaine Hydrochloride.
Suxamethonium.
Thiopental Sodium.
Gallamine triethiedide.
Tubocurarine.
Halothane.
Isoniazid Tablet.
Ethambutol Tablet.
Rifampicin.
Dapsone Tablet.
Glibenclamide.
Insulin Preparation.
Pilocarpine Drops 1%, 2%, 4%.
Emetinew Hydrochloride Injection.
Naloxone Hydrochloride
Sodium Thiosulphate Injection.
Trifluperazine.
Pralidoxime Tablet/ Injection.
Sodium Antimony Gluconate Injection.
Tincture Iodine.
Lysol/ Cresol/ Soap Solution (Surgical).
Benzyl Penicillin Injection.
Benzathine Penicillin Injection.
Erythromycin Suspension/ Tablet.
Gentamicin Injection/ Drops/ Ointment.
Cloxacillin Syrup/ Capsule/ Injection.
Ethosuximide Capsule.
Phenytoin Tablet/ Capsule/ Elixir.
Amitriptyline/ Nortriptyline Tablet.
Haloperidol Tablet/ Capsule.
- 76 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
Prochlorperazine Tablet/ Injection.
Potasium Chloride Injection/ Tablet/ Syrup.
Mannitol Solution.
Dialysis Fluid.
Plasma Substitutes.
Sodium-Bi-Carbonate Infusion 7.5% or 8.4%.
Bendrofluazide.
Acetazolamide.
Spironolatone.
Barium Sulphate (X-ray grade).
Iodipamide 30%, 50%.
Iopanic Acid/ lobenzamic Acid Tablet.
Acetrizoic Acid/ Iodized Oil Injection.
Sodium Diatrozoate.
Iron-Dextran Complex Injection.
Folic Acid Tablet.
Hydrocortisone Injection/ Ointment/ Cream.
Dexamethasone Injection/ Tablet.
Stibaestrol/ Diethylstiboestrol.
Levo-thyroxine.
Progesterone Preparations.
Neomarcazole.
Digoxin Tablet/ Injection.
Diazoxide Injection.
Methyldopa Tablet.
Glyceryl Trinitrate Sublingual Tablet/ Ointment.
Procainamide Injection/ Capsule.
Heparin Injection.
Warfarin Sodium.
Tetracaine/ Novosine.
Metaraminol Injection.
Senna Tablet.
Glycerin Suppository.
Sulphadimidin Tablet.
Ibuprofen.
Sulphanilamide Powder.
Sulphadiazine Injection.
Adrenaline/ Epinephrine Injection.
Neostigmine Tablet/ Injection.
Salbutamol Tablet/ Elixir/ Inhaler/ Injection.
ACD Blood Pack/ Double Bag/ Triple Bag.
TABC.
Anti-Rabies Vaccine.
Polyvalent Anti-Venom.
Tetanus Anti-Toxin (Minimum 10,000 Unit Dose)
Diptheria Anti-Toxin.
Vitamin B1 Injection/ Tablet.
Vitamin C Tablet.
Vitamin B12 Injection.
Vitamin K Tablet/ Injection/ Vitamin K, Injection.
Cyclophosphamide Tablet/ Injection.
- 77 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
5-Flurouracil Injection/ Capsule/ Ointment.
Methotrexate Tablet/ Injection.
Busulphan Tablet.
Vincristine Injection.
Nitrogen Mustard Injection.
Doxorubicin.
Chlorambucin.
Fluorescein Eye Drops 1%
Clofazimine Tablet.
Calciferol.
Griseofulvin.
Pyrazinamide.
Plaster or Paris.
Zonc Oxide Adhesive Bandage.
SUPPLEMENTARY LIST :
100 items of Specialized Drugs:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
Adriamycin.
Thioguanine.
Folinic acid – for use with Methotrexate.
Mitomycin tablet/ Injection.
Procarbazine.
Atropine Eye Drops/ Ointment 1%.
Phenyleprine Eye Drops 10%
Tropicamide Eye Drops 1%.
Proparacaine Hydrochloride Eye Drops 0.5%.
Methylcollulose Eye Drops 0.35 and 1%.
Idoxuridine Eye Drops.
Sulphacetamide Eye Drops 10%, 20%; 6% Ointment.
Fluorescein 10%, 20% I. V. Injection.
Neomycin-Bacitracin-Polymixin-B combined as well as separate.
Phenformin.
Beclomethasone Inhalant.
Plasma Factors.
Human-Gamma Globulin/ Immunoglobin specific for certain illnesses.
Anti-D-Immunoglobin.
Intravenous Alimentation Nutrients; Intralipid; Aminosol.
Atenolol.
Sodium Valproate.
Cocaine.
Lignocaine 2% with Adrenaline 1:2000,000.
Benzocaine Tablet.
BIPP Paste (Bismuth, Iodoform & Paraffin).
Neomycin & Bacitracin Ointment.
Thiambutacin Tablet.
8-methoxypsoralen.
Triamcionolone Tablet/ Cream.
Tolnaftate.
Clofazimine.
- 78 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77-100.
Injection Methylprednisolone Acetate.
Melphalan.
6-Mercaptopurine.
Cytosine Arabinoside.
Bleomycin.
Actinomycin-D.
L-Asparaginase.
Vinblastine.
Methyl CCNU.
Verapamil.
Nifedipine.
Disopyramide.
Dipyridamole.
Isosorbide Dinitrate.
Procainamide.
Oxprenolol.
Trimethaphan.
Saralasin.
Prazosin.
Sodium Nitroprusside Injection.
Guanethidine Tablets.
Chlorpropamide.
Clomiphene Citrate.
ACTH Injection.
Injection Vasopressin 20 Units.
Oxymetholone.
Desmopressin Nasal Drops/ Injection.
Codeine Phosphate Tablets.
Cholestyramine.
Salazopyrine.
Lactulose.
Flufenazine Injection.
Naproxen.
Injection Flupenthixol.
Lithium Carbonate.
Tablet Imiramine.
D-Penicillamine Tablet/ Capsule/ Injection.
Sodium Aurothiomalate.
Colchicine Tablet.
Sulphinpyrazone.
Beclofen.
Cinnarazine.
Niclosamide.
Miconazole Ointment/ Injection.
To be determined by Expert Committee from time to time.
- 79 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex VII - List of imported pharmaceutical products (human and
veterinary)
Government of Bangladesh
Ministry of Finance
Internal Resource Division
National Board of Revenue
(Customs)
Order
National Board of Revenue (NBR) under its power given at Section 21(B) issued S.R.O. No. 139Law/2007/2138/Customs Act, 1969 (Act IV of 1969).
(a)
(b)
In Table-I , Goods under H.S. code mentioned at Colum 2 below will be taxed at 5%.
In Table-II , Goods under H.S. code mentioned at Colum 2 below will be taxed at 15%.
Other rules and regulations will remain the same.
TABLE-I
Heading H. S. Code
(1)
(2)
Description
(3)
12.11
Buchhu powder/extracts/leaves
Cinchona/Cinchona Bark/Powder
Ergot of Rye/Lobelia powder/ Powdered paricap of sennapod
Buchhu powder/extracts/leaves
Cinchona/Cinchona Bark/Powder
Ergot of Rye/Lobelia powder/Powdered paricap of sennapod
Vegetable extract-opium, pharmaceutical grade
Aconite and Aleos, extract/dried or concentrated/crude/prepared”
Belladonna extract/dried or concentrated/prepared/crude
Calchicum Extract/Corm/Powder
Colocynth, extract/dried or concentrated/crude/prepared
Ergot extract/prepared ergot
Gentain extract/dried or concentrated/powder/prepared
Glycerrhizinate, extract, dried or concentrated/prepared/crude
Hyoscyamus, extract/dried/concentrated/prepared or crude
Ipecacuouha, extract/dried or concentrated/crude/prepared
Nuxvomica, extract/dried or concentrated/prepared/crude/powder
Pruniserotinac powder/extract/wild bark
Rauwolfia sementina dry extract
Scillia, extract dried or concentrated/prepared
Senega extract/puly
13.02
1211.90.21
1211.90.21
1211.90.21
1211.90.22
1211.90.22
1211.90.22
1302.11.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
- 80 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
15.16
17.02
26.08
27.11
28.01
28.16
28.18
28.33
28.35
28.36
28.36
28.42
28.43
28.50
28.52
29.02
29.03
29.04
29.05
29.06
29.07
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1516.20.90
1702.30.10
1702.30.10
2608.00.00
2711.14.00
2801.20.00
2816.10.10
2818.30.00
2833.27.00
2833.29.10
2833.29.20
2833.29.30
2835.10.10
2835.10.10
2835.29.10
2835.29.10
2836.91.00
2836.99.10
2842.10.10
2843.29.00
2850.00.00
2852.00.00
2852.00.00
2902.90.00
2903.22.00
2903.49.90
2904.10.90
2905.43.00
2905.59.10
2905.59.10
2905.59.10
2905.59.10
2905.59.10
2906.13.20
2906.19.10
2907.12.00
2907.21.00
2907.29.10
Senna extract liquid/concentrate/crude
Valerian, extract/dried or concentrated/crude
Vibrunum Opulus extract/dried or concentrated/crude
Vibrunum pronifoluim extract/dried or concentrated/crude
Hydrogenated oil in powder form
Dextrose anhydrous BP/USP Pyrogen free, Dextrose monohydrate
Dextrose Monohydrate/Dextrose Anhydrouse (pyrogen free) BP/USP
Calamine
Mixture of ethylene oxide (50%-90%) & carbon-di-oxide (10%-50%)
Iodine pure BP
Magnesium Hydroxide
Aluminium Hydroxide Magnesium Carbonate co-dried gel
Barium Sulphate BP
Sulbutamol Sulphate
Ferrous Sulphate Exsicated/Ferrous Sulphate B.P.93
Metaproternol Sulphate
Calcium Hypophosphite
Iron hypophospite
Aluminium Phosphate dried/gel
Ferrous Phosphate
Lithium Carbonate
Ferrous Carbonate
Aluminium Sodium Silicate”
Silver Sulphadiagine
Hexahydrate/dihydrate
Mercuric chloride ammoniated
Mercury Ammonium Chloride/Ammonated Mercury”
Isoprophylanitipyrine
Trichloroethylene
Halothane
Aluminium Hydroxide, dried gel/compressed gel/colloidal paste
Mannitol/D-mannitol
Busuiphan
Chloral Hydrate
Chlorobutanol/Chlorobutol
Penterethritol tetranitrate
Thioglycerol/Alpha-Thioglycerol
Inositol/Meso-inositol
Terpin Hydrate”
Chlorocresol
Resorcinol
Benzestrol
- 81 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.08
29.09
29.12
29.14
29.15
29.16
29.17
29.18
2907.29.10
2907.29.90
2908.19.10
2908.19.10
2908.19.10
2908.19.90
2908.19.90
2909.19.10
2909.19.10
2909.49.00
2909.49.00
2909.49.00
2909.49.00
2909.49.00
2909.50.00
2909.50.00
2909.50.00
2912.29.10
2914.19.10
2914.40.10
2914.40.90
2914.40.90
2914.69.00
2914.69.00
2914.69.00
2914.69.00
2915.39.00
2915.39.00
2915.39.00
2915.39.00
2915.39.00
2915.39.00
2915.50.10
2916.31.00
2916.32.00
2916.39.10
2916.39.10
2917.19.10
2917.19.10
2917.19.10
2918.15.00
2918.15.00
Dithranol/1.8. Dioxyanthranol BP
Metraminol
Chloroxylenol/Parachlorometaxylenol
Dichlorophen
Hexachlorophene
Chlorexolone
Hexobarbital Hexobarbitone/Sodium
Diethylastiboestrol
Methoxyflurane”
Chlorphenesin
Guaiphensin Glyceryl Guaicolate
Guapihenesin
Mephensin
Polyethylene Glycol 3350
Glycerylquaicol ether
Guaicol
Potassium guaiacol sulphonate/Sulphonate
Cinnamic Aldehyde
Methylsergide
Benzoin
Norgestirone
Nortesteaone”
Chrysarobin/Chrysophanic Acid
Dihydroxyaminoquinone
Dihydroxyanthraquinone
Menopthone sodium bisulphite
Hydrocodon Bitartrate
Menadiol dibutyrate
Menadiol sodium biophosphate
Mendiol diacetate/Acetomenaphthone
Tacrolimus
Tegaserod Maleate”
Deoxycortone phenyl propionate
Benzyl Benzoate
Benzoyl Chloride
Alcofenac
Ibuprofen
Dicotylsodium Sulphosuccinate
Ferrous Fumerate/Ferous Fumarate
Ferrous Succinate
Disodium dehydrogen citrate
Disodium hydrogen citrate
- 82 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.19
29.20
29.21
2918.15.00
2918.15.00
2918.15.00
2918.16.00
2918.16.00
2918.16.00
2918.19.10
2918.19.10
2918.19.10
2918.19.10
2918.19.90
2918.19.10
2918.22.00
2918.23.00
2918.29.00
2918.30.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2919.90.90
2919.99.10
2920.90.10
2920.90.10
2921.11.00
2921.19.10
2921.19.10
2921.19.90
2921.19.90
2921.19.90
2921.30.00
2921.30.00
2921.30.00
2921.44.00
Ferric ammonium Citrate Cryst/Flakes/Granulated
Iron choline citrate/Ferrocholinate
Tripotassium Dicitrato Bismuthate/Bismuth subcitrate
Calcium Gluconate/Lactogluconate/Galactogluconate
Cobalt Gluconate
Ferrous Gluconate
Calcium Lactate
Calcium Levulinate
Calcium Sodium Lactate
Cantharides/Cantharidin
Cyolandetate
Mandelic Acid
Aspirn BP (Acelyl Salycylic Acid)
Methyl salicylate
Difluorophenyl Triazol Propan
Ketoprofen
Atorvastatine Calcium Trihydrate
Carbenoxolone
Clofibrate
Ethacrynic Acid
Fenoprofen
Gemfibrozil USP
Naproxen/Naproxen Sodium
Rofecosib
Simvastatin
Tranexamic Acid
Zinc dnecylenate
Zinc undecenoate
Tetrasodium Fosfetrol
Triclofes
Erythrityl Tetranitrate
Isosorbide Dinitrate
Propoxyphene Hydorchloride
2-Amine-5Diethyl Aminopentane
Diethylamine Anhydrous
Famotidine
Idoxuridine
Tarfenadine
Amantadine
Mecamylamine
Prophylhexedrine
Diphenyldramine Hydrochloride
- 83 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.22
2921.46.00
2921.46.00
2921.49.00
2921.49.00
2921.49.00
2921.49.00
2921.49.00
2921.49.00
2921.49.00
2921.49.00
2921.49.00
2921.49.00
2921.51.00
2921.51.00
2921.59.00
2921.59.00
2921.59.00
2922.11.00
2922.19.10
2922.19.90
2922.19.90
2922.19.90
2922.19.90
2922.19.90
2922.19.90
2922.19.90
2922.19.90
2922.19.90
2922.19.90
2922.29.10
2922.29.10
2922.31.00
2922.31.00
2922.31.00
2922.31.00
2922.41.00
2922.41.00
2922.42.90
2922.49.00
2922.49.00
2922.49.00
2922.49.00
Amphetamine sulphate
Dexamphetamine sulphate
Amitriptyline hydrochloride
Fendiline Hydrochloride
Maprotiline HCL
Methylthiouracil
Nortriptyline & its salts
Paragyline Hydrochloride
Phenylpropanolamine Hydrochloride
Prenylamine/Prenylamine lactate
Protriptyline
Tranylcypromine Sulphate
Brobenloxaldine
Bromhexine Hydrochloride
Eronovine maleate
Pentolamine
Sulphaclozine Sodium (Monohydrate)
Monoethanolamine oleate
Ethambutol Hydrochloride
Benactyzine
Bencyclan Hydrogen Fumerate
Bromazine
Clomiphene citrate
Dextropropromyphene
Cicyclomine Hydrochloride
Fluoxetine Hydrochloride INN
Heptaminol Hydrochloride
Meglumine/N-Methyl Glucamine
Orphenadrine
Methoxyphenamine/Hydrochloride
P-acetaminophenol/Acetaminophen
Isomethadone
Methadone/Methadone Hydrochloride
Methylestrenolone/Normethandone/Methyl-nortestosterone
Normethadone
L-lysine Monohydrochloride
Lysine Hydrochloride/Lysine Monohydrochloride
Glutamic Acid
Amino Caproic Acid
Aminosidine Sulfate
Benzocaine
Benzonatate
- 84 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.23
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.50.10
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2922.50.90
2923.10.00
2923.10.00
2923.10.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
2923.90.00
Chlorambucil
Diclofenac Sodium Extra Pharma/Diclofenac Potassium
Diclofenac Sodium Gel (Diclofenac diethyl ammonium salt)
Flufenamic Acid
Iopanoic Acid
Mefanamic Acid
Oxylso-Procaine Hydrochloride
Procaine Hydrochloride
Tetracaine
Socium Valproate
Calcium para amino salicylin/Calcium Aluminium PASS
Detrothyronine
Dexpropranolol
Isoprenaline
Levodopa
Mebeverine HCL
Methozamine/Hydrochloride
Methyldopa
Metoprolol Tartrate
Nadolol INN
Oxybuprocaine Hydrochloride
Penbutolol Sulphate
Phenylephrine/Phenylephrine Hydrochloride
Propranolol Hydrochloride
Sulbutamol
Choline Chloride
Choline Chloride 50% feed gr
Choline Dihydrogen Citrate
Benzalkonium Chloride/Bromide/Hydrochloride
Benzethonium Chloride with Vitamin C
Bephenium Hydroxynaphthoate
Betaine base/Betaine Hydrochloride/Menohydrochloride/Betaine citrate
Carbachol
Carnitine/LD Carnitine/Vitamin BT
Cetalkonium Chloride
Cetrimonium Bromide/Chloride/Setrimide
Domiphen Bromide
Callamine triethiodide
Oxphennonium Bromide
Suxemethonium Chloride/Bromide
Suxethonium Chloride
Tridihexethyl Iodide
- 85 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29,24
29.25
2924.11.00
2924.19.10
2924.19.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2924.29.90
2925.19.00
2925.19.00
2925.19.00
2925.19.00
2925.29.90
2925.29.90
2925.29.90
2925.29.90
Meprobamate
Carbromal
Bromisovalum
Acebutolol/acebutolol hychloride
Acecidine/Acecidine salicylate
Allantoin
Ambucetamide
Atenolol
Buclosamide
Butobarbitone
Calcium Benzamide Salicylate/Calcium Benzoyl PAS
Diloxanide/Diloxanide furate
Dimevamide Sulphate Aminopentamide
Etofamide
Isopropamide/Isopropamide Iodide
Labetalol Hydrochloride
Lidocaine Hydochloride/or Base / Lignocaine Hydrochloride or Base
Mebrophenhydramine Hydrochloride
Metoclopramide Monohydrochloride
Neostigmine Bromide/Methylsulphate
Niclosamid
Oxalamide phosphate/Citrate
Oxethazine
Paracetamol
Permethrin
Permethrin
Phenacetin/Acetophenatidin
Prilocaine
Procainamide
Salicylamide
Sodium Paramino Salicylate/PAS
Sodium Tauroglycocholate
Styramate
Suramin Sodium
Bemegride
Ethosuximide
Mesuximide
Phensuximide
1-2-phenyl ethyl biguanide/1-2-phenyl ethyl biguamide-hydrochloride
Amicarbalide
Bathanidine
Chlorhexidine Gluconate Soln/Chlorhexidine HCL
- 86 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.26
29.27
29.28
29.30
29.31
29.32
2925.29.90
2925.29.90
2925.29.90
2925.29.90
2925.29.90
2925.29.90
2925.29.90
2925.29.90
2925.29.90
2925.29.90
2926.90.10
2926.90.10
2927.00.00
2928.00.00
2928.00.00
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2930.90.90
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2932.19.10
2932.19.10
Dibromopropamidine
Dibromopropamidine Isethionate BP
Hexamidine diiethionate
Hydroxystilbamidine
Metformin
Pentamidine Isethionate
Phenformin Hydrochloride/Pheformin 1-phenethyl biguanide
Proguanil
Propamidine Isethionate
Stilbamidine Isethionate
Isaminile
Nitroxinil 34% Solution/Nitroxynil
Benzadymine Hydrochloride
Carbidopa Monohydrate BP
Phenelozine
Acetylmethionine/DL-acetyl Methionine
Bitoscanate
Dapsone
Dimercaprol
Ecothiopate Iodide
Methionine/DL-methionine/Acetyl Methionine/DL-acetyl Methionine
Monothioglycol
Paraminebenzene Sulphothiocarbomide
Penicillamide
Terbutaline Sulphate
Tertraethyl Thiurum monosulphide
Thaiambutosine
Thiophanate
Thiophanate 70% wettable powder/Thiophanate Ethyl Vet
Acetarsol
Arsanilic Acid
Bismuth Glycolarsanilate
Carbarsone
Chlormerodrin
Glycobiarsol
Mercuderamide
Mersalyl
Phenyl mercuric nitrate
Sodium Sulphachloro Pyridazine
Thiomerosal
Nitrofural/Nitrofural Nitroxynil
Nitrofurazone
- 87 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.33
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2932.29.10
Glucoronolactone
Oxandrulone
Santonine
Spironolactone
Warfarin
Disodium Chromoglycate
Doxepin Hydrochloride
Doxepin Hydrochloride/Doxycycline with Ascorbic acid/Doxycycline
Hydrochloride/Dexycycline Hyclate
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2932.29.10
2933.11.00
2933.11.00
2933.11.00
2933.19.10
2933.19.10
2933.19.90
2933.21.00
2933.21.00
2933.21.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
2933.29.00
Glucosamine HCL
Isosorbide-5-Mononitrate BP/USP
Merbromine/Mercurochrome
Omnadin/Omnadin CL
Promethzine/Promethazine Hydrochloride/Theoclate
Propantheline Bromide
Protokylol Hydrochloride
Sodium Cromoglycate
Aminophenazone/ Aminapyrine/Amidopyrine
Dimethyl Aminophenozone
Phenazone
Betazole
Phenylbutazone
Sodium Diphenyl Hydantoinate/Phenytoin Sodium
Ethotion
Methylphanylathy Hydantion
Phenyton
Antazoline Hydrochloride/mesylate/methane sulphate
Benzoyl Metronidazole
Clotrimazole
Clotrimazole Microfine
Econazole
Econazole Nitrate
Fenpirereinium Bromide
Histamine debydrochloride and phosphate
Isoconazole nitrate micro 20
Metronidazole
Miconazole Nitrate
Naphazeline
Naphezoline Hydrochloride
Tetrahydrozoline Hydrochloride
Tetrazolie/Tetrahydroeline Hydrochloride
- 88 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2933.29.00
2933.29.00
2933.29.00
2933.32.00
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
Thiamazole/Methimazole
Tinidazole
Xylometazoline Hydrochloride
Dibengyl phenoxyl-methyl ethylp9iperidine and its salts
Anileridine
Benperidol
Bisacodyl
Brompheniramine
Bupivacaine Hydrochloride
Cetylpyridinium Chloride
Chlorodiazaroside
Chlorphenamine/Chlorphenamine maleate
Clidinium Bromide
Cyclobenzaprine HCI
Cyproheptadine & its salts
Difenoxin Hydrochloride
Esomeprazole Magnesium
Ethionamide
Fenipipramide/Fenipipramide
metho
bromide/
Fenipipramide
hydrochloride
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
Fentanyl
Haloperidol
Isoniazid
Isonicotialdehyde thiosemicarbazone
Lansoprazole
Levomethorphan
Lifibrate
Loperamide Hydrochloride
Mepyramine/Mepyramine Maleate
Methylnicotinate
Methylphenidate
Nialamide
Nifedipine
Niflumic Acid
Nikethamide
Norlevorphanol
Omeprazole all grades/forms
Pancuronium Bromide
Pentazocine and its salts
Pethidine Hydrochloride/Meperipine Hydrochloride
Pheniramine/Pheniramine maleate
- 89 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.39.90
2933.49.10
2933.49.10
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.53.00
2933.53.00
2933.53.00
2933.53.00
2933.53.00
2933.53.00
2933.54.00
2933.54.00
2933.54.00
2933.54.00
2933.54.00
Phenyramidol Hydrochloride
Pimozide
Pitofenone
Propyliodone
Prothionamide
Trifluperidol
Trihexyphenidyl
Triprolidine
Tropicamide
Amodiaquine
Montelukast Sodium
4:7 Dichloroquinoline
Broxyquinoline
Chloroquine Diphosphate/Phosphate/Sulphate
Cinchocaine Hydrochloride
Cinchocaine Hydrochloride/Dibucain Hydrochloride
Clioquinol/lodochlorydroxyquin
Cloquinate
Dequalinium Chloride
Dequalinium Chloride
Diiodohydroxyquinoline
Drotaverine HCL
Fenbendazole
Flumequine
Hydroxychloroquine
Iodochlorhydroxyquionoline
Oxyclonazide
Pamaquine
Primaquine Phosphate
Pyrvininm Chloride
Tiemonium Methyl Sulphate
Allobarbital
Amobarbital/Amylobarbitone/Amylobarbitoe Sodium
Barbital Sodium/Barbitone Sodium
Pentobarbital/Pentobarbitone
Phenobarbital/ Sodium/Phenobarbiton Sodium
Phenobarbital/Phenobarbitone
Cyclobarbitone
Methohexital/Metholhexitone
Methotrexate
Methylphenbarbitol
Nialbarbitone
- 90 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2933.54.00
2933.54.00
2933.54.00
2933.54.00
2933.54.00
2933.59.10
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.69.00
2933.72.00
2933.79.00
2933.91.00
2933.91.00
2933.91.00
Quinalbarbitone
Secobarbital Sodium/Secobarbitone Sodium
Secobarbital/Secobarbitone
Thialbarbital
Thiopental Socium/Thiopentone Sodium
Benzoyl Calcium pas
Allopurinol
Amprolium
CefrizineDi-hydrochloride INN
Chorocyelizine
Ciclizine
Cinnarizine
Ciprofloxacin Hydrochloride/Lactate
Diethylcarbamazine Citrate
Dipyridamole
Fluorouracil
Hydroxyzine Hydrochloride/Hydroxyzine
Meclozine/Meclozine Hydrochloride
Mercaptopurine
Methaqualone Hydrochloride
Mianserine Hydrochloride
Oxipurinol
Oxyphencyclimine Hydrochloride
Pefloxacin Misylate
Pefloxacine Mesylate Dihydrate
Piperazine
Piperazine Adipate/Piperazine Phosphate/Piperazine Calcium Edetate
Piperazine hydrate/Piperazine Haxahydrate/Piperazine Dihydrate
Pirenzepine-Di-Hydrochloride
Propylthiouracil
Pyritidium Bromide
Ranitidine/Ranifidine Hydrochloride
Triamterene
Trimethoprim
Trimethoprim with sulphamethoxazole
Zopiclone INN
Methenamine mandelate
Clobazam
Chlorhydroxyquinoline
Citalopram Hydrobromide
Diazepam
Flupentixol Dihydrochloride
- 91 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2933.91.00
2933.91.00
2933.91.00
2933.91.00
2933.91.00
2933.99.10
2933.99.10
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
Flurazapam
Medazepam
Melitracen HCL
Nitrazepam
Oxazepam
Dexafen
Mepacrine
Aceclofenac
Acriflavine/Acriflavide Hydrochloride
Adefovir Dipivoxil
Albendazol
Amiloride Hydrochloride
Aminacrine Hydrochloride
Amino acridine/Aminacrine Hydrocloride
Amlodipine Besylate
Atropine/Atropine Methenitrate/Atropine Sulphate
Benzilonium Bromide
Benzilonium Bromide
Bromozepam
Camazepam
Captopril
arbamazepine
Carvedilol
Celecoxil
Chondroitin Sulphate
Cimetidine
Clemizole undecylate
Clomipramine HCL
Clopidogrel Bisulphate
Desipramine
Desloratadine
Dextromethorphan Hydrobromide
Dibenzepin Hydrochloride
Dihydrailazine
Ethacridine lactate
Ethoheptazine Citrate
Flubendazole
Glucosamine Sulphate
Guanothidine/Guanethidine Sulphate
Histapyrrodine Hydrochloride
Hydralazine
Hydroxypyrozole
- 92 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.34
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2933.99.90
2934.10.00
2933.10.00
2933.30.00
2933.30.00
2933.30.00
Imafen
Imiparamine HCL
Impramine
Indolinone Compound [1-(2.6 dichloropheny)-2-Indolinone]
Indometacin/Indomethacin
Ketorolac Tromethamie
Lamivudine
Lercanidipine HCL
Lobendazole
Losartan Postassium
Mebendazole
Mebhydrolin Napadisylate
Nalidixic Acid
Naprozen Sodium
Phanquone
Phenazocine
Phenindamine
Phenylephrine HCL
Piperazine Citrate
Procyclidine/Procyclidine Hydrochloride
Pyrazinamide
Raloxifene HCL
Ramipril
Roxatidie Acetate Hydrochloride
TerazosinHCL 239
Thiotepa
Tolmetin Sodium Dihydrate
Tricyclamol Chloride
Trimetazidine HCL
Trimipramine Maleate
Verapamil HCL
1-3 Bis (4 amino 2-methyl 6-quinoly) urea
Methylelothiazide
Thiabendazole/Thiabendazole
Chlopromazine Hydrochloride
Chlorprazine/ Hydrochloride/ Chlopromazine Hydrochloride injectable
grade
2933.30.00
2933.30.00
2933.30.00
2933.30.00
Cyamepromazine
Diethazine
Fluphenazine
Levomeropmazine
- 93 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2933.30.00
2933.30.00
2933.30.00
2933.30.00
2933.30.00
Perazine
Periciaxine/Pericyazine
Perphenazine
Phenothiazine
Prochlorperazine Mateate/
Mesylate
2933.30.00
2933.30.00
2933.30.00
2933.30.00
2933.30.00
2933.30.00
2933.30.00
2933.91.00
2933.91.00
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
Promizine
Thiethyl Perazine
Thiopropazate
Thiopropazate dihydrochloride
Thioridazine
Trifluoperazine Hydrochloride
Trimeprazin Tartrate
Dextromoramide
Pemoline
Brotylium Tosilate
Cefaclor
Chlormezanonn
Cisapride Monohydrate
Clavulanic Acid
Cyclophosphamide
Dilteazem Hydrochloride
Fluconazole INN
Furazolidone
Isothipendyl
Itraconazole
Ketoconozole INN
Ketetifen Furammate
Levamisol and its salts
Levomoramide
Mesulphen
Methoxapen/Ammoidin
Morantel citrate Monohydrate
Nedocromil Sodium
Nifuratel
Nitrofurantion
Ofloxacinn INN
Paramethadione
Phenmefrazine Hydrochloride
Piroxicam
Pizotifen Maleate
- 94 -
Prochlorperazine
Methosulphonate/
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.35
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2934.99.90
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
Prazosin/Prazosi Hydrochloride
Prothipendyl
Pyrante citrate
Rosorchin
Secnidazole
Surprofen
Thenalidine Tartrate
Theyldiamine Hydrochloride
Tiaprofenic Acid
Ticonazole
Timolol Maleate
Triclabendazole
Trimethadions
Xanthinol niacenate/Xanthiol nicotinate
Zomitriptan
Acetazolamide
Acetohexamide
Bendroflumethiazide
Benzthiazide/Benzothiazide
Carbutamide
Chlorothiazide
Chlorpropamide
Clopamide
Dichlorophenamide/Diclophenamide
Dimethothiazine Mesylate
Disulfamide
Furosemide/Frusemide
Glibenelamide
Glipizide
Gluethimide
Hydrochlorothiazide
Hydroflumethazide
O-touene sulphonamide
Phthalylsulphacetamide/Phtralylsulphacetamide Sodium
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Polythiazide
Probenecid
Quinethazone
Repaglinide
Salazosulfapydine/Sulphasalazine
Salazosulphadimidine
- 95 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.36
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2935.00.00
2936.90.00
2936.21.00
2936.21.00
2936.21.00
2936.22.00
2936.22.00
2936.22.00
2936.22.00
2936.22.00
2936.23.00
2936.23.00
2936.24.00
2936.24.00
2936.24.00
Succinvlsulfuthazole/Succinysulphathiazole
Sulfacetamide Sodium/Sulphacetamide Sodium
Sulfacetamide/Sulphacetamide
Sulfadiazine/Sulphadiazine
Sulfadimethuzine/Sulphadimethoxine
Sulfadimidine Sodium/Sulphadimide Sodium
Sulfadimidine/Sulphadimidine
Sulfadoxine / Sulphadoxine
Sulfafunazole/Sulphafunazole
Sulfaguanidine/Sulphaguanide
Sulfamerazine/Sulphamethazine
Sulfamethizole/Sulphamethizole
Sulfamethoxazole/Sulphamethoxazole
Sulfamethoxypyldaine/ Sulphamethoxypyridazine
Sulfametopyzine
Sulfanilamide/Sulphanilamide
Sulfaphenazole/Sulphaphenazole
Sulfapyridine/Sulphapyridine
Sulfaquinoxaline/Sulphaquinoxaline
Sulfathiazole/Sulphathiazole
Sulfisomedine/Sulphasomidine
Sulpride
Sultiame/ Sulthiams
Suprofen
Thioproperazine
Thiothixene/Thiotixene
Tolazamide
Tolbutamide
Irradiated ergosterol
Beta Carotene (Pro-Vitamine-A)
VitaminA & D all grades/forms
Vitamin A/ Vitamin A acetate/Palmitate/Vitamin A Water soluble
Multivitamin with Carbonyl Iron Pellets
Multivitamin with Ferrous Sulphate Pellets
Thiamine Hydrochloride/Aneurine Hydrochloride
Thiamine Mononitrate/Aneurine Mononitrate
Thiamine/Vitamin B1/Thiamine HCL/Thiamine Monoxitrate
Ribaflavin –5-Phosphate Sodium
Riboflavin 7-phosphate sodium
Calcium D-Pantothenate
Dexpanthenol
D-panthenol/D-pantothenyl Alcohol/Dexpanthenol
- 96 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2936.22.00
2936.24.00
2936.24.00
2936.25.00
2936.26.00
2936.26.00
2936.27.00
2936.27.00
2936.27.00
2936.28.00
2936.28.00
2936.28.00
2936.28.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
29.37
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2936.29.00
2937.12.00
2937.12.00
2937.19.00
2937.19.00
2937.19.00
2937.19.00
2937.21.00
2937.21.00
2937.21.00
2937.21.00
Panthenic Acid/Pantothenic Acid Calcium Salt
Panthenol/DL-panthenol/DL-Panthenol
Sodium Pentothenate/D-Pentothenate
Pyridoxine Hydrochloride/Vitamin B6
Cyanocobalamin/Vitamin B6
Vitamin B-12 1% feed grade
Ascorbic Acid/Vitamin C powder/Crystal/Silicone coated/E.C.
coated/Ethocei coated
Calcium Ascorbate
Sodium ascorbate
D-alpha tocopheryl acetate/Vitamin E
D-alpha tocopheryl Acid Succinate
Tocophenyl Acetate alpha-tocophehyl acetate/Vitamin E/Vitamin E
Acetate
Tocoterol Acetate
4:4 Diamidinodipheny lamine Dihydrochloride
Acid Isonicotinic Hydrazide
Biotin
Calciferol
Ergocalciflor
Cholecalciferol/Vitamin-D
Vitamin
D2/Vitamin D3
Ergocalciferol Calciferol/Cholecalcifero
Folic Acid
Nicotinamide/Niacinamid/Nicotinic Acid
Phytomenadione/Phytonadione
Vitamin D all grades/forms
Vitamin D granules & water soluble
Vitamin D with D grades
Vitamin K all grades
Hydroxyocobalamine
Inositol
Lutein
Quercetin Dihydrate
Insulin Protamine Zinc
Insulin Zinc Suspension morphous/Crystalline
Clomiphene Citrate
Corticotrophin/ACTH
Danazol
Tibolone
Cortisone/Acetate
Hydrocortisone/Acetate/Sodium Succinate/all forms
Prednisolone and it salts
Prednisone
- 97 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.22.00
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.23.90
2937.29.00
2937.29.00
2937.29.00
Betamethasone & its salts
Chloropedrisone/ Chloropredrisone Acetate
Clobetasol-17-Propionate
Dexame-thasone & their salts
Diflucortolone-21-valerate micro 20
Flucortolone
Fludroxycortide/Flurandrhclone
Fluocinolone Acetonide
Fluocortolone caproate m 20
Fluocortolone pivalate
Fluprednisolone
Halcinonide
Triamcinolone Hexacetonide/Acetonide
Allylstrenol
Chloramadinone Acetate
Dimethisterone
Eatradiol Benzoate/Oestradiol Benzoate
Estradio/Oestradiol
Estradiol phenyl propionate/Oestradiol phenyl proprionate
Estradiol undecylate/Oestradiol undecylate
Estrenone
Estriol (Micronised)
Estriol succinate/Oestriol succinate
Ethisterone
Ethylestradio/Ethinyloestradiol
Ethylestrenol/Ethyloestrenol
Ethynodiol deacetate
Ethynodiol deacetate with ethidyloestradiol
Hydroxyprogesterone
Lynostrenol/Lynoestrinal
Medroxyprogesterone
Megesterol Acetate
Mestranol
Norethindrone Acetate
Norethisterone/Norethindrone Acette
Norgestral
Oestriol Oestradiol Benzoate/Pheny propionate
Oestrone
Progesterone
Aldosterone
Desoxycorticosterone/Desoxycortone
Methylprednisolone/Methyprednisolns Sodium succinate
- 98 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.38
29.39
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2937.29.00
2938.10.00
2938.90.00
2938.90.00
2938.90.00
2938.90.00
2938.90.00
2938.90.00
2938.90.00
2938.90.00
2938.90.00
2939.11.00
2939.11.00
2939.11.00
2939.11.00
2939.11.00
2939.11.00
2939.11.00
2939.11.00
Prednisolon caproate
Tetracosactide
Adrenaline Tartrate/Hydrochloride
Beclomethasone Dipropionate
Epenephrine/Epenephrine Hydrochloride/tartrate
Epinephrine/Adrenaline
Fluoxymesterone
Levothyroxine sodium
Lypressin/Lysin vasopressin
Metandriol
Methytestosterone
Nandrolone deanoate/Phenyl propionate
Nandrotone
Oxymetholone
Oxytacin
Stanozolol
Testosterone
Testosterone decanoate
Testosterone Isocaproate
Testosterone phenyl propionate
Testostrone Propionate
Thyroxine of all grades
Vasopressin
Rutin/Rutoside
Acetyldigitoxin
Aloin
Calcium Aennosides
Deslanoside
Digitoxin
Digoxin
Gliclazide INN
Juercetin
Lovastatin
Codeine/Codeine Phosphate
Dihydrocodin Bitarrate/Dihydrocodin Acid Tartrate
Ethylmorphine Hydrochloride
Hydromorphine
Methyldehydromorphine
Morphine/Morphine Hydrochloride/Morphine Sulphate
Pholcodine
Nalorphine
- 99 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2939.19.00
2939.19.00
2939.19.00
2939.19.00
2939.19.00
2939.20.90
2939.20.10
2939.20.10
2939.20.10
2939.20.90
2939.20.90
2939.41.00
2939.41.00
2939.42.00
2939.49.00
2939.51.00
2939.59.00
2939.59.00
2939.59.00
2939.59.00
2939.59.00
2939.59.00
2939.59.00
2939.61.00
2939.61.00
2939.62.00
2939.62.00
2939.63.00
2939.63.00
2939.63.00
2939.69.00
2939.69.00
2939.99.10
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
Narcotine/Narcosin
Noscapie
Noscapine/Noscapene Hydrochloride
Opium and their desivatives
Papaverine Papaverine Hydrochloride
Decoquinate
Quinine Metamizol Complex
Quinine Sulphate/Hydrochloride/bisulphate/dihydrochloride
Quinidine Sulphate
Other alkaloids of cinchona
Tolaquin
Ephedrine Resinae
Ephedrines and salts, Pseudoephedrine HCL2939.42.00
Ephedrines and salts, Pseudoephedrine HCL2939.42.00
Ephedrines and salts, Pseudoephedrine HCL2939.42.00
Pentoxifylline/Oxypentifylline
Choline Theophyllinate
Dimenhydrinate
Phenmetrazine Theoclate
Pyrimethamine
Sodium Glycinate
Theophylline Eqhedrine/Theophyllineanhydrous/Theophylline and it
salts
Theophylline, Aminophylline and their derivatives
Ergometrine and its salts
Ergotamine and its salts
Ergotamine and its salts
Ergotamine tartrate/Maleate
Lysergamide Amide
Lysergide
Dihydroergo tamine methane sulphonate
Methylergometrin Maleate
Other alkaloids of rye ergot and its derivatives
Atropine suphate and thyocine hydrobromie
Benatropine
Colchincal Powder
Dehydroemetine
Emetine Hydrochloride
Eserine Sulphate/Salicylate
Homatropine Hydrobromide
Hyoscine
Hyoscine-n-butyl bromide/Hyoscine Butyl Bromide
- 100 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2939.99.90
2939.99.90
29.40
29.41
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2939.99.90
2940.00.00
2940.00.00
2940.00.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.10.00
2941.20.00
Lobeline
Metamizol/Methampyrine Methampyrine/Analgin Calcium Salt of
Metamizol
Methamphetamine
Methylergometrine
N acetyl Sulphamethopridexine
Other vegetable alkaloids
Pilocarpine Hydrochloride/Nitrate
Rescinnamine
Reserpine
Strychnine and its salts
Theobroine and its salt
Thioacetazone/ Thiacetazone
Tropenziline Bromida
Tubocurarine Chloride
Vincristine
Vincristine
Vinpocetine INN
Yohimbin Hydrochloride
Lactolose Concentrate Solution
Lactulose Concenrate (67-68%) Solution USP/BP
Sucralfate (Alumnium Sucrose Sulfate)
Alfacillin
Amoxicillin all grdes/forms
Ampicillin all grades/form
Benzathine
Benzathine Penicillin all grades/forms
Benzyl penicillin/ Penicillin G sodium/Penicillin G Potassium/all
grades/forms
Benzylpenicillin Sodium/Penicillin G
Carbnicillin/Carbinicillin Sodium/Potassium/Disodiu/Indanyl Sodium
Cloxacillin all grades/forms
Epicillin
Flucloxacillin Sodium
Meticilin/Methicillin
Penicillin/Penicillin VK
Phenticillin/Phenethicillin
Pivampicillin
Potassium Phenoxymehtyl Penicillin all grades/forms
Procaine penicillin, Procaine Benzyl Penicillin/Procaine Penicillin G,
all grades/forms
Beknamycin/kenamycin B
- 101 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
2941.20.00
2941.20.00
2941.20.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.30.00
2941.40.00
2941.50.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
Dihydrostreptomycin/Dihydrostreptomycin Sulphae
Streptomycin Sulphate
Streptoniazid
Calcium Oxyte-tracycline/Calcuium Oxyte-tracycline Hydrochloride
Chlortetracycline & its salts
Demeclocycline
Dimethyl Chlortetracycline
Lymecycline/Tetracycline L-methylenelysin
Metacycline/Metacycline
Methacycline
Oxytetracycline & its salts
Rolitetracycline
Tetracycline 50% 2
Tetracycline base
Tetracycine Hydrochloride/ Phosphate complex/L-methylenelysin
thihydrate and its salts
Chloramphenicol/Palmitate/Succinate/Levo
Erythromycin Base/stearate/Ethyl succinate
Amphotericin B
Azithromycin/Azithromycin dihydrate
Bacitacin zinc/Zinc Bacitracin
Bleocycin
Cefiximine Anhydrous INN
Cephalexin all grades/forms
Cephradine all grades/forms
Cofuloridine/Cephaloridine
Cycloserine
Dioloxacellin
Finasteride
Framycetin Sulphate
Fumafillin
Gentanycin/Gentamycin Sulphate
Griseofulin
Kanamycin Sulphate
Levofloxacin Hemithydrate
Licomycin/Licomycin hydrochloride
Mitomycin
Neohetramine Hydrochloride
Neomycin Hydrochloride (Microfine)
Neomycin Sulphate
Nystatin/Fungicidine
Oleandomycin/Triacetryl oleandomycin
- 102 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.42
30.01
30.02
30.03
30.04
32.01
32.03
32.15
33.01
34.05
38.14
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2941.90.00
2942.00.00
2942.00.00
2942.00.00
2942.00.00
2942.00.00
2942.00.00
2942.00.00
3001.20.00
3001.20.00
3001.20.00
3001.90.00
3001.90.00
3002.10.00
3003.90.10
3004.90.99
3201.90.90
3203.00.00
3215.11.10
3215.19.10
3301.90.90
3405.90.20
3504.00.10
3505.20.00
3507,90.00
3507.90.00
3507,90.00
3507,90.00
3507,90.00
3507,90.00
3507.90.00
3507,90.00
3507.90.00
3507,90.00
3507.90.00
3814.00.00
Pirmaricin
Polymyxin B/Polymyxin B Sulphate
Rifampicin/Rifampicin all grades/forms
Rifamycin
Spiramycin (spira 200) feed grade/ Spiramycin Imbemate 200g
Tyrothricin
Viomycin
Esculin FR.P
Magaldrate
Monosemicarbazone odronochrome/Corbarochrome Dihydrate
Salmeterol Xinaoate
Sodium Stibogluconate/ Sodium Antimony Gluconate
Terbinafine
Tetramisole HCL
Liver, extract/powder/concentrated/liquid
Ox Bile Extract Desiccated
Bile salt
Heparin
Thyroid/Thyroid gland powder/Thyrodine
Haemoglobin/Oxyhaemoglobin
Chiniofon
Acyclovir/Acyclovir Sodium
Gall/Nut Gall extrac/powder
Betacarotene
Disposable syringe barrel printing ink
Disposable syringe barrel printing ink
Hydrogenated oil in powder form
Polishing compound (special type)
Protamia Sulphate
Expoxy glue
Amylase
Chymotrypsin/Alpa Chymotrypsin
Diastase all concentrations/polyenzymes
Fibrinolysin (Human)
Hyalurounidase
Lipase
Pancreatin/Pancreatin Hemicellulose with (out) Bile Salts
Pepsin all concentrations
Streptokinase
Trypin
Urokinase
Genesolv – 2000 (special type volatile)
- 103 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
38.24
39.01
39.02
39.03
39.04
39.05
39.07
39.10
39.13
39.17
39.19
39.20
39.23
39.26
40.01
40.14
40.16
48.02
48.10
3824.90.10
3824.90.10
3901.10.10
3901.10.10
3901.10.90
3901.20.10
3901.20.10
3902.10.00
3903.30.00
3904.10.00
3904.10.00
3904.40.00
3905.99.00
3907.40.00
3910.00.00
3910.00.00
3910.00.00
3913.90.90
3913.90.90
3917.23.10
3917.32.90
3919.10.00
3920.10.90
3920.20.90
3920.49.10
3920.71.00
3923.30.10
3923.50.00
3923.50.00
3926.90.90
3926.90.90
4001.10.00
4014.90.00
4016.99.90
4802.54.00
4802.57.00
4810.29.00
Ichthammol
Sodium polyhydroxy aluminium monocarbonate hexytol complex
Polyethylene having a specific gravity of less than 0.94 Pellet
Pramaceutical grade polythelene granules BP/USP
Polyethylene having a specific gravity of less than 0.94
: Others
Polyethylene having a specific gravity of 0.94 and above : pellet
Pharmaceutical grade polyethylene granules BP/USP
Polypropylene (film and injection grade)
Acrylonitrile-butadiene-styrene (ABS) copolymers
Pharmaceutical grade PVC resin/granules BP/USP
PVC resin/granuls BP/USP
Pharmaceutical grade poly carbonate graules BP/USP
Providone
Polycarbonate granules BP/USP
Dimethicone
Dimehyl polysiloxana
Silicone compound (special type)
Dextran all grades
Iron extran
PVC tube (shrinkable special type)
Polystene/plastic tubes <=10” diam in rolls for packing intervaneous
solutions
Tape (special type)
Pilofilm accetate polythene lined
Plates, sheet, film and strip of Polymers for propylene
Polyvinylchloride (PVC) film/polyvinyledine chloride (PVDC) film for
blister packing
Viscose film (moisture proof & heat sealable)
Sachet/paper
for
sachet
poly
glycin/poly
aluminium
paper/aluminum/polythene pouches (sachet) printed with the name of
medicine
Caps bakelite/polythene/plastic all sizes with embossing/printed
Stopper/plugs
Plastic & rubber parts for infusion set
Plastic inhaler
Rubber Latex Injection Port
Rubber disc hand wads/ptfee disc rubber teat
Rubber & polythene plugs for vials
Special type paper for blister foil of a width of 380 to 460 mm
Special type paper for blister foi of a width of 380 to 460 mm
Polythelene coated paper
- 104 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
48.19
4819.50.00
68.04
6804.10.00
6804.21.00
7010.10.00
7010.10.00
7010.90.30
7010.90.30
7018.10.00
7607.19.00
7607.20.90
7607.20.90
7612.90.20
7612.90.20
70.10
70.18
76.07
76.12
82.03
83.09
8203.10.10
8309.90.10
8309.90.39
84.24
90.18
8424.20.90
9018.32.00
9018.39.90
9018.39.90
9018.90.90
Sacher/paper for sachet poly glycin/poly aluminium paper/
aluminium/polythene pouches (sachet) printed with the name of
medicine
Grinding stone (special type)
Abrasive Cutting wheel (special type)
Glass ampoules
Neutral Glass ampoules
Glass phials/vials and glass bottles for infusion
Special bottles for eye/ear drops with fitments
Glass bead (special type)
Aluminium foil plain
Aluminium foil polythene lined and lacquered Aluminium foil
Aluminium foil (other)
Aluminium can, 19ml for inhaler
Sacher/paper for sachet poly glycin/poly aluminium paper/
aluminium/polythene pouches (sachet) printed with the name of
medicine
Files for cutting ampoules
Combination of rubber nd aluminium seal for vial
Sachet/paper for sachet poly glycin/poly aluminium paper/
aluminium/polythene pouches (sachet) printed with medicine name
Metered value for inheler
Needle Cannulae
Luet needle
Needle Cannulae
I. V. Fluid bag of 100 ml-500 and 1000 ml capacity, stopper and giving
set.
TABLE-II
Heading H. S. Code
(1)
(2)
Description
(3)
05.10
05.11
07.09
11.08
Ambergris (Gen 15%)
Cochneal
Rhubarb
Amylum in all combination & form
Amylum in all combination & form
Amylum in all combination & form
Amylum in all combination & form
Amylum in all combination & form
Cascara Sagrada/Chirata/Cocillana
LiacticAcin/Peppermint/Peppermint composition
12.11
0510.00.10
0511.99.00
0709.90.91
1108.11.00
1108.12.00
1108.13.00
1108.14.00
1108.19.00
1211.90.21
1211.90.21
- 105 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
13.01
13.02
15.04
15.05
15.08
15.09
15.15
15.16
15.21
17.01
17.02
1211.90.21
1211.90.22
1211.90.22
1211.90.22
1211.90.91
1211.90.91
1212.20.11
1212.20.12
1301.90.90
1301.90.90
1301.90.90
1301.90.90
1301.90.90
1301.90.90
1302.12.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1302.19.00
1504.10.00
1505.00.10
1505.00.10
1508.90.00
1509.90.00
1515.30.00
1516.10.00
1516.20.90
1521.10.10
1521.90.90
1701.99.00
1702.11.00
1702.11.00
Sarsaparila/Stramonium/Witch Hazel, all sorts
Cascara Sagrada/Chirata/Cocillana
LiacticAcin/Peppermint/Peppermint composition
Sarsaparila/Stramonium/Witch Hazel all sorts
Condurango
Condurango
Johannis Brotmehl/johannis Brotkernel/Algroba
Johannis Brotmehl/johannis Brotkernel/Algroba
Acacia
Balsum Tulo
Myrrh
Myrrh extract/crude/ prepared
Myrrh extract dried or concentrated
Tragacanth powder
Liquorice extract
Capsicum extract
Cardco Fluid-Extract
Colstfoot extract
Curcuma extract
Ephedra Vulgaris Pro-Tincture extract
Grindelia Pro. Tincture extract
Hydrastic Pro Tincture extract
Jaborandi Pro Tincture extract
Jalap/Jalap extract & resin
Liriosma Ovata, extract/powder
Podophyllin resin/extract
Tincture Cudbear
Vasaka extract Adhatoda
Pectin
Cod liver Oil crude & refined
Lanolin Anhydrous/Lanolin Hydrogenated
Lanolin Hydrogenated
Arachis Oil
Olive Oil
Castor Oil
Hydrogenated Castor Oil
Astra Fat (UL Archidis hydrogenatum)
Carnauba wax BP
Spermaceti (walrat)
Socrose
Lactose Monohydrate/Anhydrous Fine/Coarse powder
Lactose, Sugar of milk
- 106 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
21.06
22.02
22.07
25.01
25.07
25.08
25.12
25.19
25.20
27.10
27.11
27.12
28.01
28.03
28.04
28.05
28.06
28.09
1702.30.90
1702.40.00
1702.50.00
1702.60.00
1702.60.00
1702.90.00
2106.10.00
2202.90.00
2207.10.00
2207.10.00
2501.10.10
2507.00.00
2508.10.00
2508.10.00
2508.10.00
2508.10.00
2512.00.00
2512.00.00
2512.00.00
2519.90.00
2519.90.00
2520.10.00
2520.10.00
2710.19.36
2711.14.00
2712.90.00
2801.10.00
2801.20.00
2801.20.00
2801.30.00
2803.00.00
2804.61.00
2805.11.00
2805.19.00
2805.40.00
2806.10.00
2806.20.00
2809.20.00
2806.20.00
2806.20.00
2806.20.00
Poly saccharide
Glucose mixed with fructose
Fructose
Fructose
Fructose, other than pure
Caramel
Protein Hydrolysate
Cherry Laurel Water
Alcohol in all forms
Ethyl alcohol
Sodium Chloride BP/PG Eur (pyrogen free)
Kaolin light/heavy
Benegel E.W.
Bentonite
Attapulgite in all forms
Laponite CP/XLG
Celite
Hyflo Supercel
Super-Cel
Calcined Megnesite
Magnesium Oxide all grades
Calcium Sulphate Dihydrate
Terra Alba
Paraffin liquid
Ethylene Oxide Gas
Ceresin
Chlorine
Endoliodin
Iodine
Bromine
Ultra Carbon
Dow corning Antifoam MSA compound (silicone MS antifoam A),
pharmagrade
Croscarmellose Sodium USP – xxii/NF XVI
Potassium/Metal
Mercury
Hydrochloric Acid
Chlorosulphonic Acid
Acid Phosphoric
Meta Phospho9ric Acid
O-phosphoric Acid/Phosphoric Acid
Phosphoric Acid
- 107 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
28.10
28.11
28.12
28.14
28.15
28.17
28.18
28.19
28.20
28.21
28.22
28.24
2810.00.00
2810.00.00
2811.19.00
2811.19.00
2811.19.00
2811.19.00
2811.22.00
2811.22.00
2811.22.00
2811.22.00
2811.22.00
2811.29.00
2811.29.00
2811.29.00
2812.10.00
2812.10.00
2812.10.00
2812.10.00
2814.20.00
2811.20.00
2811.20.00
2811.20.00
2815.11.00
2815.11.00
2815.12.00
2815.20.00
2815.20.00
2817.00.00
2818.20.00
2818.30.00
2819.10.00
2819.10.00
2819.90.00
2820.10.00
2820.90.00
2821.10.00
2821.10.00
2821.10.00
2821.10.00
2822.00.00
2824.10.00
2824.90.00
Acid Boric BP
Boric Acid
Acetoarsenic Acid Disodium salt
Acid Hydrocyanic
Hydrobromic Acid
Perchloric Acid
Aerosil
Colloidal Silicon Dioxide
Silica gel, Bagettes/Capsules
Silicon Oil
Sillica Gel
Acid Genetisic
Arsenic Trioxide
Arsenic Trioxide powder
Phosphorous Penta Chloride
Phosphorus Oxychloride/Phosphoryl Chloride
Trionyl Chloride
Boron Trifluoride Diethozate
Ammonia Solution (all types)
Ammonium Hydroxide
Liquid ammonia Forte
Liquor Ammonia
Caustic soda (Sodium Hydroxide)
Sodium Hydroxide pallets/tablets
Caustic soda (Sodium Hydroxide)
Caustic potash
Potassium Hydroxide
Zinc Oxide, feed grade BP
Alumunia
Hydrated Alumina powder
Chromic Acid
Chromium Trioxide
Chromic Oxide
Manganese Dioxide
Manganese Gluconate
Eisen Oxide Yellow
Ferric Oxide in all forms
Iron Sesquioxide
Red Precipitated Ferric Oxide
Cobalt Oxide
Lead Monoxide
Dioctyl sodium sulphosuccinate
- 108 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
28.25
28.26
28.27
28.29
28.30
28.32
28.33
2825.10.00
2825.10.00
2825.50.00
2825.90.00
2826.19.00
2827.10.00
2827.20.00
2827.20.00
2827.31.00
2827.32.00
2827.39.10
2827.39.90
2827.39.90
2827.39.90
2827.39.90
2827.20.00
2827.39.90
2827.39.90
2827.39.90
2827.39.90
2827.51.00
2827.59.00
2827.60.00
2827.60.00
2827.60.00
2827.60.00
2827.60.00
2827.60.00
2829.10.10
2829.10.10
2829.10.10
2830.10.00
2830.10.00
2832.10.00
2832.20.00
2833.19.10
2833.19.00
2833.19.00
2833.21.00
2833.22.00
2833.22.00
2833.22.00
Hydrazine Dihydrochloride
Hydrazine Hydrate
Copper Oxide
Calcium Hydroxide
Ammonium Bifluoride
Ammonium Chloride
Calcium Chloride
Calcium Phosphoryl Choline Chloride
Magnesium Chloride
Aluminium Chloride
Mercury Amide Chloride/ Mercuric Chloride Ammoniated
Antimony Chloride/Trichloride
Barium Chloride
Cobalt Chloride
Copper Chloride
Cupric Chloride
Ferric Chloride
Iron Chloride
Lithium Chloride
Manganese Chloride
Potassium Bromide BP/USP
Ammonium Bromide
Calcium Iodide
Potassium Iodide
Potassium Iodide 89-91%
Potassium Iodide BP/USP
Potassium Iodide Dibasic Calcium Phosphate
Sodium Iodide
Potassium Chloride
Calcium Iodate
Potassium Iodate BP/USP
Sodium Sulphide
Sodium Sulphite/Sodium Sulphite Anhydrous
Sodium Metabisulphate
Potassium Metabisulphite/Potassium Pyresulphite
Sodium Cetostearyl Sulphate
Sodium Lauryl Sulphate
Sodium Lauryl Sulphate BP
Magnesium Sulphate
Aluminium Sucro Sulphate
Aluminium Sulphate
Ammonium Aluminium Sulphate
- 109 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
28.34
28.35
28.36
2833.25.00
2833.25.00
2833.25.00
2833.25.00
2833.29.20
2833.29.90
2833.29.90
2833.29.90
2833.29.90
2833.29.90
2833.29.90
2833.29.90
2834.21.00
2834.29.90
2835.10.90
2835.10.90
2835.22.00
2835.22.00
2835.22.00
2835.22.00
2835.22.00
2835.22.00
2835.22.00
2835.24.00
2835.24.00
2835.24.00
2835.26.00
2835.26.00
2835.29.10
2835.29.10
2835.29.90
2835.29.90
2835.39.00
2835.39.00
2835.39.00
2836.20.00
2836.30.00
2836.40.00
2836.40.00
2836.50.00
2836.50.00
Copper Sulphate
Copper Sulphate Hydrate
Cupric Sulphate
Ferrous Sulphate/Ferrous Sulphate dried/Anhydrous
Ammonium Sulphate Anhydrous
Calcium Sulphate Dihydrate
Cobalt Sulphate
Cobalt Sulphate Heptahydrate
Manganese Sulphate
Manganese Sulphate/Monohydrate/Anhydrous
Manganese Sulphate/Manganese Sulphate Monohydrate/extra pure
Zinc Stearate/Sulphate/Chloride
Potassium Nitrate
Colloidal Bismuth Subnitrate
Magnesium Hypophosphite
Sodium Hypophosphite
Disodium Hydrogen Phosphate
Disodium Phosphate Crystalline
Di-Sodium Phosphate/Di-Sodium Pamoate
Monosodium Phosphate
Monosodium Phosphate/Sodium Phosphate (Monobasic)
Sodium Dihydrogen Phosphate
Sodium Phosphate
Monopotassium Phosphate
Potassium Dihydrogen Phosphate
Potassium Phosphate
Calcium
Phosphate
Tribasic
(Tricalcium
Phosphate)
Dihydrate/Anhydrous
Tricalcium Phosphate
Ferric Phosphate
Ferric Pyrophosphate
Manganese Phosphate
Trisodium Phosphate
Acid Sodium Pyrophosphate
Potassium Metaphosphate
Sodium Hexametaphosphate/ Sodium Polymetaphosphate
Sodium Carbonate, exsiccated dried BP
Sodium Bicarbonate BP
Potassium bicarbonate
Potassium Carbonate
Calcium Carbonate
Chalk Precipitated
- 110 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
28.37
28.39
28.40
28.41
28.42
28.47
28.50
28.52
29.01
29.02
29.03
2836.60.00
2836.99.90
2836.99.90
2836.99.90
2836.99.90
2836.99.90
2836.99.90
2837.20.00
2939.90.90
2839.90.90
2939.90.90
2939.90.90
2839.90.90
2839.90.90
2840.20.00
2840.20.00
2841.50.00
2841.50.00
2841.61.00
2841.70.00
2841.70.00
2841.90.00
2841.90.00
2842.90.00
2842.90.00
2842.90.00
2847.00.00
2850.00.00
2852.00.00
2852.00.00
2901.10.00
2902.11.00
2902.20.00
2902.30.00
2902.30.00
2902.30.00
2902.41.00
2902.90.00
2902.90.00
2903.11.00
2903.11.00
2903.11.00
Barium Carbonate/Chloride/Hydrate/Nitrate/Peroxide
Ammonium bicarbonate
Ammonium Carbonate
Bismuth Subcarbonate
Bismuthoxycarb Bismuth Carbonate
Copper Carbonate
Magnesium Carbonate, light/heavy
Potassium Ferrocyanide
Calcium Silicate
Levynite/Calcium Aluminosilicate
Magnesium Aluminium Silicate
Magnesium Silicate
Magnesium Trisilicate
Veegum/ Aluminium Magnesium Silicate
Borax
Sodium Tetraborate/Borax/Sodium Borate
Potassium Chromate
Potassium Dichromate
Potassium Permanganate
Ammonium Molybdate
Sodium Molladate
Aluminate of Bismuth
Sodium Aluminate
Ammonium Triocyanate
Potassium Thiocyanate
Sodium Selenite/2.2% Selinica
Hydrozen Peroxide, all percentages and volumes
Potassium Borohydride
Mercuric Oxide Yellow
Mercurous Nitrate
Hexane
Cychlohexane
Benzene
Butylated Hydroxyl Toluene
Ionol/Butylate Hydroxytoluene
Toluene
Zylene
1-Phenyl-2-Pylidyl Pentane
1-Phenyhl-Hydroxy Pentane
Methyl Chloroform Trichlorethane/Chlorothene
Tetrachloroethane
Dichlorodifluoromethane
- 111 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.04
29.05
2903.12.00
2903.12.00
2903.12.00
2903.12.00
2903.13.00
2903.14.00
2903.19.00
2903.23.00
2903.29.00
2903.39.00
2903.39.00
2903.39.00
2903.39.00
2903.41.00
2903.41.00
2903.44.00
2903.62.00
2903.69.00
2903.69.00
2904.10.10
2904.10.90
2904.10.90
2904.10.90
2905.11.00
2905.11.00
2905.11.00
2905.13.00
2905.13.00
2905.13.00
2905.14.00
2905.16.00
2905.17.00
2905.17.00
2905.17.00
2905.17.00
2905.19.00
2905.19.00
2905.19.00
2905.22.00
2905.29.00
2905.29.00
2905.42.00
Dichloromethane
Mathylene Dichloride
Methylene Chloride
Chloroform
Carbon Tetra Chloride
Ethylene Dichloride
Trichloriethane
Tetrachlorethylene
Dichloroethylene
Allyl Bromide
Dibromobutane
Ethalene Iodide
Propyl Gallate Bromide
Trichloro Fluoromethane with Bichlorodifluoromethane
Trichloromino Fluoro Methane (freon-11)
Dichlorotetra Fluoro Ethane (freon-114)
Gamma Benzene Hexachloride
Benzyl Chloride
Chlorxylen
Methane Sulphonate
Methane Sulphonic Acid
P-Trimethyl Cetyl Ammonium Toluenesulphonate
Methane Sulphonyl Chloride
Denatured Spirit/Industrial Methylate Spirit (IMS)
Methanol (Methyl Alcohol)
Olevel Alcohol
Butanol
Isopropyl/Butyl Alcohol
Pheyl Propyl Aldehyde
Acetone Chloroform/Chlosobutanol
Octyl Alcohol
Cetyl Alcohol
Cetyl Stearyl Alcohol
Eutanol G
Stearyl Alcohol
Amyl Alcohol
OTM (Octylthyotene)
Shuogly Cerol
Propylene Glycol
Proparbyl Alcohol
Propargyl Alcohol
Ethylene Glycol Monoethyl Ether/(Oxitol)/2-Ethoxysthanol
- 112 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.06
29.07
29.08
29.09
29.10
29,12
29.14
2905.44.00
2905.45.00
2905.45.00
2905.49.00
2906.19.90
2906.19.90
2906.21.00
2906.29.00
2906.29.00
2906.29.00
2907.12.00
2907.12.00
2907.12.00
2907.15.00
2907.19.00
2907.22.00
2907.22.00
2908.19.90
2908.19.90
2909.11.00
2909.19.00
2909.30.00
2909.30.00
2909.30.00
2909.30.00
2909.49.00
2910.10.00
2910.10.20
2912.19.00
2912.21.00
2912.29.10
2912.41.00
2912.42.00
2912.42.00
2912.50.00
2914.11.00
2914.12.00
2914.19.90
2914.21.00
2914.21.00
2914.40.10
Crystalline D-Sorbitol Powder
Clycerine concentrations
Monothio Glycerol
Bronopol
Bromopregnane
Terpineol
Benzyl Alcohol
2-Phenyl Ethanol
Dichlorbenzyl Alcohol Dybenal
Phenyl-Ethyl Alcohol/Phenethyl Alcohol/Phenylethanol
Cresol
Meta Cresol
Tricresol
Napthol
Chlorinated Xylenol
Hydroquinone
Quinol/Hydroquinone
Bromo Cresol
Promo Phenol
Diethyl Ether
Ether
Anethole
Anethole Triothione
Butyl Hydroxy Anisole
Butylaed Hydroxyanisole
Ether
Ethylene Oxide
Addition product of Propylene Oxide and Hydroxyl group of Propylene
Glycol
Cital
Benzaldehyde
Cinnamaldehyde
4-Hydroxy-3-Methoxy Benzaldehyde
Actone Ethyl – Vanillin
Ethyl Vanilin all types
Paraldehyde
Acetone
Methyl Ethyl Ketone
Acetyl Acetone
Camphor
Camphor/Camphor Monobrom/Bromo-Camphor
Tr. Benzoin
- 113 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.15
29.16
2914.4090
2914.69.00
2914.69.00
2915.11.00
2915.13.00
2915.21.00
2915.24.00
2915.29.10
2915.29.90
2915.29.90
2915.31.00
2915.31.00
2915.31.00
2915.39.00
2915.39.00
2915.39.00
2915.50.90
2915.70.10
2915.70.10
2915.70.10
2915.70.10
2915.70.10
2915.70.20
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2915.90.00
2916.15.00
2916.15.00
2916.15.00
2916.15.00
2916.19.00
2916.19.00
2916.20.00
Rhodigel 23
1:8 Dichlorodifluoromethane/Danthron
L-Arginine
Formic Acid
Magnesium Formate
Monochloro Acetic Acid
Acetic Anhydride
Sodium Acetate
Cupric Acetate Monohydrate
Lead Tetra Acetate
Potassium Accetate BP/USP
Ethyl Acetate
Ethyl Acetate NF
Amyl acetate
Benzyl Acetate
Bornyl Acetate/Borneol Acetate
Diacetin/Glycerol Diactale
Linalyl Acetate
Phenyl Propoinic Acid
Di-Glycol Stearate Pharm. Grade/Di-Glycol Monosterate
Methyl Steorate
Polyoxyethelene Streatte
Stearate
Stearic Acid (all forms)
Isopropyl Palmitate
Adrenochrome Semacarbazone Sulforic Ester
Aluminium Stearate
Calcium stearate
Decanoic Acid/N-Capric Acid
Decanoyl Chloride
Glyceryl Monostearate
Glycrylpolyoxomethylene Glycol Stearate
Isopropyl Myristate
Palmityl Chloride
Propionic Anhydride
Ethyl Oleate
Labrafil
Olcic Acid
Poloxy-5-Oleate
Potassium Sorbate
Sorbic Acid
Ethyl Cellulose 30% Aqueous dispersion (Aquacost ECD-30)
- 114 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.17
29.18
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.31.00
2916.39.90
2916.39.90
2916.39.90
2916.39.90
2916.39.90
2917.11.00
2917.11.00
2917.13.00
2917.14.00
2917.19.90
2917.19.90
2917.19.90
2917.32.00
2917.34.00
2917.34.00
2917.35.00
2917.39.00
2918.11.00
2918.11.00
2918.12.00
2918.13.00
2918.13.00
2918.13.00
2918.13.00
2918.13.00
2918.14.00
2918.15.00
2918.15.00
2-Naphthyl Benzoate/B-Naphthyl Benzoate
Benzoic Acid
Ethyl Hydroxy Benzoate
Methyl Hydroxy Benzoate
Methyl Paraben
Methyl Para-Hydroxy Benzoate Sodium
Methyl-Para-Bydroxy Benzoate/Methylparaben
N-Bytyl-Hydroxybenzoate
Propyl Hydroxybenzoate
Propyl Paraben
Sodium Benzoate
Sodium Methylhydroxybenzoate
Sodium Propylhydroxybenoate
Butyl Paraben (Butyl Para Benzoate)
Cinnamic Acid
O-Chlorobenzoic Acid
Phenyl Propeonyl Chloride
Phenyl Propionic Acid
Acid Oxalic
Ammonium Oxalate
Dibutyl Sebacate
Maleic Anhydride
Fumaric Acid
Magnesium Stearate
Maleic Acid
Dioctyl Orthopthatete (DOP)
Dibutyl phathalete
Dimethyl phthalete and Diethyl phthalete
Phthalic Anhydride
Lauryl dimethyl aminoxide, Potassium bi phthatete/Potassium
hydrogen phthalete
Ferrous Lactate
Sodium Lactate/Sodium-Lactate 50% solution
Acid Tartaric
Antimony Potassium Tartrate
Ferrous Tartrate
Potassium Antimonyl Tartrate
Potassium Bitartrate
Potassium Tartrate
Citric Acid Anhydrous/Hydrus/ Monohydrate-Crystalline/Granular
Calcium Citrate
Sodium Citrate
- 115 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.20
29.21
29.22
2918.15.00
2918.15.00
2918.15.00
2918.15.00
2918.16.00
2918.16.00
2918.16.00
2918.19.90
2918.19.90
2918.19.90
2918.19.90
2918.19.90
2918.19.90
2918.19.90
2918.19.90
2918.19.90
2918.19.90
2918.23.00
2918.23.00
2918.29.00
2918.29.00
2918.29.00
2918.29.00
2918.30.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2918.99.00
2920.99.90
2920.99.90
2921.19.10
2921.21.00
2921.29.00
2921.42.00
2921.51.00
2921.51.00
2921.51.00
2921.51.00
2922.11.00
Sodium Citrate (powder)
Triethyl Citrate
Trisodium Citrate
Trisodium Citrate Dihydrate gran (Sodium Citrate BP grade)
Acid Glyconic/Acid Gluconic
Calcium Heptagluconate
Potassium Gluconate
Acetobutyl Recinoleate
Calcium Carragheenate
Calcium Disaocharate
Calcium Sacchrate/Calcium D-saccharate
Cholic Acid
Glycol Salicylate
Manganese Citrate
Monosodium Citrate
Quinic Acid
Sodium Starch Glycollate
Phenyl Salicylate/Salol
Salicylic Acid/Benzyl Ester/Benzyl SAlicylate
3-Hydroxy-2-Naphthoic Acid
Gentisic Acid
Potassium Acid citrate
Sodium Gentisate
Acid Dehydrocholic
Adapalene
Ammonium Ferric Acid
Calcium Bromolactobionate
Calcium Lactobionate
Carbelapentane Citrate
Embonic Acid/Pamoic Acid
Potassium Citrate BP/USP
Glyceryl Trinitrate
Silicic Acid
Dimethylamine
Ferric Monosodium Edathamil/Socium, Iron Edetate
Disodium Edetate/Disodium Dihydrogen Ecetate/Disodium Edothamil
Dimethylamiline
4:4 Diamidinodipheylamine Dihydrochloride
Paraphenylenediamine
Phenylamine/Auiline
P-Methylaminophenol Sulphate
Ethanolamine
- 116 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.23
29.24
29.25
29.26
29.27
29.29
29.30
2922.11.00
2922.13.00
2922.19.90
2922.19.90
2922.19.90
2922.29.90
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.49.00
2922.50.90
2923.10.00
2923.10.00
2923.90.00
2924.19.10
2924.19.10
2924.19.10
2924.19.10
2924.19.10
2924.19.10
2924.19.90
2924.19.90
2924.19.90
2924.19.90
2924.29.90
2924.29.90
2924.29.90
2925.19.00
2925.29.90
2925.29.90
2926.90.90
2927.00.00
2929.90.00
2930.90.90
2930.90.90
2930.90.90
2930.90.90
Formaldehyde
Triethanolamine Trolamine
2(2-6-Dichlorophenylamine)-2-Imidazoline Hydrochlorides
Ambodryl Hydrochloride/Bromodiphenhydramine Hydrochloride
Amino Methyl Proponediol
N-Paraminophenol
Aluminium Glycinate
Amino Acetic Acid
Butosin/Butamben
Butyl Aminobenzoate
Calcium Disodium Edetate
Dihydroxy Aluminium Aminoacetate/Aluminium Glycinate
Ethylenediamine Tetraacetic Acid Disodium
Glycine/Aminoacetic Acid/Glycocoll
P-aminophenyl Acetic Acid & its derivatives
2-Amino-Ethanol
Choline Crotate
Colite powder
Calemel
Aminopentamide
Carragherate/Carrageenart/Chandrus
Dimethyl Acetamide
Monochloro-acetamide
Suppocire (Triglyceride, Semi-synthetic) AM
Suppocire (Triglyceride, Semi-synthetic) BP
Bromodiethyl Acetyl Carbamide
Diethyl Formomide
Dimethyl Formamide
L-Asparagine
Acetanilide
Diethyl Toluamide
N-Acetylsulfanilyl Chloride
N-Bromo-Succinamide
Amicarblide
Guanidine Carbonate/Nitrate
Aceto Nitrile/Methyle Cyanide
Azorubin
Cyclamic Acid
Cyseine
Ethane Dithiol/Ethylenelidimereaptan
L-Crystine
Sulphonic Acid
- 117 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.31
29.32
29.33
2930.90.90
2930.90.90
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2931.00.00
2932.11.00
2932.19.90
2932.21.00
2932.29.10
2932.29.90
2932.29.90
2932.29.90
2932.29.90
2932.99.00
2932.99.00
2933.21.00
2933.21.00
2933.29.00
2933.29.00
2933.29.00
2933.31.00
2933.32.00
2933.39.90
2933.39.90
2933.39.90
2933.41.00
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.49.90
2933.59.10
2933.59.90
2933.59.90
2933.59.90
2933.59.90
2933.79.00
2933.99.90
2933.99.90
2933.99.90
Thiolycollic Acid
Thiourea
Phenyl mercuric Borate
Phenyl Mercuric Acetate
Sodium Merthiolate/Thiomersal
Sodium Monomethyl Arsenate
Sodium Tetraphenyl Borate
Tetra Hydrofuran
Tribenoside
Coumarin
Glucono-D-lectone
Haloxon
Phemerol Chloride/Benzethonium Biphalate
Phenolphthalein
Qnassin Solution
Escitalopram (Citalopram Hydrobromide)
Heliotropin/Piperonel
Amino Hydantion Sulphate
Nipagin
Carmoisine
Creatinine
Tartrazin (F.D.& C. No. Yellow)
Pyridine/Pyridine Technically pure
Piperidine
2-Amino Pyridine
Carbinoxamine Maleate
Pantoprazole sodium
Moxifloxacin HCI
8-Hydroxyquinoline
Bis (2-methyl-4 amino-6 quinolyl) Urea/Surfeny/Surfen Hydochloride
Dimethissoquin
Quinoline
Surfen Hydrochloride
Xanthine
Adenine Sulphate
Ororic Acid
Pyrimidine
Uracil
5-Chloro 8-Hydroxyquinoline
2-Nitroindazole
Hematoporphrine
Hexamine
- 118 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
29.34
29.35
29.36
29.38
29.39
29.40
29.41
29.42
30.01
30.03
30.06
31.02
31.04
32.01
32.03
32.04
2933.99.90
2934.10.00
2934.20.00
2934.30.00
2934.91.00
2934.99.10
2934.99.10
2934.99.10
2934.99.10
2934.99.90
2934.99.90
2935.00.00
2935.00.00
2936.24.00
2936.24.00
2936.24.00
2936.29.00
2938.10.00
2938.90.00
2938.90.00
2939.99.90
2939.99.90
2940.00.00
2941.50.00
2941.90.00
2942.00.00
2942.00.00
2942.00.00
2942.00.00
3001.20.00
3001.20.00
2003.90.99
3006.10.00
3102.10.00
3102.30.00
3104.20.00
3104.90.00
3104.90.90
3201.90.90
3203.00.00
3204.12.00
3204.12.00
Phenazine
2-Amino Triazole
Chlor Benzisothiazoline
Dioxin/Dimethoxane
Leflunomide
Adenosine & its salts
Amino Oxazolidone
Resazurin/Diazoresorcinol
Thioctic Acid
Linezolide
Zidovudine
Halazon powder BP
Tamsulocin Hydrochloride
Calcium Pantothenate/Calcium D. Pantothenate
Pantothenyl Alcohol
Bioptorin
Dioptorin
Ammonium Glycyrrhizinate/Glycyrrhyzin Acid
Hesperedin
Hesperidine
Boldine
Serpentaria/Serpentary
Sorboso
Erythrosine
Tobramycin
Cetostearyl Alcohol
Condensation product of Cetostearyl Alcohol & Ethylene Oxide
Levilite
Triclosan
Oxbile extract
Bee Venum
Adrenochrome Monosemicarbazone/Carbazochrome
Harmless Absorbent Bagettes/Tubes
Urea
Ammonium Nitrate
Potassium Chloride BP/USP
Potassium Sulphate
Potassium Bi-Sulphate
Tannic Acid
Chlorophyll
Megenta Acid/Fuchsine Acid/Roseine Acid
Tartrazine
- 119 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
32.05
33.01
34.02
35.02
35.03
35.04
35.05
38.02
38.05
38.07
38.23
38.24
3204.19.00
3205.00.00
3301.29.00
3402.13.00
3402.19.10
3402.19.90
3402.19.90
3402.19.90
3502.90.10
3503.00.30
3504.00.90
3505.10.10
3505.10.10
3505.10.10
3507.10.10
3507.90.00
3802.10.00
3802.10.00
3802.10.00
3802.10.00
3802.90.00
3802.90.00
3802.90.00
3802.90.00
3805.90.00
3807.00.10
3823.19.00
3824.60.00
3824.90.10
3824.90.10
3824.90.10
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
Phenosafranie
Carmine
Cubeb
Pluronic 1.62
Anti-foam Emulsion
Antifoarm FD
Cetaoeum
Seprmaceti
Albumin powder
Gelatin powder
Beef paptone
Amylopectin-Starch
Dextrin in all forms
Rennin/Rennet
Hemicellulose
Maltin
Activted Carbon/Activated Charcoal
Carbo Adsorbene/Charcoal/Activated/Charcoal/Absorbent Charcoal
Carbon Amorphous
Charcoal Decolouring
Animal Charcoal
Bentone E.W.
Charcoal Decolourising
Diatomite
Pine Oil BP
Creosote
Span all grades
Sorbitol all grades, forms & concentrations
Ichthyol
Sodium-L-G-Butamate feed grade
Sodium-L-glatamate feed grade
Coparaffinate
Dioctyl Sodium Sulphosucinate
Eldoform
Eudragit 1 100
Ferrous sulphate and folic acid blended pellets
Nifedipine blended pellets
Non-specific antigens
Polyethylene glycol sorbitan
Polyethylene glycol-6000
Polyethylene sorbitan monolaurate
Poly-glyceryl recinoleate
- 120 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
39.01
39.02
39.03
39.04
39.05
39.07
39.10
39.12
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3824.90.90
3901.20.10
3901.90.00
3901.90.00
3901.90.00
3902.10.00
3903.19.00
3904.30.00
3905.19.00
3905.30.00
3905.30.00
3905.99.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3907.20.00
3910.00.00
3910.00.00
3910.00.00
3910.00.00
3912.31.00
3912.31.00
3912.31.00
3912.31.00
3912.31.00
3912.31.00
Polyxyethylene Sorbitan Monestearate/ Arlacel-60
Polyethylene Glycol Sorbilam
Soda lime
Sorbitan stearate
Sorbitan Trioleate
Tefose
Texofor f-13 (polyethylene glycol 600 monostearate bpe/bp
High Moleecular High Density polythylene (pharmaceutical grade)
Carbonec 940
Carbopol
Carboxypolymethylene
Polypropylene (pharmaceutical grade)
High impact polystyrene (pharmaceutical grade)
Kollidon va 64
Vinac 7/b7
Mowital
Polyvinyl alcohol
Polyvinyl pyrrolidone/pvp
Cetomacrogol 1000 dpe
Macrogol stearate
Octoxynol
Octoxynol
Octyphenoxy polythoxyethanol
Poloxalene
Poloxamer all grades
Polyethylene glycol stearate
Polyethylene Glycol Stearate
Polysorbate all grades
Poxyethylene sorbitan monooleate/tween80/polysorbate
Poxyethylene Sorbitan Monooleate/Tween80/Polysorbate 80/Tween
Texofor/cetomacrogol
Texofor/Cetomacrogol
Dimethicone
Dimethicoe emulsion
Dimethicone Emulsion
Slimethicone, all grades & forms
Carboxy Methyl Cellulose
Carboxy Methyl Cellulose Sodium
Carboxymethyl cellulose
Cellulose
Sodium carboxy methyl cellulose bp
Sodium carboxy Methyl Cellulose BP
- 121 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
3912.39.00
76.12
3912.39.00
3912.39.00
3912.39.00
3912.39.00
3912.39.00
3912.39.00
3912.90.00
3912.90.00
3912.90.00
3912.90.00
3912.90.00
3913.10.00
3913.10.00
3913.90.90
3920.49.90
3921.14.00
3921.19.00
3923.50.00
3923.90.90
4014.90.00
4014.90.00
4014.90.00
4805.40.00
7010.10.00
7010.90.10
7010.90.20
7010.90.90
7612.10.10
76.16
81.04
90.19
7612.90.91
7616.99.10
8104.30.00
9019.20.90
39.13
39.20
39.21
39.23
40.14
48.05
70.10
Avicel
PH101/RE581/Avicel
RC591/Avicl
PH02
Avicel
(Microcrystaline Cellulose)
Castor oil
Celacol
Ethocel
Ethyl cellulose
Ethyl methyl cellulose
Methylcellulose
Cellulose powder
Hydroxyethyle cellulose
Hydroxypropyl cellulose, usp xxii/nf xvi
Hydroxypropyl methylcellulose
Hypromenose/ Hydroxypropyl Methocel
Alginic acid, its salts & dervates
Propylenglycol alginate
Plastic base all types
Vinylite pulp linear material for wading caps
Cellulose bands
Saram film
Viscose rings & caps excl. pilfer proof caps
Dropper
Dropper
Rubber Bungs/Stopers/Teats saram film
Rubber bungs/stoppers/teats saram film
Filter pads, filtersheets
Ampoules
Jars of glass
Neutral amber glass bottle USP type 1
Plials/Tubes/Vials, all sorts
Aluminium Collapsible tube fitted with nozzle having less than 15 mm
dia fit for application of ointment
Aluminium rigid container
Aluminium collars
Magnesium Metal
Plastic Nebuliser
- 122 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex VIII - List of the top 40 pharmaceutical companies in
Bangladesh
(Not chronologically arranged)
SL. No
1.
2.
3.
4.
5.
6.
7.
8.
Name of the Company
Square Pharmaceutical Ltd.
Square Centre, 48 Mohakhali, CA, Dhaka-1212.
Fax: 8812180
E-mail: isaac@squaregroup.com
Aventis Limited
6/2A Segunbagicha, Dhaka-1000
Fax: 9550009,9562149
E-mail: iftekharul.islam@sanofi-aventis.com
Beximco Pharmaceutical Ltd
House – 19, Road – 7
Dhanmondi R/A, Dhaka-1205.
Fax: 8614601, 8613888
Ph: 8619151-5, 8619735
E-mail: naz@bpl.net
Opsonin Pharma Ltd.
Opsonin Bhaban,
30, New Eskaton Road
Dhaka-1000
Fax-8311905
E-mail: info@opsonin.net
GlaxoSmithkline Ltd.
House-2A,Road-138, Gulshan-1, Dhaka-1212
Fax-8826628
Email: E-mail-azizul.m.huq@gsk.com
The ACME Laboratories Ltd.
1 /4 Main Road, Kallanpur, Mirpur, Dhaka-1207
Ph:9005620
Fax: 9016872
E-mail: acmeexpo@bangla.net
Renata Limited,
House-450,Road-31,New DOHS,
Mohakhali, Dhaka-1206
Fax-8815210
E-mail:renata@renata-ltd.com
ACI Ltd. Dhaka
245 Tejgaon I/A, Dhaka –1208
E-mail: Coo@aci-Bd.com
Ph: 88 02 9885694
Fax: 8802 9884784
- 123 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
9.
10.
11.
12.
13.
14.
15.
16.
17.
Eskayef Bangladesh Ltd.
Gulshan Tower(9th Floor),
Plot-31
Road.-53
GulshanNorth CA, Dhaka-1212
Fax-9850809
Jayson Pharmaceutical Ltd. Dhaka
28, Purana Paltan, Dhaka-1000
E-mail: jpl@jaysonbd.com
jayson@citechco.net
Ph: 8802 9561643
Fax: 8802 9560491,9562482
Essential Drugs Company Limited
395-97, Tejgaon I/A, Dhaka –1208
E-mail: edcl@bttb.net
Ph: 8111853-4,9130489-90
Fax: 8802 8119697
Globe Pharmaceutical Ltd.
251-L Dhanmondi RA, Road-11A
Dhaka-1205, Fax-9126122
E-mail: globe.pl@bdcom.com
Ibn Sina Pharmaceutical Ltd. Dhaka
House# 41, Road# 10/A, Dhanmondi R/A, Dhaka-1209, Bangladesh
E-mail: ibnsina@bagla.net
Ph; 8123320, 9114710
Fax: 8118432
Novartis (Bangladesh) Ltd.
50, Dhanmondi RA, Road # 2A, Dhaka-1209
Ph: 8611805, 8615302-07
Fax: 8613489, 8610060
E-mail: novartis.bd@sandoz.com
Incepta Pharmaceuticals Limited
Ahmed Mansion,24 shantinagar (Chamelibag)
Dhaka-1217
Fax-9350684
E-mail: incepta@inceptapharma.com
Beacon Pharmaceuticals Ltd.
153-54 Tejgaon IA, Dhaka-1208
Ph: 9888494, 9888176, 8827234
Fax: 8826374
e-mail: akhter@beacon-pharma.com
Ambee Pharmaceuticals Limited
184/1 TejgaonI/A, Dhaka-1208
Fax-8827777, 96655555
E-mail: info@
- 124 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
18.
19.
20.
21.
22.
23.
24.
25.
26.
Orion Laboratories Limited
153-154, Tejgaon I/A, Dhaka –1208
E-mail: tkronon@yahoo.com
Ph: 8802 9888494, 9888176
Fax: 8802 8826374
Aristopharma Limited
7, Purana Paltan Line, Dhaka, Bangladesh
E-mail: aristo@accesstel.net
noh@aristophrma.com
Ph: 8802 9351691-3
Navana Pharmaceuticals Limited
3/C Purana Paltan,
Dhaka, Bangladesh
E-mail: ahd@navanapharm.com
Ph: 8802 9557410, 9562714,
Fax: 8802 9569113
General Pharmaceuticals Limited
48/A Dhanmondi RA, Road# 11A,
Dhaka-1209,
Ph:9132594, 8124649
Fax:9120657
E-mail: md@generalpharma.com
Pharmadesh Limited
334, Segun Bagicha, Dhaka-1000, Bangladesh
E-mail: pdesn@bol-online.com
pdsh@dhaka.net
Tel: 8802 9330048,
Fax: 8802 9345892
Bio-Pharma Laboratories Ltd.
1/12 Lalmatia , Block-B, Dhaka-1207
Ph: 8157953, 8150928,8159481
Fax: 9134684
E-mail: b.pharma@aitlbd.net
Therapeutics (Bangladesh) Limited
12 Mohakhali CA (2nd Floor), Dhaka-1100.
Ph: 9880605
Fax: 8826343
Nipa Pharmaceuticals Limited
10/16 Iqbal Road, Block-A, Mohammadpur, Dhaka-1207
Ph: 8121504
Fax: 8127320
Hudson Pharmaceuticals Limited
house#157, Lane-3 (Eastern Road),
New DOHS, Mohakhali, Dhaka-1206
Ph: 8815372-3, 9896175,9860543
Fax: 827979
E-mail: aunik@bdcom.com
- 125 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
27.
28.
29.
30.
31.
32.
33.
34.
35.
Medimet Pharmaceuticals Limited
13(770 Bijoynagar, Segunbagicha, Dhaka.
Ph: 9351796, 9361831,8351098
Fax: 8315363,
E-mail; mystic@bijoy.net
Remon Drugs Laboratories Limited
392, New Eskaton Road, Dhaka-1000, Bangladesh
Ph: 8802 9331820
Fax: 8312943
Doctor’s Chemicals Limited
44, Dilkhusha Commercial Area, Dhaka, Bagladesh
E-mail: shiam-tc@bttb.net.bd
Ph: 8802 9551981
Fax: 8802 9564245
Pharmaco International Limited
30-B Purana PaltanVIP Road,
Dhaka-1000
Ph: 9353746, 8311695
Fax: 9353746, 9560398
National Pharmaceuticals Limited
38, Green Road
Kathal Bagan Dhanmondi, Dhaka , Bangladesh
Ph: 8802 9664617, 8625706,
Fax : 8802 9116886
Mystic Pharmaceuticals Limited
House# 15, Road#13/A, Dhanmondi R/A, Dhaka-1209, Bangladesh
E-mail: mysticra@bonline.org
Ph: 8802 9124110,9125456, 9126530
Fax: 8802 9122106
Reckitt & bBenckiser BD Limited
Plot# 2B,Block# SE(C), Road#138,
Gulshan-1, Dhaka-1212
Ph: 9887209
Fax: 9887354
Apollo Pharmaceuticals Ltd.
Apollo Tower
Plot # M 1/3
Section # 14, Mirpur1/A
Dhaka.
E-mail: mobin@bangla.net,
Ph: 8802 9001794, 8010747,
Fax: 8802-9000713
Benham Pharmaceuticals Ltd.
TMC Building (8th Floor)
52 New Eskaton Road, Dhaka-1000
Ph: 8321340
Fax: 8317424
E-mail : benham@bangla.net
- 126 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
36.
37.
38.
39.
40.
Popular Pharmaceuticals Ltd.
25 Dhanmondi RA, Road#2,
Dhaka-1205
Ph: 9669301-5, 675600, 675611
Fax: 9675633
E-mail: info@popularbd.com
Central Pharmaceuticals Ltd.
33Dhanmondi RA, road#2, Dhaka-1205
Ph: 8631045, 663610, 615188
Fax: 9664867
E-mail: metro1@gni.com
Hallmark Pharmaceuticals Ltd.
Uttara Center,
102 shahid Tajuddin Ahmed Sarani (3rd Floor),
Tejgaon IA, dhak-1208
Ph; 8115425, 8142694
Fax: 9130917
E-mail: hpl@ugc-bd.net
Gonoshastha Pharmaceutical Ltd
Remo Chemicals Limited
235, Tejgaon I/A, Dhaka –1208, Bangladesh
Email: remo@bolonline.com
Ph; 8828197, 8821559
Fax: 8802 8821559
- 127 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex IX - Company-wise Export Information of 2006
Export –2006
Sl
Name
of Generic Name
Value TK
No. Pharmaceuticals
1.
M/S. Beximco
Al/
Mg
Hydroxide+ 350097219.50
Simethicone
Albendazole
Amidarone
Amlodipine+ Atenolol
Amoxycillin
Antihaemorrhoidal
Atorvastatin
Azithromycin
Beclomethasone
dipropionate
Captopril
Cefixime
Ceftriaxone
Celecoxib
Cephalexin
Cephradine
Cetirizine Hydrochloride
Ciprofloxacin
Clotrimazole
Cotrimoxazole
Dextromethorphan
Dextrose 25%
Diclofenac sodium
Domperidone
Enalapril meleate
Esomeprazole
Famotidine
Ferrous fumarate + Folic
Acid
Finasteride
Flucloxacillin
Fluconazole
Fluoxetine
Fructose
Glipizide
Glycine
Guaiphenesin,
Pheudoephedrine
&
triprolidine
Hyoscine Hydrochloride
Hyoscline Butylbromide
Iron+ Folic Acid
Ketotifen
Lactulose
Lansoprazole
Loratadine
- 128 -
Value USD
5006388.85
Importing
Country
Pakistan
Nepal
Kenya
Singapore
Myanmar
Sri Lanka
Yemen
Cambodia
Somalia
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Losartan Potassium
Magnesium Sulphate
Mannitol 20%
Mebeverine
Metronidazole
Multivitamin+ Minerals
Nitrofurazone
Nortryptyline
HCl
&
Fluphenazine HCl
Nystatin
Omeprazole
Oxymetazoline
Paracetamol
Ranitidine
Repaglinide
Salbutamol
Salbutamol
Sparfloxacin
Terbinafine
Thiamine
Vitamin B-Complex
Vitamins and Minerals
2.
M/s. Novartis
1471391438.00
Amlodipine Maleate
Amlodipine Maleate
Azithromycin Dihydrate
Azithromycin Monohydrate
Ciprofloxacin
Hydrochloride
Clarithromycin
Clarithromycin
Micropellets
Famotidine
Fluconazole
Lamotrigine
Loratadine
Mirtazapine
Omeprazole Pellets Capsule
Ondansetron
Pyrazinamide
Ramipril
Rifampicin/ Isoniazid
Rifampicin/
Isoniazid/Pyrazinamide
Rifampicin/
Isoniazid/Pyrazinamide/Eth
ambutol Hydrochloride
Risperidone
Sertraline Hydrochloride
Sinvastatin
Sodium Alendronate
Sumatriptan Succinet
- 129 -
21435578.00
Brazil
Antill
Austria
Belgium
Brasil
Columbia
Denmark
Frankreich
Germany
Hong Kong
Hungary
Indonesia
Italy
Malaysia
Mexico
Netherlands
Panama
Philippines
Poland
Portugal
Singapore
Slovenia
South Af.
Spain
Sri Lanka
Switzerland
Thailand
Ukingdom
Venezuela
Vietnam
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
3.
Renata Ltd.
Celicoxib 100mg, 200mg 39470693.00
Capsule
Ranitidine 150mg Tablet
Omeprazole 20mg Capsule
Azithromycin
500mg
Tablet, Suspension,
Cimvastatin 10mg Tablet
Losartan 50mg Tablet
fluconazole 150mg Capsule
Atorvastatin 20mg Tablet
579915.00
Vietnam
Sri Lanka
4.
5.
Medimet
The Acme Lab.
Cefixime Trihydrate Syrup 1330080.50
Diclofenac+Lidocaine HCl 40791777.44
Inj.
Flucloxacillin
250mg,
500mg, Inj./Cap.
Fenofibrate 67mg, 200mg
Cap.
Torasemide 2.5mg, 5mg
Tablet,
Dotaverine 40mg Tablet
Flupentixol Melitracin
Zafirlukast Tab
Tacrolimus Ointment
Fluticasone
Propionate
Tablet
Fluticasone
Propionate
50mg, 100mg, 250mg,
500mg
Beclometasone
Dipro
100mg, 200mg
Salmeterol Xinafoate
Lansoprazol 30mg Cap.
Antacid Tablet
Ferrosulphate Syrup
Cephlaxin Susp, 500mg
Capsule
Cloxacillin P/Sol.
Amoxycillin P/Pd. Susp.
Calcium 250mg, 500mg
Amlodipine
5mg,10mg
Tablet
Omeprazole 20mg, 40mg
Cap.
Metformin 850mg Tablet
Glibenclamide 5mg Tablet,
Ciprofloxacin
500mg,
250mg Tablet
Famotidine 20mg Tablet,
Cetirizine diHCl 10mg
Tablet,
Acetazolamide
250mg
Tablet,
Nystatin Susp. Ointment,
19001.15
599879.08
Vietnam
Nepal
Myanmar
Papua New
Guinea
Afghanistan
Philippines
Sri Lanka
Hong kong
Pakistan
Vietam
Bhutan
Kenya
East Timor
- 130 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Oral Susp.
Xylometazoline N/D.
Vitamin B-Complex Tablet
Sulbatamol Sulphate Tablet
Ranitidine HCl 150mg
Tablet
Atenolol 50mg Tablet
Fifedipine 10mg Tablet
Cetirizine 10mg Tablet
Potassium Chloride Tablet
Aspirine 75mg Tablet
Multivitamin Drop, Tabelt
Metronidazole
400mg,
Syrup Tablet
Gliclazide 80mg Tablet
Oxyphenoium Bromo. 5mg
Tablet
Cefixime P/Susp.
Azithromycin
250mg
Tablet
Loratadine 10mg Tablet
Bromazepan 3mg Tablet
Glarithromycin
500mg
Tablet
Levofloxacin 500mg Tablet
Valdecoxib 20mg Tablet
Simvastatin 10mg 20mg,
Tablet
Acetazolamide Tablet
Chloramphenicol E/Drop
Nalidixic Acid Susp.
Cepharadine Powder for
Susp.
Ibuprofen Susp.
6.
Asiatic Lab.
7.
Gonoshasthaya
Pharma. Ltd.
Marksman
Pharma
Essential Drugs
8.
9.
10.
GlaxoSmithKlin
e
Cefixime Trihydrate 200mg 1783600.00
Capsule
Albendazole Tablet
4357080.00
25480.00
Singapore
6244.00
UK.
Amlodipine Tablet
7200.00
897520.00
1871580.63
Chloroquine Syrup
Frusemide Inj.
Gentamicin Inj.
Salbutamol Syrup, Tablet
Metronidazole
400mg
Tablet
Tetracycline Eye Ointment
Salbutamol Sulphate 2mg 37812594.00
Tablet
Chlorpheniramine Maleate
4mg Tablet
- 131 -
27161.32
Bhutan
113226.00
Myanmar
Sri Lanka
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
11.
Orion
Ltd.
9571834.30
Infusion Amlodipine 5 mg
Atorvastatin
Azithromycin
Calcium Carbonate
Cefixime 200 mg
Cefuroxim Axetil 250
Cephradine 125 mg/5ml
Clobazam
Clopidogrel
Desloratadine
Domperidone
Eperisone
Erythromycin
Ethylsuccinate
Ferrus Sulphate+Folic acid
+ zinc sulphate
Flucloxacillin
500mg,
250mg, P/D
Fluconazole 150mg Tablet
Flupentixol + Melitracen
Tablet
Gliclazide 80 mg Tablet
Glimepiride 1 mg, 2mg
Tablet
Mecobalamine
Metformin HCL 500 mg
Tab;et
Multivitamins+Minerals
Tablet
Omeprazole 20 mg Capsule
Rinitidine 150mg Tablet
Spironolactone
+
Frusemide Tablet
Tamsulosin
Thiamine
Hydrochloride
100 mg Tablet
Trimetazidine
Dihydrochloride
Vitamin E + Vitamin C
Tablet
Zinc Sulphate 10 mg/5 mg
Sysup
Zinc Sulphate 61.8 gm +
Folic Acid 500 mcg Tablet
- 132 -
136740.49
Nepal
Myanmar
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
12.
143414810.00
Global Capsules Empty Gelatin Capsule
Ltd.
Bon Greas
Dry Calcium Phosphate
Gelatin & Scrub Gelatin
Capsule
13.
Opso Saline Ltd.
14.
Navana Pharma
Ltd.
15.
Orion
Laboratories
Ltd.
IV. Salaine
Metro I.V
Steripack
Syringe
2048783.00
4595500.00
65650.00
13466747.00
192382.10
Disposable
Enalapril Maleate 5mg 9571834.30
Tablet
Amlodipine 5mg Tablet
Cefuroxim Axetil 125mg,
250mg Tablet
Flucloxacillin
Sodium
250mg, 500mg, Syrup
Zinc Sulphate+Folic Acid
Capsule
Ranitidine HCl 150mg
Calcium Carbonate Tablet
Gliclazide 80mg Tablet
Cotrimoxazole
960mg
Tablet
Omeprazole 20mg Capsule
Cephradine 250mg, 500mg
Capsule, Syrup, Dead.
Drops
Thiamine
HCl
100mg
Tablet
Cefixime 200mg Tablet
Atorvastatin Calcium 10mg
Tablet
Clopidogrel
Bisulphate
75mg Tablet
Cotrimoxazole Tablet
Climepiride 1mg, 2mg
Tablet
- 133 -
1367740.49
Indonesia
Malaysia
Korea
Japan
USA
Pakistan
Ukraine
South Af
India
Germany
Cambodia
Syria
India
Zimbabwe
Jordan
Philippines
Kenya
Nepal
Pakistan
Philippines
Ghana
New Zeal.
Singapore
Myanmar
Ghana
Nepal
Myanmar
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Azithromycin
500mg
Tablet
Vitamin E+Vitamin C
Tablet
Spironolactone+Fresemide
Tablet
Metfromin HCl 500mg
Zinc Sulphate Syrup
Domperidone 10mg Tablet
Multivitamins+Minerals
Tablet
Desloratidine Tablet
Tamsulosin Tablet
Drug Ciprofloxacin Eye drops, 3810103.00
Eye Ointment,
Betamethason
Sodium+Bhosphate
+
Neomycin Sulphate Eye
Drops
Chloramphenicol Eye drops
Chloramphenicol
Eye
Ointment
Natamycin Drop
Dexamethasone
Sodium
Phosphate+Chloramphenic
ol Eye Drops
Diclofenac Sodium Eye
drops
Acyclovir Eye ointment
Gentamycin Sulphate Eye
drops
16.
Reman
Lab.
17.
Ibna Sina
18.
Aristopharma
Azithromycin
Syrup, 5783571.05
Capsule
Albendazole 400mg Tablet
Ketotifen Fumarate Syrup
Hyiscine-N-Butyl Bromide
Tablet
Cetrizine Dihydrochloride
Tablet, Syrup,
Cefixime
Trihydrate
Capsule
Cephradine P/D
Ciprofloxacin Eye Drops
Diclofenac Sodium Eye
Drops
Paracetamol Suspension
Vitamin B-Complex
Nystatin Suspension
Lactulose Oral Solution
20150364.00
Betamethasone
Sodium
Phosphat + Neomycin
Sulphate N/E drop
Chloramphenicol Ery droop
- 134 -
56480.00
Myanmar
Vietanam
85618.43
Sri Lanka
Myanmar
293285.77
Vietnam
Mauritius
Myanmar
Hong Kong
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Lomefloxacin Eye drop
Dexamethasone+Polymyxi
n B Sulphate+Neomycin
Sulphate N/E drop
Naphazoline Nitrate +Zinc
Sulphate Eye drop
Dexamethasone
Phosphate+Chloramphenic
ol Eye drops
Nimesulide tablet
Diclofenac Sodium Gel
Omperazole Capsule 20mg
Fusidic
Acid+Hydrocortisone
Cream
Sodium fusidate Ointment
Ranitidine
150mg,
300mgTablet
Lansoprazole
30mg
Capsule
Levofloxacin
Dihydrochloride
500mg
Tablet
Azithromycin
500mg,
250mg Capsule
Calcium Carbonate 500mg
Capsule
Cefpodoxime Proxetil D
Syrup
Lactolose Oral Solution
Isosorbide-5 mononitrate
Amlodipine Besylate 5mg
Tablet
Cetirizine Tablet, Liquid
Rofecoxib 25mg Tablet
Metformin HCl 500mg
Tablet
Gliclazide Tablet
Cephalexin
250mg
Capsule, oral Suspension
Sodium Fusidate Ointment
Erythromicine Powser for
Suspension
cefixime
Powser
for
suspension
Sparfloxacin tablet
Pantoprazole tablet
Lomefloxacin
Povidone Iodine Ointment
Nalidixic Acid Suspension
Flupentixol+Melitracen
Tablet
Vitamin B Complex Tablet
Multivitamins+Mineral
Tablt
- 135 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Super Antixidant+Minerals
Tablet
19.
Incepta
Cefpodoxime
Proxetil 10762565.10
100mg, 200mg Tablet,
Suspension
Cefuroxime Axetil 500mg
Tablet, Suspension
Mometasone Furoate Nasal
Spray
Permethrin Cream
Guaiphenesin+Pseudoephe
drine HCl+Triprolidine HCl
Syrup
Cefadroxil
Monohydrate
500mg Capsule
Ciprofloxacin
750mg
Tablet
Erythromycin Suspension
Roxithromycin
300mg
Tablet, Suspension
Azithromycin Tablet
Fluconazole 50mg, 150mg
Capsule
Vitamin
B1+B6+B12
Injection
Hydrochlorothiazide
50
Tablet
Cefadroxil Mono 500mg
Capsule
Ambroxol Hydrochloride
Syrup
Angifix 20mg Tablet
Prednisolone 5mg Tablet
Ketocanazole Shampoo
Ceftriaxine 1gm IM/IV
500mg IM/IV Inj.
Montelukast Sodium 4mg,
5mg Tab.
Losartan Potassijm 50mg
Tablet
Metoprolol tartrate Tablet
Timolol 0.5, 0.25 Eye Drop
Tetosterone Gel
Salbutamol Sulfate 4mg
Tablet
Simethicone Drops
Omeptazole 20mg, 40mg,
Sachet
Theophylline 400mg Tablt
Celecoxib 200mg Cap.
Hydrochlorothiazide 25mg,
50mg Tablet
Ambroxol HCl Syrup
Isosorbide-5-mono
20
- 136 -
153750.90
South Am.
Togo
Belize
Central Am.
Afghanistan
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Tablet
Terbinafine HCl Cream
Tropicamide 1% Eye drops
Permethrin Cream
Cefixime Capsule
Esomeprazole 40mg Tablet
Diclofenac Sodium 50mg
Tablet
IV Injection
Glucosamine-Chondroitin
Tablet
Clopidogrel Tablet
Dexamethasone 0.1% Eye
drops
Metformin Hydrochloride
500mg Tablet
Domperidone Tablet
Motoprolol
Trihydrate
Tablet
Multivitamin
&
Multimineral A-Z Tablet
Hydrochloride 80mg tablet
Warfarin Sodium Tablet
Iron
+Folic
Acid+BVitamin & Vitamin-C
Capsule, Syrup
Calcium+Vitamin-D
&
Multimineral Tablet
Folic acid Tablet
Loratadine Tablet
Ceftriaxone 1gm IM/IV,
250mg IM/IV, 500IM/IV
Injection
Hydrocortisone
Acetate
Cream
Hydrochloride Tablet
Ketotifen Tablet, Syrup
Hemihydrate 250mg Tablet
Levofloxacin Hemihydrate
500mg Tablet
Cefaclor 250mg. 500mg
Capsule
Cefradine 250mg 500mg,
Capsule,
1gm
IM/IV
Injection P/D.
Paracetamol
Tablet,
Suspension, P/D
Bromazepam
Alprazolam 0.25mg, 0.5mg
Tablet
20.
Popular Pharma
Ceftriaxone 500mg IV/IM 216315.00
Injection
- 137 -
3135.00
Kenya
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
21.
Halmark
Citirizine HCl Tablet
Omeprazole 20mg Capsule
22.
Aventies
23.
Opsonin
24.
Fisons
Ltd.
25.
General
5950.00
Myanmar
Promethazine
Theoclate 36965272.60
25mg Tablet
Chlorpromazine
Hydrochloride 50mg Tablet
Metronidazole
200mg,
400mg, Tablet, Injection,
Suspension
Prochlorperazine Maletate
5mg Tab.
Zopiclone 7.5mg Tablet
Ketoprofen
100mg
Capsule, Inj., Tab.
Sacnidazole 1gm Tablet
Mepyramine
Maleate
Cream
543606.95
Sri Lanka
Myanmar
Hong Kong
5109930.00
Tolperisone 50mg Tablet
Ceftriaxine 2gm Injection
Methylergonovine Maletat
Injection
Ketotifen 1mg Tablet,
Syrup
Cefuroxime 250mg Tablet
Azithromycine
500mg,
250mg Tablet, Powder for
Suspension
Levofloxacin
250mg,
500mg tablet
Amoxicillin
500mg
Injection
Cephradine 1gm Injection
72999.00
Vietnam
Yemen
Hong Kong
Macau
UAE
(BD) Amiloride Hydrochloride 2164848.00
5mg+Hydrochlorothiazide
50mg Tablet
Ranitidine
150mg,
Metochlopramide
HCl
10mg
Salbutamol Sulphate 2mg
Tablet
31836.00
Sri Lanka
Myanmar
6127468.00
Pioglitazone 15mg Tablet
Domperidone 10mg Tablet
Gliclazide 80mg Tablet
Levofloxacin 250mg
Atorvastan 10mg Tablet
Olanzapine 10mg, 5mg
Tablet
Risperidone 2mg Tablet
Triamcinolone
acetonide
Ointment
88460.02
Myanmar
Bhutan
Macau
Hong Kong
Somalia
- 138 -
416500.00
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
26
Square Pharma
Clotrimazole 1% Ointment
Sibutramine HCl 10mg,
5mg Capsule
Losartan Potassium 50mg,
10mg Tablet
Mirtaazapine 15mg Tablet
Sibutramine HCl 5mg,
10mg Capsule
Azithromycin Tablet, P/D
Ferrous
Sulphate+Folic
Acid+Ascorbic
Acid+Thiamine
Mononitrate+Riboflavin+P
yridoxine
HCl+Nicotinamide Capsule
Thiamine
Mononitrate
+Pyridoxine
HCl+Cyanocobalamin
tablet
Lansoprazole
+Clarithromycin
+Amoxicillin
Ferrous
Fumarate+Folic
Acid Capsule
Pantoprazole 40mg Tablet
Tolterodine Tartrate 2mg
Tablet
Vit. B Complex Syrup
Zinc Sulphate Syrup
Vit. B Complex & Zinc
Syrup
Chlorpheniramine maleate
DS Susp. Carbocisteine DS
Syrup
Paracetamol+Caffeine
Tablet
Ferrous Fumarate Syrup
Xylometazoline HCl 0.5% 312941508.00
Nasal Drop
Amlodipine 10mg, 5mg
Tab.
Atenolol 100mg Tab.
Ciprofloxacin 0.3% eye
drop
Ciprofloxation
250mg,
500mg Tab.
Doxicycline 100mg Cap.
Loperamide HCl 2mg Cap.
Loperamide HCl 2mg Cap.
Sulfadoxine
50mg+Pyrimethamine
25mg Tab.
Sodium
Cromoglycate
20mg Eye drop
Neomycin
Sulphat
- 139 -
4602081.00
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
+Bacitracin Zinc
Lansoprazole
+amoxycillin+Clarithromyc
in
Sulbutamol Inhaler
Enalaril Maleate Tab.
Enalapril Maleate 5mg
Azithromycin
250mg,
500mg Cap./Tab./Susp.
Clarithromycin 250mg Tab.
Timolol Maleate eye drop
Paracematol 125mg, 250mg
Supp.
Paracetamol 500mg Tab.
Cetirizine Dihydrochloride
Tab.
Metronidazole 400mg Tab.
Tramadol 50mg Cap./Inj.
Losartan potassium 25mg,
50mg Tab.
Vitamin
B
Complex
Inj./tab.
Betamethasone +Neomycin
Cream
Calcium carbonate 500mg
tab.
Nystatin 100000unit Suspn.
Ferrous Sulphate +Folic
acid Cap.
Ceftriaxone IM Inj.
Cephalexin 250mg, 500mg
Cap.
Diclofenac Sodium 12.5mg,
50mg,
Suppository/Eye
drop
Gliclazide
Sulphamethoxazole+Trimet
hoprim 480mgTab.
Co-trimoxazole Suspension
Xoxycycline 100mg Cap.
Glibenclamide tab.
Antacid Tab.
Mebendazole
100mg,
500mg, Suspension
Erythromycin
250mg,
500mg Tab.et
Ibuprofen
400mg, SR
Tablet
Famotidine 20mg, 40mg
tab.
Fluconazole 150mg, 50mg
Cap.
Miconazole
Nitrate
+Hydrocortiazone Cream
Frusemide 40mg Tab.
- 140 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Inj.Gentamicin
20mg,
40mg Inj. E/E drop
Ketoconazole 200mg Tab.
Ketoprofen 100mg, 50mg
tab. Inj.
Lansoprazole 30mg cap.
Cephradine 1g, 500mg Inj.
Cephraclor 250mg Cap.,
Susp
Loratadine 10mg tab.
Cefotraxime 250mg Inj.
domperidon 10mg Tab.
P/D.
Amoxicillin 250mg DT,
250mg, 500mg Cap.
Multivitamin+Meneral Tab.
Ranitidine 150mg, 300mg
Tab.
Nifedipine 10mg, SR Tab.
Phenoxymethyl Penicillin
Dry syrup
Haloperidol 5mg Tab. Inj.
Lansoprazole+Clarithromyc
in+Amoxycillin kit.
Clarithromycin 500mg
Beta Carotene, Vit. c & vit
E tab.
Omeprazoly 20mg, 40mg
Cap.
Diazepam 5mg tab. Inj.
Naproxen 5omg Tab.
salbutamol 100mcg Inhaler
Temolol E/Drop
Enalapril Maleate 10mg,
5mg Tab.
Acyclovir 5% Cream Tab.
Metronidazole
200mg,
400mg tab.
Thiamine HCl tab.
Metformin HCl Tab.
Fusemide 40mg Tab.
Isorbide Mono. Tab.
Drotaverine HCl Tab.
Rofexoxib 12.5mg, 25mg
Tab.
Allopurinol
Lamivudine tab.
Cefaclor 250mg, 500mg
Cap.
Sodium Cromoglycate 2%
eye Drops.
Lactulose Cap.
Fluoxetin HCl Cap.
Ofloxacin 200mg, 400mg
Tab.
- 141 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Salmeterol
Xinafoate
Inhaler
Hydrocortisone 1% Cream
Nalidixic Acid Tab.
Scnidazole 1000mg Tab.
zinc
Sulphate+Ferrous
Sulphate+Folic acid Cap.
Levofloxacin 500mg Tablet 88900.00
Doxicilline 100mg Capsule
Amlodipine+Atenolol
Tablet
Omeprazole 20mg Capsule
Albendazole 400mg Tablet
Iron+Folic
Acid+Zinc
Capsule
Flucloxacillin
500mg
Capsule, Syrup
Aceclofenac Tabelt
Multi
Vitamin+Multi
Meneral
27
Exim Pharma
28.
Bangla German Natural Latex
35596893.00
latex Co. Ltd.
Eskayef BD Ltd. Enalapril 5mg, 10mg Tablet 12575115.1
Losartan Potassium 25mg,
50mg Tablet
Hydrocortisone
Acetate
Cream, Glimepiride 1mg,
2mg Tablet
Banbuterol HCl 10mg,
20mg Tablet
Flucloxacillin
250mg,
500mg, Cap. Suspension
Atorvastatin 10mg Tablet
Omeprazole 20mg, 40mg
Capsule
Naproxen 250mg, 500mg
Tablet
Calcium Carbonate 250mg,
500mg Tab
Domperidone 10mg Tablet
Cefixim
200mg
Capsule/Suspension
Cephradine
500mg
Cap./Dry Sus./P.drop
Amlodipine 5mg Tablet
Azithromycin
500mg
Tablet
29.
- 142 -
12877.00
Nigeria
Burk. Faso
515897.00
Honduras
UK
Nepal
Sri Lanka
UAE
Vietnam
184806.66
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
30.
Jayson
80270703.88
Alendronat 10mg
Azithromycin
200mg,
250mg, 500mg
Ciprofloxacine
250mg,
500mg
Clarithromycin
250mg,
500mg
Famotidine 20mg, 40mg
Fluconazole
150mg,
200mg, 50mg
Loratadin 10mg,
Lovostatin 20mg, 40mg'
Lamotrigine 50mg, 100mg,
200mg
Mirtazapine 30mg
Naprox 500mg
Omeprazole 20mg
Pyrazinamide 500mg
Pyrazinamide+Rifampicin+
Isoniazide
Ramipril 10mg, 2.5mg,
5mg
Risperidone 2mg, 3mg
Rifampacine 150/100mg
Rifampicin+Isoniazid+PZA
Rifampicin+Isoniazid+PZA
+Ethambutol HCL
Simvastatin 10mg, 20mg,
40mg
Sertraline 100mg,
Sumatriptan 50mg
1179688.20
Grand Total
39461841.41
2663404365.00
- 143 -
Bhutan
Ethiopia
Kenya
Myanmar
Nepal
Pakistan
Papua New
Guinea
Singapore
Sri Lanka
Sudan
Ukraine
Vietnam
Yemen
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex X - The drugs (control) ordinance, 1982
[Published in the Bangladesh Gazette, Extraordinary, dated the 12th June, 1982.]
GOVERNMENT OF THE PEOPLE'S REPUBLIC OF BANGLADESH
MINISTRY OF LAW AND LAND REFORMS
(Law and Parliamentary Affairs Division)
NOTIFICATION Dacca, the 12th
June, 1982
No. 354-Pub. — The following Ordinance made by the Chief Martial Law Administrator of the
People's
Republic of Bangladesh, on the 11th June, 1982, is hereby published for general information: —
THE DRUGS (CONTROL) ORDINANCE, 1982
Ordinance No. VIII of 1982
AN
ORDINANCE
to control manufacture, import, distribution and sale of drugs.
WHEREAS it is expedient to control manufacture, import, distribution and sale of drugs;
Now, THEREFORE, in pursuance of the Proclamation of the 24th March, 1982, and in exercise of
all powers enabling him in that behalf, the Chief Martial Law Administrator is pleased to make and
promulgate the following Ordinance: —
1. Short title — This Ordinance may be called the Drugs (Control) Ordinance, 1982.
2.Application of other Laws, etc.—
The provisions of this Ordinance shall be in addition to,and not in derrogation of, the Drugs Act,
1940 (XXIII of 1940), and any other law for the timebeing in force and shall have effect
notwithstanding anything to the contrary contained in that Act or in any such law or in any contract,
agreement or document.
3. Definitions.—
(1) In this Ordinance, unless there is anything repugnant in this subject or context,—
(a) "Act" means the Drugs Act, 1940 (XXIII of 1940);
(b) "Committee" means the Drugs Control Committee constituted under this Ordinance ;
(c) "Council" means the National Drugs Advisory Council constituted under this Ordinance :
(d) "Drug" shall have the same meaning as in the Act and shall also include any substance
exclusively used or prepared for use in accordance with the ayurvedic, unani and homeopathic or
biochemic system of medicine;
(c) "Schedule" means Schedule to this Ordinance.
(2) Words and expressions used but not defined in this Ordinance shall have the same meaning as in
the Act.
- 144 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
4. Drug Control Committee. —
(1) The Government shall constitute a Drug Control Committee consisting of a Chairman and such
other members as it may appoint from time to time.
(2) The Committee shall perform such functions as are specified in this Ordinance.
5. Registration of Medicines.—
(1) No medicine of any kind shall be manufactured for sale or be imported, distributed or sold
unless it is registered with the licencing authority.
(2) The licencing authority shall not register a medicine unless such registration is recommended by
the Committee.
(3) A registration shall be granted on such conditions as may be specified by the licencing authority.
(4) A registration shall, unless cancelled earlier, be valid for a period of five years.
6. Cancellation or suspension of registration. —
(1) The licencing authority may cancel the registration of any medicine if the Committee
recommends such cancellation.
(2) The Committee shall evaluate every medicine registered before the commencement of this
Ordinance
and every medicine that may be manufactured or imported after such commencement in order to
determine its safety, efficacy and usefulness.
(3) If on such evaluation the Committee finds that any such medicine is not sale, efficacious or
useful it may recommend to the licencing authority cancellation of registration of the medicine.
(4) The licencing authority may, if it is satisfied that a medicine is substandard, suspend the
registration of such medicine till he is satisfied that the medicine has attained its standard.
7. Fees for registration.—
No registration of a medicine shall be granted unless a fee to be determined by the Government is
paid at the time of application for registration.
8. Prohibition of Manufacture, etc, of certain medicines.—
(1) On the commencement of this Ordinance, the registration or licence in respect of all medicines
mentioned in the Schedules shall stand cancelled, and no such medicine shall, subject to the
provisions of sub-section (2) Be manufactured, imported, distributed or sold after such
commencement.
(2) Notwithstanding anything contained in sub-section (1),—
(a) The medicines specified in Schedule I shall be destroyed within three months from the date of
commencement of this Ordinance;
(b) The medicines specified in Schedule II may be manufactured or sold for a period of six months
from the date of commencement of this Ordinance and thereafter their manufacture and sale shall be
permitted only if they are registered alter change in their formulation in accordance with the
direction of the licencing authority;
(c) The medicines specified in Schedule III may be manufactured, imported, distributed and sold for
a period of nine months after the commencement of this Ordinance, and thereafter there shall not be
any manufacture, import, distribution or sale of such medicines.
- 145 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
9. Restriction on import of certain pharmaceutical raw material.—
(1) No pharmaceutical raw material necessary for the manufacture of any medicine specified in any
of the Schedules shall be imported.
(2) No drug or pharmaceutical raw material shall be imported except with the prior approval of the
licencing authority.
(3) The licencing authority may award an approval under sub-section (2) on such conditions as it
deems fit to specify.
10. Restriction on manufacture of certain drugs under licence.—
No drug shall, alter six months from the date of commencement of this Ordinance, be manufactured
in Bangladesh under licence granted by a foreign company having no manufacturing plant in
Bangladesh if, such drug or its substitute is produced in Bangladesh.
11. Fixation of price of drugs.—
(1) The Government may, by notification in the official Gazette, fix the maximum price at which
any medicine may be sold.
(2) The Government may by notification in the official Gazette, fix the maximum price at which
any pharmaceutical raw material may be imported or sold.
12. Review of certain licencing agreement with foreign concerns.—
(1) The Government may review any licencing agreement between a Bangladeshi concern and a
foreign concern for manufacture of any drug in Bangladesh in order to find out if it contains any
provision against the national interest.
(2) If on such review the Government finds that any such provision of any such agreement is
against (he national interest, it may direct the concerns to modify such provision.
(3) If any such concern fails to comply with the direction given under subsection (2) the
manufacturing licence of such concern may be cancelled by the Government.
13. Employment of pharmacists. —
(i) No person shall manufacture any drug except under the personal supervision of a pharmacist
registered in Register 'A' of the Pharmacy Council of Bangladesh: Provided that this provision shall
not apply to the manufacture of any drug under the ayurvedic, unani, or homeopathic or biochemic
system of medicine.
(2) No person, being a retailer, shall sell any drug without the personal supervision of a pharmacist
registered in any Register of the Pharmacy Council of Bangladesh: Provided that this provision
shall not apply to the retail sale of any drug under the ayurvedic, unani, or homeopathic or
biochemic system of medicine.
14. Control of advertisement and claims in respect of drugs.—
No person shall publish or take any part in die publication of any advertisement which relates to the
use of any drug or contains any claim in respect of therapies or treatment without the prior approval
of the licencing authority.
- 146 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Explanation.— "Advertisement" includes any notice, circular or other document displayed on or in
any
public place or public transport or published in any newspaper or periodical and any announcement
made
orally or by any means of producing or transmitting light or sound and any trade circular, insert and
level.
15. Good practices in the manufacturer and quality control of drugs.—
(1) Every manufacturer of drugs shall follow the good practices in the manufacture and quality
control of
drugs recommended by the World Health Organisation.
(2) If any manufacturer does not follow such good practices his manufactured licence may be
cancelled orsuspended.
16. Penalty for manufacture, etc., of certain drugs.—
Whoever manufactures, imports, distributes or sells—
(a) Any medicine which is not registered under this Ordinance, or
(b) Any medicine in contravention of the provisions of section 8, or
(c) Any drug which is adulterated or spurious.
shall be punishable with rigorous imprisonment for a term which may extend to ten years, or with
fine which may extend to two lac taka, or with both, and any implements used in the manufacture or
sale of such medicine or drug may, by order of the Drug Court, be forfeited to the Government.
17. Penalty for manufacture or sale of sub-standard drugs.—
Whoever manufactures or sells any sub-standard drug shall be punishable with rigorous
imprisonment for a term which may extend to live years, or with fine which may extend to one lac
taka, or with both.
18. Penalty for un-authorised import of drugs.—
Whoever imports any drug or pharmaceutical raw material without the prior approval of the
licencing authority shall be punishable with rigorous imprisonment for a term which may extend to
three years, or with fine which may extend to fifty thousand taka, or with both and such drug or raw
material may be order of the Drug Court, be forfeited to the Government.
19. Penalty for sale of medicine or import or sale of pharmaceutical raw material at a higher
price.—
Whoever sells any medicine or imports or sells any pharmaceutical raw material at a price higher
than the maximum price fixed by the Government under section 11 shall be punishable with
rigorous imprisonment for a term which may extend to two years, or with fine which any extend to
ten thousand taka, or with both.
20. Penalty for theft, etc., of Government drugs.—
Whoever commits theft in respect of any drug in any Government store, hospital, clinic or health
centre or sells any such drug or keeps in his possession any such drug for sale shall be punishable
- 147 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
with rigorous imprisonment for a term which may extend to ten years, or with fine which may
extend to two lac taka or with both.
21. Penalty for illegal advertisement and claims.—
Whoever contravenes the provision of section 14 shall be punishable with fine which may extend to
twenty-five thousand taka.
22. Cognizance of offences.—
Notwithstanding anything contained in the Code of Criminal Procedure, 1898 (V of 1898),—
(a) An offence punishable under this Ordinance shall be non-cognizable:
(b) No Court oilier than a Drug Court shall try an offence punishable under this Ordinance:
(c) No Drug Court shall take cognizance of an offence punishable under this Ordinance except on a
report in writing made by the licencing authority or ;in officer authorised by him in this behalf.
23. Drug Courts.—
(1) The Government may, by notification in the official Gazette establish as many Drug Courts as it
considers necessary and where it establishes more than one Drug Court shall specify in the
notification the territorial limits within which each one of them shall exercise jurisdiction under this
Ordinance.
(2) A Drug Court shall consist of a person who is or has been a Sessions Judge and he shall be
appointed by the Government.
(3) A Drug Court shall sit at such place as the Government may direct.
(4) A Drug Court may pass any sentence authorised by this Ordinance and shall have all the powers
conferred by the Code of Criminal Procedure, 1898 (V of 1898), on a Court of Session exercising
original jurisdiction.
(5) A Drug Court shall not, merely by reason of a change in its composition, be bound to recall and
rehear any witness who has given evidence, and may act on the evidence already recorded by or
produced before it.
(6) A Drug Court shall, in all matters with respect to which no procedure has been prescribed by
this
Ordinance, follow the procedure prescribed by the Code of Criminal Procedure, 1898 (V
of 1898). for the trial of summons cases by Magistrates.
(7) A. Drug Court may, on application in ill is behalf being made by the prosecution.try an offence
under this Ordinance summarily in accordance win the provisions contained in sections 262 to 265
ol the Code of Criminal Procedure, 1898 (V of 1898).
(8) An appeal from the judgement of a Drug Court shall lie to the High Court Division.
24. National Drug Advisory Council, —
1) The Government shall constitute a National Drug Advisory Council consisting of a Chairman
and such oilier members as it may appoint from time to lime.
(2) The Council shall advise the Government on—
(a) measures to be adopted for the implementation of the national drug policy that may be adopted
by the Government from time to time;
(b) measures for the promotion of local pharmaceutical industries and production and supply of
essential drugs for meeting the needs of the country.
(c) matters relating to the import of drugs and pharmaceutical raw materials.
- 148 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
(d) measures for the co-ordination of the activities of the various Ministries, agencies and persons
dealing with manufacture, import, distribution and sale of drugs.
25. Power to make rules. —
The Government may, be notification in the official Gazelle, make rules for carrying out the
purposes of this Ordinance.
- 149 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex XI - Incentives and facilities for the foreign investors
Facilities / INCENTIVES:
(a) For Foreign Direct Investment, there is no limitation pertaining to foreign equity participation,
I.E. 100% Foreign Equity is allowed. Non resident institutional or individual investors can
make portfolio investments in Stock Exchanges in Bangladesh. Foreign investors or companies
may obtain full working loans from local banks. The terms of such loans will be determined on
the basis of bank-client relationship.
(b) A foreign technician employed in foreign companies will not be subjected to personal tax up to
3 (three) years , and beyond that period his/ her personal income tax payment will be governed
by the existence or non-existence of agreement on avoidance of double taxation with country of
citizenship. Exemption of income tax up to 3 years for the foreign technicians employed in
industries specified in the relevant schedule of income tax ordinance.
Tax exemption on income of the private sector power generation company for 15 years from
the date of commercial production
(c) Full repatriation of capital invested from foreign sources will be allowed. Similarly, profits and
dividend accruing to foreign investment may be transferred in full. If foreign investors reinvest
their repatriable dividends and or retained earnings, those will be treated as new investment.
Foreigners employed in Bangladesh are entitled to remit up to 50 percent of their salary and
will enjoy facilities for full repatriation of their savings and retirement benefits.
(d) Foreign entrepreneurs are, therefore, entitled to the same facilities as domestic entrepreneurs
with respect to tax holiday, payment of royalty, technical know-how fees etc.
Tax holiday:
Tax holiday facilities are available for 5 or 7 years depending on location of the industrial
enterprise.
Accelerated depreciation:
Industrial undertakings not enjoying tax holiday will enjoy accelerated depreciation allowance.
Other incentives:
•
Tax exemption on royalties, technical know-how fees received by any foreign collaborator,
firm, company, an expert.
•
Tax exemption on the interest on foreign loans under certain conditions.
•
Avoidance of double taxation in case of foreign investors on the basis of bilateral agreements.
(e) The process of issuing work permits to foreign experts on the recommendation of investing
foreign companies or joint ventures will operate without any hindrance or restriction. Multiple
entry visa" will be issued to prospective foreign investors for 3 years. In the case of experts,"
multiple entry visa" will be issued for the whole tenure of their assignments.
(f) Citizenship by investing a minimum of US $ 500,000 or by transferring US$ 1,000,000 to any
recognised financial institution ( Non-repatriable ).
- 150 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
(g) Permanent residentship by investing a minimum of US$ 75,000 ( Non-repatriable).
(h) Tax exemption on capital gains from the transfer of shares of public limited companies listed
with a stock exchange.
(i) Special facilities and venture capital support provided to export-oriented industries under
“Thrust sectors”.Thrust Sectors includes:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
Agro-based industries,
Artificial flower-making,
Computer software and information technology,
Electronics,
Frozen food,
Floriculture,
Gift items,
Infrastructure,
Jute goods,
Jewellery and diamond cutting and polishing,
Pharmaceuticals ,
Leather,
Oil and gas,
Sericulture and silk industry,
Stuffed toys,
Textiles,
Tourism.
Incentives to export-oriented and export-linkage industries:
•
Concession on duty rate for import of capital machineries and spare parts.
•
Bonded Warehouse and back-to-back Letter of Credit allowed.
•
Duty drawback on exportable and potentially exportable goods
•
Easy availability of loans up to 90 percent of the value against irrevocable and confirmed Letter
of Credit/Sales Agreement.
•
Incentives to the “deemed exporters” supplying indigenous raw materials to export-oriented
industries.
•
The export-oriented industries are entitled to receive additional foreign exchange on a case by
case basis for publicity campaign in opening overseas offices and participating in international
trade fairs.
•
Export earning from handicrafts and cottage industries is exempted from income tax. For all
other industries, income tax rebate on export earnings is given at 50 percent.
•
Import of raw materials, which are included in the banned / restricted list, will be allowed if
required in the manufacture of exportable commodities.
•
Specified quantities of duty-free samples for manufacturing exportable products are allowed.
•
Locally manufactured products supplied to local industries or projects against foreign exchange
payment or foreign exchange L/C is treated as indirect exports.
- 151 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
•
Export Credit Guarantee Scheme.
•
10 percent of production of enterprises, located in both public and private EPZs is allowed to be
exported to domestic tariff area against foreign currency L/C on payment of applicable duties
and taxes.
•
100% percent export-oriented industry outside EPZ is allowed to sell 20% percent of their
products in the domestic market on payment of applicable duties and taxes.
•
The Export-oriented industries which are identified by the government as “Thrust Sector” are
provided special facilities and venture capital support.
- 152 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex XII - Composition of Board of Directors of EDCL
The Board is comprised of 8 members follows:
1. Minister of Health & Family welfare
2. Secretary, Ministry of Health & Family welfare
3. Additional Secretary, Ministry of Health and Family Welfare
4. Director General, Ministry of Health & Family welfare
5. Director General, Family Planning
6. Director, Drug Administration
7. Director, Central Medical Store Depott
8. Managing Director, Essential Drugs Company Limited.
- 153 -
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
Annex XIII - Bangladesh Healthcare And Pharmaceutical Sector:
At A Glance
Particulars
Total Area of Bangladesh
Population more than
Crude Birth Rate (CBR)
Crude Death Rate (CDR)
Per Capita Annual Income (CAI)
Total National Export
Total National Import
Number of Countries Exported (P/ products)
Total Number of Registered P/Industries
Total Number of P/Industries in operation
Total Market Size
Percentage of Production of Local Industries
Percentage of Import against local market
Number of generics/substances registered
Number of drugs controlled
Number of drugs decontrolled
Number of drugs mostly demanded
Number of Industries producing raw materials
Number of API being produced
Drugs produced in generic Name
Drugs produced in brand Name
Drugs produced in dosage form and strength
(number )
Contribution to the revenue sector
Contribution to the GDP
Total Employment Creation (more than)
Number of Licensed Chemist (Drug seller)
Number of Chemist without License
- 154 -
Number/Quantity
147,570
140.6
20
5
482
12177.861
16532.9762
68
239
161
600
98.5%
1.5%
600
117
483
50
21
40
600
8,000
10,914
generic items
generic items
generic Items
generic Items
companies
Items
items
items
items
5.00
1.25
100,000
75,000
52,000
US$
percentage
nos.
nos.
nos.
Sq.Km
Million
(per 1000)
(per 1000)
(in US$)
million US$
million US$
nos.
nos.
nos.
million US$
Supply and demand survey on pharmaceuticals and natural products - Bangladesh
REFERENCES
1. Bangladesh Economic Survey 2007
2. Revised National Drug Policy 2005
3. National Drug Policy 1982
4. Souvenir Publication on ‘Asia Pharma Expo 2007’
5. Annual Reports of Bangladesh Export Promotion Bureau
6. Annual Report of Bangladesh Association of Pharmaceutical Industries (BAPI)
7. Annual Reports of leading pharmaceuticals companies
8. Foreign Trade Statistics of Bangladesh: Bangladesh Bureau of Statistics.
9. Annual Import Payment 2004-2005, 2005-06, Statistics Department, Bangladesh Bank.
10. Annual Export Receipts 2004-2005, 2005-06 Statistics Department, Bangladesh Bank
11. Statistical Bulletin, Bangladesh Bureau of Statistics
12. Statistical Year Book of Bangladesh Bureau of Statistics
13. Export Policy 2006-2009
14. Import Policy 2006-2009.
15. Bangladesh Bank Bulletin
16. Annual Publication of Hamdard Laboratories (WAQF) Bangladesh.
17. Articles of various newspapers on pharmaceuticals and health care
18. Web site of ITC and other international trade promotion organizations
19. Memorandum and Articles of Association of the trade body (BAPI)
20. Publications of Quality and ISO Experts
21. Study reports on Pharmaceutical and herbal sector
22. News paper articles on Pharmaceutical and herbal sector
23. Publications of professionals in Pharmaceutical sector
24. Publications of Researchers in Pharmaceutical sector
25. Bangladesh Investment HANDBOOK, Board of Investment Bangladesh National Formulary
2006 Published by Directorate of Drug Administration in association with Banagldesh Medical
Association and Bangladesh Pharmaceutical Society27report of BAPI
26. Medicinal Plant Marketing in Bangladesh prepared by IFC, World Bank , SDC and SEDF
- 155 -
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Md. Faruquzzaman, Manager MID
Company name:
Ambee Pharmaceuticals Ltd
Street – POB:
184/1, Tejgaon I/A
City – Country:
Dhaka, Bangladesh
Email:
Tel: 88028827777
Fax: 88028827777
Year established: 1976
Bank Ref: Eastern Bank
Legal status: Private Limited
Website:
Other office(s) location(s): Tejgaon, and
Headquarters location: Gulshan
www.ambeepharma.com
other 7 sales offices all over the world
Quality certification (ISO; GMP):
Annual turnover (USD):
Share exported (%):
ISO, GMP
Current export/import markets:
Myanmar, India, China, Italy
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email:
anirbanmedicinalindustries@yaho
o.com
Year established: 1984
Website: www.anirban-bd.com
Dr. Selim Mohammad Shajahan
Anirban Medical Industries
1086/3B, East Jurain, Baganbari
Dhaka-1204, Bangladesh
Tel: 7415525, 7420460
Fax: 7420460
Bank Ref: Janata
Legal status: Pvt. LC
Other office(s) location(s): Sales Office
Headquarters location: Dhaak
Quality certification (ISO; GMP):
Annual turnover (USD): 3.6 cr Taka
Share exported (%): 0%
Current export/import markets:
Local
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: aplhc@bangla.net
Year established: 1978
M.A. Hassan, Chairman & Managing Director
Aristopharma Ltd
Plot#21, Road# 11, Shampur-Kadamtali I/A
Dhaka-1204, Bangladesh
Tel: 9351691-3
Fax: 8317005
Bank Ref: National Bank
Legal status: Pvt Ltd Com
Other office(s) location(s): Noakhali,
Chittagong, Cox'sbazar, Cml, Kln, Jsr, Brs,
Headquarters location: Dhaka
Fdr, Bgr, Raj
Website:
www.aristopharma.com
Quality certification (ISO; GMP):
ISO 9001:2000, GMP
Annual turnover (USD): 15 million
Share exported (%): 2.5%
Germany, Spain, Italy, China, India, Singapore, Hong Kong, Ukraine, Maccao, Vietnam, Sri
Lanka
Registration with export promotion bodies, chambers of commerce, business associations (specify):
MCCI, BASS
Current export/import markets:
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: akhter@beaconharma.com
Year established: 2001
Mohammad Akhter Hussain
Beacon Pharmaceuticals Ltd
153-154 Tejgaon 1/A
Dhaka-1208, Bangladesh
Tel: 88-02-988 8494 / 988 8176 / 0171 404
1393
Bank Ref: Janata Bank
Website: www.beaconharma.com
Headquarters location: Tejgaon
Legal status: Private Limited
Other office(s) location(s): Bhaluka, Banani
and other sales offices all over the country
Quality certification (ISO; GMP):
WHO GMP
Annual turnover (USD): New company
Share exported (%):
Fax: 88-02-882 9314
Import from China, Germany, Korea, India, Japan, UK, USA, ETc. Export: Registration
procedure has been started to Myanmar, Sri Lanka, Libya, Tanzania, etc
Registration with export promotion bodies, chambers of commerce, business associations (specify):
Current export/import markets:
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: info@bpl.net
NAZMUL HASSAN; CHIEF EXECUTIVE OFFICER
BEXIMCO PHARMACEUTICALS LTD
19 DHANMANDI R/A, ROAD NO. 7
DHAKA-1205, BANGLADESH
Tel: +880-2-8619 151-5
Fax: +880-2-8613888, 880-2-8614601
Bank Ref: Janata Bank Local Office 1
Year established: 1976
Legal status: Public Limted Company
Dilkush C/A, Dhaka-1000
Other office(s) location(s): Corporate
Website:
Headquarters location: 19 Dhanmondi R/A,
Headquarter: 17 Dhanmondi R/A, Road
www.beximcopharma.com
Road No. 7, Dhaka
No. 2, Dhaka 1205
Annual turnover (USD): 52,890,245 (in
Quality certification (ISO; GMP):
Share exported (%): 3.16
GMP, ISO 9001:2000
2006)
Export Market: Singapore, Hong Kong, Kenya, Myanmar, Nepal, Sri Lanka, Cambodia,
Current export/import markets:
Botswana, Pakistan, Yemen, Philippines, Jordan, PNG, Somali, Belize, Ghana, Fiji, Bhutan
Registration with export promotion bodies, chambers of commerce, business associations (specify):
FBCCI, DCCI, EPB
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email:
ngrintra@biopharmabd.com
Year established:
Saiful Huq Rushdi, Executive International Marketing
BIOPHARMA Laboratories Ltd
7/16, Block-B, Lalmatia
Dhaka-1207, Bangladesh
Website:
Tel: 815953, 8150928
Fax: 9134684
Bank Ref:
Legal status:
Other office(s) location(s):
Headquarters location:
Quality certification (ISO; GMP):
Annual turnover (USD):
Share exported (%):
Current export/import markets:
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: saifuland@yahoo.com
Year established: 1980
Mr. Saiful Islam, President
Daffodil Health Care
BCIC Bhaban (19th floor), 30-31, Dilkusha C/A
dhaka, Bangladesh
Tel: 9568523, 9558580
Fax: 9561851
Bank Ref: AB
Legal status: Private Co.
Other office(s) location(s):
Headquarters location: Dhaka
Website:
Quality certification (ISO; GMP):
Annual turnover (USD):
Share exported (%):
Current export/import markets:
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email:
Year established:
Mahmud Hasan, International Business Manager
Eskayef Bangladesh Ltd
Dhaka, Bangladesh
Tel: 9882843, 01714041393
Bank Ref: HSBC
Website: www.skfbd.com
Headquarters location: Gulshan, Dhaka
Fax: 9897864
Legal status: Private Ltd
Other office(s) location(s): Banani, Mirpur,
Tongi and other 23 sale offices all over
Bangladesh
Quality certification (ISO; GMP):
Annual turnover (USD):
Share exported (%):
WHO, GRIP
Current export/import markets:
41 Million
Registration with export promotion bodies, chambers of commerce, business associations (specify):
Sri Lanka, Germany, Vietnam, UAE, Iraq, Belize, Guatemala, Nepal
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: edcl@bttb.net.bd
Year established:
Col. Meheboobul Hoque, Managing Director
Essential Drugs Co. Limited
395-397, Tejgaon Industrial Area
Dhaka-1208, Bangladesh
Tel: 9130489, 9130490, 9130036
Bank Ref: Prime, Shahjalal, Sonali
Website:
Headquarters location: Dhaka
Fax: 8119697
Legal status: Public Limited Co.
Other office(s) location(s): Gogura, Khulna
Quality certification (ISO; GMP):
Annual turnover (USD): 200 cr. Tk.
Share exported (%): Negligible
GMP, UNICEF
Current export/import markets:
Bhutan, Myanmar, China, India, Germany, Korea, Switzerland
Registration with export promotion bodies, chambers of commerce, business associations (specify):
BAPI
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify): Joint production
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email:
exceedherbal@yahoo.com
Year established: 2005
Md. hasan Imam Khan; Chief Executive Officer
Exceed
161, Lake Circus (Kalabagan), Mirpur Road
Dhaka-1205, Bangladesh
Website: N/A
Tel: 88 02 9131997, 88 01711-640683
Fax: N/A
Bank Ref: EBL
Legal status: Partnership Company
Other office(s) location(s):
Headquarters location: Kalabagan
Quality certification (ISO; GMP):
Annual turnover (USD): 8,000 US$
Share exported (%): N/A
N/A
Current export/import markets:
N/A
Registration with export promotion bodies, chambers of commerce, business associations (specify):
N/A
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: msid@etclbd.com
Year established: 1972
M.S.I. Dastagir, Executive Vice-President & CEO
Excelsior Trading
345, Segun Bagicha
Dhaka, Bangladesh
Tel: 8316805, 8316271, 9353485
Fax: 8313687, 9330909
Bank Ref: Standard Chartered
Legal status: Pvt Ltd Co
Other office(s) location(s): Chittagong,
Headquarters location: Dhaka
Singapore, Changhai
Website: www.etclbd.com
Quality certification (ISO; GMP):
Annual turnover (USD): US$ 37.5 m
Share exported (%):
ISO
Current export/import markets:
EU, China, India, USA, Korea, Malaysia
Registration with export promotion bodies, chambers of commerce, business associations (specify):
DCCI
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: ferdousbt@gmail.com
Year established: 2001
Ferdosi Begum Ph.D
Ferdous Biotech Pvt. Ltd
Bangladesh
Tel: 8114827
Bank Ref: NCC Bank
Website:
Headquarters location:
Quality certification (ISO; GMP):
Fax: 8115155
Legal status:
Other office(s) location(s):
Annual turnover (USD):
Share exported (%):
Current export/import markets:
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email:
Year established:
Dr. Md. Niamat Ali Fakir, Associate Prof.
Govt. Homeopathy Medical College & Hospital
Tel: 9001150, 01819562640
Bank Ref:
Website:
Headquarters location: Dhaka
Quality certification (ISO; GMP):
Fax:
Legal status: Govt.
Other office(s) location(s):
Annual turnover (USD):
Share exported (%):
Current export/import markets:
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: nishun@dhaka.net
Year established: 1983
Md. Nurul alam, Managing Director
Grand Corporation (Pvt) Ltd
95, Motijheel C/A (3rd floor)
Dhaka, Bangladesh
Tel: 9558593, 9563463, 9568079
Bank Ref: UCBL
Website:
Headquarters location:
Quality certification (ISO; GMP):
Annual turnover (USD): 25m
Fax: 9565118, 9568124
Legal status: Private Limited Co.
Other office(s) location(s):
Share exported (%):
Current export/import markets:
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: hpl@ugc-bd.net
Year established: 1997
Website: www.hallmarkpharmabd.com
Md. iftekharul Islam, Director Operations
Hallmark Pharmaceuticals Ltd
Uttara Centre, 102, Shahid Tajuddin Ahmed Sarani (3rd floor), Tejgaon I/A
Dhaka, Bangladesh
Tel: 8115425, 8142694
Fax: 9130917
Bank Ref: Dutch Bangla
Legal status: Private Ltd
Other office(s) location(s): 9 sales offices all
Headquarters location: Dhaka
over the country
Quality certification (ISO; GMP):
Annual turnover (USD): 1.43m US$
Share exported (%):
WHO, GMP
Current export/import markets:
Myanmar
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: hamdard@bdmail.net
Year established: 1906
Rafiqul Islam
Hamdard Laboratories (WAQF) Bangladesh
99, Bir Uttam C.R. Datta Road
Dhaka-1205, Bangladesh
Tel: 9665965-66
Bank Ref: Islami
Website: www.hamdard-bd.com
Headquarters location: Dhaka
Fax: 9669823
Legal status: WAQF
Other office(s) location(s):
Quality certification (ISO; GMP):
Annual turnover (USD): 20,00,000
Share exported (%): Nill
ISO
Current export/import markets:
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: jpl@jaysonbd.com
Year established: 1956
MR. MD. SALIMULLAH, MANAGING DIRECTOR
JAYSON PHARMACEUTICALS LTD
28 PURANA PALTAN
DHAKA-1000, BANGLADESH
Tel: +(88 02) 956 1643
Fax: +(88 02) 956 0491, 956 2482
Bank Ref: ONE BANK LTD
Legal status: LIMITED COMPANY
Other office(s) location(s): 15 BRANCH
Headquarters location: 28 PURANA
OFFICERS ACROSS BANGLADESH
PALTAN, DHAKA
Website: www.jaysonbd.com
Quality certification (ISO; GMP):
Annual turnover (USD): 9.1 MILLION
Share exported (%): 13.08%
ISO; GMP
Current export/import markets:
EXPORT TO COUNTRIES OVER 16.
Registration with export promotion bodies, chambers of commerce, business associations (specify):
EXPORT REGISTRATION CERTIFICATE (ERC), DCC&I, BANGLADESH ASSOCIATION OF PHARMACEUTICAL
INDUSTRIES.
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify): Financial investor
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: sak@bol-online.com
Year established: 1974
Shabbir Ahmed Khan, Chief Executive
Khan & Deen Traders
9/29 Eastern Plaza, Sonargaon Road
Dhaka, Bangladesh
Tel: 8618781, 8618783
Bank Ref:
Website:
Headquarters location: Dhaka
Quality certification (ISO; GMP):
Annual turnover (USD): 5 mil
Fax: 8610522, 8610786
Legal status: Ownership
Other office(s) location(s):
Share exported (%):
Current export/import markets:
Pharmaceuticals
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Dr. Md. Mahadiz Zaman (Mahadi)
Company name:
Meena Herbal Products
Street – POB:
719/A, Satmosjid Road, Dhanmondi
City – Country:
Dhaka-1209, Bangladesh
Email: mahadidr@yahoo.com
Tel: 9138242-3
Fax: 9115242
Year established:
Bank Ref: NCC Bank
Legal status: Pvt. LC
Website:
Other office(s) location(s):
Headquarters location:
www.meenaherbal.com
Quality certification (ISO; GMP):
Annual turnover (USD):
Share exported (%): 0%
STI, Du, Drug Licence
Current export/import markets:
India, Pakistan
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Md. Sami Akhtar, Asstt. Manager Export
Company name:
Navana Pharmaceuticals Ltd
Street – POB:
3/C, Purana Paltan
City – Country:
Dhaka, Bangladesh
Email: md@navanapharma.com
Tel: 9557410, 9562714, 7160411
Fax: 9569113
Year established:
Bank Ref: Eastern Bank
Legal status:
Website:
Other office(s) location(s):
Headquarters location: Dhaka
www.navanapharma.com
Quality certification (ISO; GMP):
Annual turnover (USD): 60 Cr Tk
Share exported (%): 0.8m US$
ISO
Current export/import markets:
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: iinh@gnbd.net
Year established: 2000
Website: www.neemkimya.com
Quality certification (ISO; GMP):
Dr. M.A. Hakim, Chairman
Neem Laboratories (Pvt) Ltd
House # 497, Road # 33, New DOHS, Mohakhali
Dhaka, Bangladesh
Tel: 8856894
Fax: 8815281
Bank Ref: Agrani
Legal status: Registered with joint stock
Other office(s) location(s):
Headquarters location: Dhaka
Annual turnover (USD):
Share exported (%): 1.5%
Current export/import markets:
Gulf region, Japan
Registration with export promotion bodies, chambers of commerce, business associations (specify):
EPB & DCCI
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: monjur@renata-ltd.com
Year established:
Monjurul Alam, International Business Manager
Renata Limited
House-450, Road-31, New DOHS, Mohakhali
Dhaka, Bangladesh
Tel: 8850918-9, 9860914-5
Fax: 8815210
Bank Ref: HSBC
Legal status:
Other office(s) location(s):
Headquarters location: 50 M
Website:
Quality certification (ISO; GMP):
Annual turnover (USD):
Share exported (%): 5%
Current export/import markets:
Sri Lanka, Vietnam, Kenya, China, India, EU
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: mynul@squaregroup.com
Year established:
Md. Mynul Islam, Sales Coordinator
Square Herbal & Nutraceuticals Ltd
48, Mohakhali C/A
Dhaka, Bangladesh
Tel: 8833047-56, 8859007
Bank Ref:
Website:
Headquarters location:
Quality certification (ISO; GMP):
Annual turnover (USD): 101.90
Fax: 8828768, 8828609
Legal status:
Other office(s) location(s):
Share exported (%):
Current export/import markets:
UK
Registration with export promotion bodies, chambers of commerce, business associations (specify):
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org
COMPANY PROFILE FORM
“ASIAHEALTHCARE 2008”
Malaysia, March 2008
Name and Title:
Company name:
Street – POB:
City – Country:
Email: mahbubsaki@yahoo.com
Year established: 1953
Mahbubur Rahman Saki
The Acme Laboratories Ltd
1/4, Kallyanpur, Mirpur Road
Dhaka, Bangladesh
Tel: 9004 194-6, 9004748
Bank Ref: Standard Chartered, HSBC
Website:
Headquarters location: Dhaka
Fax: 9016515
Legal status: Private Limited Co.
Other office(s) location(s): 15 offices
Quality certification (ISO; GMP):
Annual turnover (USD):
Share exported (%): 10%
ISO, ANSI, ASQC
Current export/import markets:
Turkey, Vietnam, Sri Lanka, Singapore, Ethiopia, etc.
Registration with export promotion bodies, chambers of commerce, business associations (specify):
FBCCI, DCCI, BAPI
ACTIVITIES
Manufacturer/Producer
Wholesaler/Retailer
Trader
Service provider: quality control, packaging, machinery, business
information (specify):
EXPORT/IMPORT INTEREST
Active
Pharma
Ingredients
(API)
ESSENTIAL DRUGS
1
Anaesthetics:
General anaest. & oxygen
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Formulas/
Finished
Products
Local anaesthetics
Preoperative med. and sedation
Analgesics, Antipyretics, Anti-inflammatory, Non-steroidal (NSAIMs), medicines used to treat
gout and disease modifying agents in rheumatoid disorders (DMARDs):
NSAIMs
Opioid analgesics
Used to treat gout
DMARDs
Antiallergics and medicines used in anaphylaxis
Antidotes and other substances used in poisoning:
Non-specific
Specific
Anticonvulsants / Antiepileptics
Anti-Infective medicines:
Anthelminthics
Antibacterials
Antifungal
Antiviral
Antiprotozoal
Antimigraine medicines:
For treatment of acute attack
For prophylaxis
Antineoplastic, Immunosuppressives and medicines used in palliative care:
Immunosuppressive
Cytotoxic medicines
Hormones and antihormones
Medicines used in palliative care
Antiparkinsonism medicines
Medicines affecting the blood:
Antianaemia medicine
Medicines affecting coagulation
Blood products and plasma substitutes:
Plasma substitutes
Plasma fractions for specific use
Cardiovascular medicines:
Antianginal
Antiarrhythmic
Antihypertensive
Used in heart failure
Antithrombotic
Lipid-lowering
Dermatological medicines:
Anti-inflammatory
Antifungal
Anti-infective
/antipruritic
Astringent
Skin differentiation /proliferation
Scabicides/pediculicides
Ultraviolet
Diagnostic agents:
Ophthalmic
Radiocontrast media
Disinfectants and Antiseptics:
Antiseptics
Disinfectants
Diuretics
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
17
Gastrointestinal medicines:
18
Antacids and other antiulcer
Antiemetic
Laxatives
Used in diarrhoea
Hormones, other endocrine medicines and contraceptives:
Adrenal/synthetic substitutes
Estrogens
Anti-inflammatory
Androgens
Contraceptives
Insulins/oth. Antidiab.agents
Ovulation inducers
Progestogens
Immunologicals:
20
Diagnostic agents
Sera and immunoglobulins
Muscle relaxants (Peripherally-acting) and cholinesterase inhibitors
21
Ophthalmological preparations:
22
Anti-infective agents
Miotics and antiglaucoma
Oxytocics and Antioxyytocics:
23
Oxytocics
Peritoneal Dialysis Solution
24
Psychotherapeutic medicines:
Anti-inflammatory agents
Mydriatics
Local anaesthetics
Used in mood disorders
Used in obsess. compulsive disorders &
panic attacks
Used in generaliz. anxiety & sleep disorders
27
Vaccines
Antioxytocics (tocolytics)
Used in psychotic disorders
26
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
I
E
Thyroid hormones/antithyroid medicines
19
25
I
Used in substance dependence programmes
Medicines acting on the respiratory tract
Antiasthmatic and medicines for chronic
Other medicines acting on the respiratory
obstructive pulmonary disease
tract
Solutions correcting water, electrolyte and acid-base disturbances:
Oral
Parenteral
Miscellaneous
Vitamins and Minerals
NATURAL RAW MATERIALS, EXTRACTS & OILS
28
30
32
34
36
38
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
80
82
84
Ajowan (seed) fruit (Trachyspermum ammi)
Aloe Vera ( A.vulgaris lam)
Amla fruit (Phyllanthus emblica)
Arjuna (Terminalia arjuna)
Artemisia (Artemisia annua)
Asafoetida oleoresin (Ferula asafoetida) or Oleogum resin
Ashwaagandha (Withania somnifera)
Astragalus root pwd (Astragalus membranaceus)
Belleric myrobalan fruit (Terminalia bellerica
Bosewellia (Bosewellia serrata)
Caralluma extract(Caralluma fimbriata)
Chebulic myrobalan fruit (Terminalia chebula)
Cherokee rose hip (Rosa laevigata)
Chicory root (Cichorium intybus)
Chinese Hibiscus (Hibiscus rosasinensis)
Chirata herb (Swertia chirayita)
Corydalis (Corydalis yanhusuo)
Dang gui (Angelica sinensis)
Eleuthero root (Eleutherococcus senticosus)
Epimedium herb (Epimedium brevicornum)
Garcinia Fruit (Garcinia bambogea)
Garlic bulb (Allium sativum)
Ginger rhizome (Zingiber officinale
Ginkgo leaf (Ginkgo biloba)
Ginseng root (Panax ginseng)
Green tea (Camellia sinensis)
Gotu Kola (Centella asiatica)
Guduchi (Tinospora cordifolia)
Guggul (Commiphora mukul)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
Gymnema (Gymnema sylvestre)
Gynostemma herb (Gynostemma pentaphyllum)
Hawthorn (Fructus crataegi)
Hop strobile (Humulus lupulus)
Jujube date powder (Ziziphus jujuba)
Kelp thallus (Laminaria japonica)
Kudzu root ( pueraia lobata)
Licorice root (Glycyrrhiza uralensis)
Lycium fruit (Lycium barbarum)
Madagascar Periwinkle (catharanthus roseus)
Magnolia bark (Magnoliae officinalis)
Manjishta (Rubia cordifolia)
Neem leaf (Azadirachta indica)
Niuri (Phyllanthus amarus)
Parmelia lichen extract (Parmelia cryptochloropbaea)
Prisniparni (Uraria picta)
Psyllium husk (plantago ovata)
Rhodiola (Rhodiola rosea)
Safed musli tuber (Chlorophytum borivillianum
Sandalwood heartwood (Santalum album)
Sargassum alga (Sargassum pallidum)
Sarpagandha (Rauwolfia serpentia)
Schisandra fruit (Schisandra chinensis)
Sea buckthorn (Hippophae rhamnodies)
Shatavari root (Asparagus racemosus)
Star anise fruit (Illicium verum)
Tribulus terrestris (Tribulus zygophyllacae)
Vanilla fruit (Vanilla planifolia)
Velvet bean (Mucuna pruriens)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
EXCIPIENTS
86
88
Binders (pre gelatinized cellulose, lactose)
Compression aids (dextrose, lactose, microcrystalline
cellulose)
I
E
87
Colors (titaium dioxide)
I
E
I
E
89
Disintegrants (sodium starch glycolate, croscarmellose)
I
E
I
E
I
E
I
E
I
I
E
E
90
Fillers/diluents (dicalcium phosphate, starches sucrose)
I
E
91
92
Flavours (Sodium chloride, citric acide)
I
E
93
94
Lubricants (Magnesium stearate, talc)
I
E
95
96
98
Suspensing / dispersing agents (gelatins, starches, gums)
I
E
97
Others (specify):
Film formers/coating (maltodextrin, hydroxyl, methyl
prophyl cellulose
Glidants (flow enhancers) (silicon dioxide, cellulose,
titanium dioxide, talc)
Preservatives (citric acid, sodium citrate, methyl
paraben)
Sweeteners (surcrose, fructose, dextrose annitol)
INTEREST IN OTHER BUSINESS PARTNERSHIPS
My company is seeking for:
My company is offering:
Joint sourcing
Joint distribution
Complementary production
Concerted marketing / promotion
Technology transfer
Development of new product / technology
Product registration
Contract manufacturing
Other (specify):
OTHER INFORMATION
To obtain maximum benefit from your participation in “AsiaHealthCare 2008”, it is highly important that you bring full
details regarding your product specifications and quality standards, indicative prices, stock availability, production
capacity, information about your company, and customer references. You may also wish to bring a large supply of
business cards and brochures, which will contribute to the success of your business consultations. Space for the
display of a limited range of samples will be available. A detailed programme and request to confirm your
participation will be sent to you within the next weeks. For more information, please contact ITC at:
betemps@intracen.org